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Abstract 
Gene trapping in murine embryonic stem (ES) cells provides a method to create random insertional 
mutations in mice which are easily accessible to molecular characterisation. This approach involves 
electroporating a reporter gene construct into ES cells which is transcribed following integration into 
an endogenous transcription unit. In an effort to understand the molecular mechanisms that mediate 
cellular interactions during development I have used a modified gene trap vector, the secretory trap 
vector (pGT1. 8TM), to enrich for insertions in genes encoding secreted and membrane-spanning 
molecules. The selective property of this vector depends on the presence of a 680 bp fragment 
containing the transmembrane domain of CD4 fused to the bgeo reporter gene. 
Secretory trap lines were generated by electroporating pGTI . 8TM into CGR8 ES cells. The 
expression patterns of trapped genes were determined by monitoring reporter gene activity in 
chimeric embryos between 8.5d and 10. 5d of development. The endogenous genes carrying vector 
insertions were identified from the fusion transcripts using the 5 RACE. Two thirds of the 
insertions occurred in secretory molecules with the remainder in non-secretory molecules. A model is 
proposed to explain why the insertions in non-secreted genes are detected. 
The requirement for pGT1.8TM to insert into introns is likely to favour insertion into genes 
composed of large intronic regions. To detect insertions in smaller transcription units composed of 
few or no introns I developed an exon trap version of this vector (pET 1 .8TM) by removing the splice 
acceptor sequence from pGT1 .8TM. Previous reports indicated that the efficiency of gene trapping 
was reduced by 12 to 40 fold in the absence of a splice acceptor, however I obtained similar numbers 
of Bgal staining colonies following electroporation of pGT1.8TM and pET1.8TM in ES cells. In all 
eight pET 1.8TM integrations characterised deletions had occurred at the S end of the vector prior to 
integration into the genome. Deletions which interfere with reporter activity may explain the poor 
frequency of events seen with previous attempts at exon trapping and suggest that the addition of 
buffer sequences upstream of the reporter increases the efficiency of pET 1 .8TM. 
One line generated in this study, JST185, carries an insertion of pGT1.8TM and was selected 
for detailed characterisation on the basis of its spatially restricted expression pattern during 
development. The disrupted gene encodes a multimembrane spanning protein which contains a 
tandem array of tetratricopeptide repeats (TPRs), motifs shown to mediate protein-protein 
interactions. The expression pattern of JST185 during embryogenesis suggests it plays a role in 
mediating epithelial-mesenchymal interactions during development. Most animals homozygous for 
the insertion die shortly after birth due to respiratory failure. However, a few homozygous animals 
survive beyond weaning and display a striking lung pathology. 
Abbreviations 
Ac Activator hsp heat shock protein 
ATG Initiation of translation codon LTR long terminal repeat 
f3gal /3galactosidase neoR G418 resistant 
f3geo f3galactosidase and neomycin fusion PCR Polymerase Chain Reaction 
cm centiMorgan RACE Rapid Amplification of cDNA Ends 
CHL chiorambucil RFLP restriction fragment length 
CNS central nervous system polymorphism 
dpc days post coitum RPA RNase protection assay 
DNA deoxyribonucleic acid RNA ribonucleic acid 
Ds Dissociation sm-actin smooth muscle actin 
En2 mouse engrailed-2 SA splice acceptor 
ENU ethylnitrosourea SD splice donor 
ER endoplasmic reticulum SS signal sequence 
ES cells Embryonic Stem cells T Brachyury 
exon trap Ti tumour inducing plasmid 
GalTase /31,4-galactosyltransferase TPR tetratricopeptide repeat domain 
gDNA genomic DNA TM transmembrane 
GT gene trap UTR untranslated region 
Nomenclature 
Gene symbols are always italicised. All letters in human genes are upper-case; all letters in mouse 
genes are lower case, excepting the first letter. 
Protein products of genes are in Roman type; human proteins are upper-case. 
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Chapter 1 
GENERAL INTRODUCTION 
1.1 Introduction to mutational analysis of development 
Mutation analysis is a powerful tool that has been used to unravel many of the 
complexities of embryonic development. By creating mutations, the biological 
function of a single gene product can be studied in vivo. Interactions among gene 
products can also be deciphered by breeding different mutations together. Probably 
the most informative mutagenic screens have been performed in the fruiffly Drosophila 
melanogaster where the systematic isolation and analysis of mutants have revealed 
many of the genes involved in embryonic pattern formation (NU sslein-Volhard et al., 
1984). A similar large scale genetic screen has been performed in the nematode 
Caenorhabditis elegans (reviewed in Kemphues, 1988) and more recently in a 
vertebrate, the zebrafish Danio rerio (Driever et al., 1996; Haffter et al., 1996). 
During the latter screen over 400 genes essential for early vertebrate development were 
identified. Phenotypic descriptions of these mutations have already identified many of 
the morphogenetic processes which lead to vertebrate embryonic patterning. 
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However, in any genetic screen it is essential that the mutated gene be easily 
identifiable, and in zebrafish this is not straightforward at present. However, 
understanding vertebrate development, and in particular mammalian development, 
requires genetic analysis. 
An obvious candidate for a vertebrate genetic screen is the mouse as its 
detailed genetic map should allow the identification of virtually any disrupted gene. 
However, the small litter size and the relatively long generation times of mice 
compared to invertebrates make large genetic screens very costly. Consequently other 
strategies have been used to identify genes involved in early mammalian development. 
One particularly fruitful strategy has been the creation of null mutations using 
homologous recombination in embryonic stem (ES) cells (Capecchi, 1989). 
Candidate genes for targeted loss of function analysis are selected for study on the 
basis of the biochemical properties of the encoded protein, their expression patterns, 
or by extrapolation from data on the function of their homologues in other systems 
such as Drosophila (reviewed in Kessel & Gruss, 1990). Although more than 700 
genes have been disrupted in this manner (Brandon et al., 1995), the isolation and 
mapping of genomic clones and construction of targeting constructs for each candidate 
gene is labour intensive and not amenable to a large scale screen. In addition, the 
'homology cloning' approach, although very successful, will fail to identify genes 
which are specifically involved in mammalian development. Thus it is important to 
consider alternative methods to creating new mutations. 
The purpose of this introduction is to review the mutagenic strategies being 
used to generate a resource of new mouse mutants. Particular emphasis is placed on 
comparing the ease with which disrupted loci can be identified using the different 
approaches. The first section describes commonly used mutagens; radiation, DNA-
modifying chemicals and foreign DNA. The second section introduces the entrapment 
technique which involves the random integration of a vector into a transcriptional unit 
such that a reporter gene is placed under the control of endogenous regulatory 
elements. Insertions simultaneously mutate the endogenous gene and provide, a 
molecular tag to simplify its identification. Entrapment technology in the mouse 
derives in part from strategies used in other organisms, so these too are discussed. 
The advantages of applying such techniques in mouse ES cells are discussed in the 
third section. Briefly, the use of these cells allows pre-selection of mutations based on 
in vitro criteria and also allows the subsequent germline transmission of the mutation. 
The pre-selection for insertions into secreted and membrane bound proteins using a 
modified gene trap vector is discussed in the final section. 
1.1.1 	Classical mouse mutants 
The first mouse mutants to be studied arose spontaneously or were the 
offspring of mice exposed to X-rays (Lyon et al., 1996). They were identified on the 
basis of a visible mutant phenotype such as coat colour, hair morphology, gross 
behavioural defects and skeletal abnormalities. Advancing from descriptions of 
phenotype to identifying the responsible molecular lesion is the rate limiting step in 
these types of studies. In some cases the mutated genes have been identified 
serendipitously by colocalizing "candidate" genes on the physical genetic map. This 
approach identified the gene on chromosome 5 responsible for the various Dominant 
white spotting (W) phenotypes which display defects including lack of hair 
pigmentation, sterility and severe macrocytic anaemia (Chabot et al., 1988). The c-kit 
receptor tyrosine kinase was selected as a candidate gene for the W locus on the basis 
of it mapping to the human region syntenic to mouse chromosome 5 and from the 
observation that it is expressed in haematopoietic tissues. Interspecific backcross 
analysis demonstrated that the W locus is tightly linked to c-kit. Later characterisation 
confirmed the presence of point mutations in the kinase domain of c-kit which 
accounted for deficient enzyme activity in several W alleles (Reith et al., 1990). 
Another spontaneous mutant, Steel (SI), shows similar pleiotropic defects to W and 
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has been found to encode the ligand for the c-kit receptor (Huang et al., 1990). 
Analysis of the W and Sl mutants has revealed a role for Kit mediated signal 
transduction pathways in the development of haematopoietic, melanogenic and germ 
cell lineages. 
In the absence of candidate genes, mutant loci can in principle be identified by 
positional cloning. This approach depends on finding linkage to the mutant phenotype 
which can then be used to create a high resolution genetic map followed by a physical 
map. Finally the region is examined for candidate genes. The complexity of the 
mammalian genome makes such an approach a formidable undertaking. The first 
mouse gene to be positionally cloned was Brachyury (T) located on chromosome 17 
(Hermann, 1990). The adult heterozygous phenotype is a short tail. Embryos 
homozygous for the phenotype die during midgestation. The success of positionally 
cloning T was undoubtedly due to a 60 year accumulation and analysis of different 
alleles and locus rearrangements in the T region. 
Cloning of another classic mutant, the short ear locus, was aided by the 
inclusion of this gene in large specific-locus mutagenesis experiments (Russell, 1951). 
In the specific locus test, wild type animals were treated with X-rays or chemicals and 
mated to a special marker strain which is homozygous for the short ear mutation and 6 
distinct recessive coat colour markers. If a mutation is induced at one of the specific 
loci, the associated mutant phenotype is uncovered in offspring. Such experiments led 
to the identification of hundreds of new mutations that affect the short ear gene and 
closely linked coat-colour markers. A detailed linkage map was built around the short 
ear and dilute loci which was the basis of a chromosome walk (Kingsley et al., 1992). 
The gene for bone morphogenetic protein 5 (BMP-5) was identified in the short ear 
region and found to be deleted or rearranged in several independent short ear mutants 
(Kingsley et al., 1992). 
1.1.2 	"Saturation" mutagenesis 
Due to its high mutational efficiency chemical mutagenesis was used to 
generate Drosophila mutants in the saturation screen of NUsslein-Volhard and co-
workers (Nusslein-Volhard et al., 1984). In the mouse, chemical mutagens such as 
ethylnitrosourea (ENU) and chlorambucil (CHL) can induce mutations at an average 
per locus frequency of greater than 1 in 1000 which is ten fold more efficient than 
using X-irradiation and up to a thousand fold more efficient than spontaneous rates 
(Rinchik, 1991). Rather than the large chromosomal deletions and rearrangements 
induced by X-rays, ENU generates point mutations in DNA and CHL induces short 
chromosomal deletions. 
Although genetic screens for recessive phenotypes in mice are a huge 
undertaking, two regions of the mouse genome have been subjected to ENU 
mutagenesis (Shedlovsky et al., 1988; Rinchik, 1991). In the first example alleles of 
new genes were isolated from the t region of chromosome 17. The breeding strategy 
is described in Figure 1.1 A. The offspring of mutagenised males were screened 
directly for dominant mutations and a three generation breeding protocol was used to 
recover recessive mutations. From 423 mutagenised gametes 17 lethal mutations were 
recovered. This screen was a large undertaking and was aided by a number of linked 
markers and an inversion that prevents recombination yet it still failed to saturate an 
area which is equivalent to only 0.01% of the mouse genome. If a random ENU 
screen for recessive lethal mutations was to be performed without linked markers huge 
numbers of mice would be required. For example, if we presume an average litter size 
is 8 offspring, starting with only 100 mice, by the third generation 51,200 mice will 
have been generated. Such enormous numbers only make it feasible to mutagenise 
small well-defined areas containing selectable genetic markers. 
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Figure 1.1. Breeding schemes to detect ENU-induced mutations 
Recessive mutations were identified within a 15cM region of mouse chromsome 17 around the 
t region (taken from Shedlovsky et al., 1988). Chromosomal markers (proximal to distal) are: T 
(Brachyury), if (tufted), and haplotypes of the major histocompatibility complex locus a and b. 
The asterisks indicate the mutagenized chromosome. By the third generation new, recessive 
ENU-induced mutations can be detected by the absence of normal tailed, tufted H2b/H2b 
animals. 
Recessive mutations were recovered in the albino region by breeding mutagenized males to a 
mutant carrying a deletion around albino. Genetic markers include the c (albino) and cch  
(chinchilla) alleles of the albino locus. The heavily outlined box represents the G2 albino test 
class. The absence of albino progeny indicates a new recessive lethal. The G2 light chinchilla 
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In the second example Rinchik and colleagues utilised mice carrying deletions 
around the albino locus in an ENU mutagenesis screen. To recover recessive lethal 
mutations a two generation screen was devised in which the progeny of mutagenised 
males were mated to the deletion stock. As the chromosomes are genetically marked 
by coat colour the mutagenised chromosome can be tracked through the crosses. 
(Figure 1.1B). 3000 gametes were screened and 6 new lethal loci were identified. 
Repeat mutations were discovered at each newly defined locus suggesting that 
saturation mutagenesis of the region was reached. 
Breeding ENU mutagenised males to a deletion stock is a powerful way to 
create new mutants using fewer animals than the three generation crosses. However, 
it is dependent on deletion stocks covering the genome which need to be genetically 
characterised. The recent development of efficient methods to generate new 
chromosomal deletions in defined areas using site specific recombination (Ramirez-
Solis et al., 1995) or y-irradiation (You et al., 1997) should make this a feasible 
approach to take. In addition, the recovery of recessive mutations against a defined 
chromosome deletion pre-localises the mutation thus simplifying identification of the 
disrupted gene. However, less than 11 % of the genes responsible for mutant 
phenotypes have been cloned in the 900 mouse strains carrying spontaneous, radiation 
or chemical induced mutations (Dietrich et al., 1995). Currently the genetic map in the 
mouse contains over 14, 000 markers (Dietrich et al., 1995), which is equivalent to 
one approximately every 0.1 cM or 200 kb. However, as the resolution of this 
physical map increases it will undoubtedly become feasible to clone mutated genes on 
the basis of position alone. In summary, the difficulty in making the leap from mutant 
phenotype to a molecular analysis of the defect continues to pose a serious drawback 
to radiation and chemical induced mutagenic strategies. 
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1.1.3 	Insertional mutagenesis 
Insertional mutagenesis aims to alleviate problems associated with cloning 
mutant loci as the introduction of foreign DNA provides a molecular tag to simplify 
cloning. Although the mutation rate is less efficient than chemical mutagenesis the 
benefit of easy access to mutated loci makes it an attractive approach to take. 
Insertional mutations have been introduced into mice by microinjection of cloned DNA 
into zygotes to generate transgenic mice, by retroviral infection of embryos or 
embryonic stem cells and by electroporation of DNA into ES cells (reviewed in 
Rijkers et at., 1994). Approximately 5-10 % of transgenic lines and retroviral 
insertions result in mutant phenotypes. 
Although in theory transgene insertions should simplify the identification of 
the mutated gene, in reality cloning is often complicated by complex deletions, 
duplications and rearrangements which often accompany transgene insertion events. 
Nevertheless, a number of classical mutations have been identified using transgene 
insertions as a molecular tag such as limb deformity (Woychik et at., 1990), 
microphthalmia (Hodgkinson et at., 1993) and dystonia (Brown et at., 1995). In 
contrast to transgenic insertions, cloning genes interrupted by retroviral infection is 
often more straightforward. This is because the viral endonuclease which catalyses 
integration does not generate gross DNA rearrangements. Integration simply results in 
a 4-6bp duplication of cellular DNA at the integration site. 
Curiously over half the transgenic insertional mutations (13/23) have been 
found to be allelic with classical mutations (Meisler, 1992). A number of factors may 
contribute to such a high frequency of re-isolation. A major consideration is that 
transgenic insertional mutations are not made with the sole purpose of generating 
mutant phenotypes. As it is easier to characterise a phenotype that has been previously 
isolated it is likely that viable insertional mutants that exhibit visible abnormalities, like 
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most of the classical mutants, will be frequently re-isolated. Another contributing 
factor is the evidence for particular sites in the genome being more susceptible to 
insertion than others. Evidence for preferred sites comes from two sets of data which 
show that independent transgene insertion events occurred in the same genes 
(Hodgkinson et al., 1993; Krakowsky et al., 1993; Vogt et al., 1992). Interestingly 3 
out of 13 of the re-isolated classical mutations occurred on chromosome 10. In 
another report of twenty five mapped transgene insertions five occurred on 
chromosome 10 and four occurred on chromosome 6 (Rijkers et al., 1994). There is 
also strong evidence that retroviral integration is not random (discussed in Section 
1.3.2 b). Such biases would make saturation mutagenesis hard to achieve. 
1.2 Entrapment technology 
Although the methods for insertional mutagenesis described in the previous 
section allow the mutated locus to be cloned from genomic DNA, the identification of 
genes from flanking sequences remains time consuming. To allow rapid identification 
of mutated genes, entrapment vectors have been developed (reviewed in Skarnes, 
1990). These vectors contain a reporter gene which can only be expressed if the 
vector integrates into a gene or close to cis-acting elements in the genome. Such 
vectors can create reporter fusion transcripts with endogenous genes allowing direct 
identification of the mutated locus thus alleviating the problem of searching for exons 
in large flanking genomic DNA. 
Expression of some genes which are known to be important for specific 
developmental processes exquisitely reflect their function in those tissues. For 
example, at the onset of gastrulation Brachyury (T) is expressed in the primitive 
streak, mesoderm emerging from the streak, head process and notochord (Beddington, 
1992). Mouse embryos that are homozygous for a T deletion die at mid-gestation with 
prominent defects in the notochord, the allantois and the primitive streak. These 
defects are thought to be due to defective cell mesoderm movements (Beddington et al, 
1992). The presence of a reporter gene in entrapment vectors allows the selection of 
mutations in genes showing interesting spatial or temporal expression patterns during 
embryogenesis. Moreover, such screening is anticipated to lead to the identification of 
genes which would be missed in conventional mutagenesis screens. For example, if a 
gene is functionally redundant because of the presence of a second locus that can 
substitute for the same function, inactivation of the gene will not result in any 
phenotype (Cooke et al., 1997). Such genes cannot be identified in screens for mutant 
phenotypes but may be detected by screening for restricted expression patterns. 
Two categories of entrapment construct have been developed which differ in 
the elements required from the endogenous locus to produce reporter activity. 
Enhancer traps contain a minimal promoter driving a reporter gene (Figure 1.2A). The 
minimal promoter is silent unless the vector inserts near an endogenous enhancer 
element. Promoter traps contain no promoter elements of their own and rely on 
endogenous promoter elements for expression. This category can be sub-divided into 
three groups, exontraps, genetraps and polyadenylation A (poly A) traps (Figure 
1.213). Firstly, exon trap vectors simply contain a reporter gene and require 
integration into an exon in the correct orientation and reading frame to produce reporter 
activity (von Meichner, 1989; Friedrich and Soriano, 1991; von Melchner, 1989; 
Friedrich, 1991; Macleod et al., 1991). Insertions can also be detected in non-
translated exons if the reporter gene has its own ATG. Secondly, gene trap vectors 
contain a splice acceptor site upstream of a reporter so that integration into an intron 
creates a spliced fusion transcript which encodes a fusion protein with reporter activity 
when the reading frame is maintained (Gossler et al., 1989; Friedrich and Soriano, 
1991). Once again if the reporter includes an ATG codon insertions can be detected in 
untranslated regions. Theoretically gene trap insertions can also be detected in exons. 
Finally, poly A trap vectors are designed such that they need to trap an endogenous 
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Figure 1.2 Structure and mode of action of different entrapment vectors. 
There are two categories of entrapment vector which differ with respect to the modes of 
activation of the reporter gene. (A) Enhancer trap: contains a minimal promoter 
driving the reporter gene which has its own translation initiation start site. The promoter 
is silent unless the vector inserts near an endogenous enhancer element. (B) Promoter 
trap: relies on endogenous promoter elements for expression. There are three types. 
I Exontrap: inserts into an exon of an active transcription unit in the correct orientation 
and reading frame. If the reporter has its own translation initiation site insertions can be 
detected in coding exons in any reading frame and in non-translated exons. II Genetrap: 
a splice acceptor site is placed upstream of the reporter. Integration into an intron in the 
correct orientation and reading frame results in a primary reporter fusion transcript which 
is further processed. If the reporter has its own translation initiation site, insertions can be 
detected in non-translated regions. Insertions can also be detected in exons. On these 
occasions there will be competition between the endogenous splice acceptor and the 
introduced splice acceptor. III PolyA trap: vector needs to acquire a poly A addition 
signal to allow selectable drug resistance. 
poly A signal for expression of the drug resistance selection gene (Niwa et al., 1993; 
Yoshida et al., 1995). The next three sections review the development and use of 
entrapment vectors in lower organisms before focusing on their use in mammals. 
	
1.2.1 	Bacteria 
The prototypic promoter trap vectors were developed in bacteria to identify 
temporally controlled genes (Casabadan & Cohen, 1979; Bellofatto et al., 1984). The 
vectors utilise the integration properties of the bacteriophage Mu genome. The coding 
regions of either an assayable enzyme such as 3galactosidase (I3gal) or an antibiotic 
resistance gene were incorporated at the end of the Mu genome. After transposition to 
random sites in the genome the reporter gene came under the control of regulatory 
elements from cellular promoters close to the insertion site. Vectors were made in 
which the initiation codon of 3ga1 was deleted thus forcing the expression of reporter 
activity to be driven via gene fusion (Casabadan et al., 1980). The authors found that 
pgal could tolerate large N-terminal fusions whilst retaining enzyme activity. 
1.2.2 	Plants 
Transposon-mediated mutagenesis has been adapted to trap cellular promoters 
and enhancers in tobacco and Arabidopsis. The first promoter trap screen utilised the 
tumour inducing (Ti) plasmid of Agrobacterium which is transferred and inserted into 
the host genome on infection (Koncz et al., 1989). In both Arabidopsis and tobacco 
25 % of transformants expressed the reporter gene. The similarity is unexpected as the 
density and distribution of transcribed sequences of both plants is very different 
(Koncz et al., 1989). It suggests that Ti plasmid, rather than inserting into the genome 
in a random manner, preferentially integrates into sequences that can be potentially 
transcribed. Only one out of 450 transformants produced a morphologically visible 
mutant phenotype when bred to homozygosity. 
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In another more efficient gene trap approach the maize transposable elements 
Activator (Ac) and Dissociation (Ds) were used (Sundaresan et al., 1995). A two-
element transposon system was devised in which transgenic Arabidopsis plants 
carrying an immobilised Ac element were crossed to plants carrying a Ds gene trap 
element. The Ds element carries a Pglucuronidase (GUS) reporter gene preceded by a 
splice acceptor site. As introns in plants are small the gene trap vector was designed to 
detect insertions in exons as well as introns. This was achieved by the presence of 
multiple splice donor sites at the end of the Ds element. When the Ds element inserts 
into an exon, the sequence between the splice donor site at the end of the element and 
the splice acceptor in front of the GUS gene, can be spliced out from the transcript 
resulting in a fusion transcript that encodes GUS activity. Of the transformed lines, 
14% showed restricted expression patterns and 4 % had a visible mutant phenotype. 
One of insertions occurred in a novel gene, PRL, which is required for embryo 
development (Springer et al., 1995). It was possible to confirm that insertion of the 
Ds element into PRL was responsible for the mutant phenotype by generating Ds 
revertants by crossing in Ac which effectively excises the Ds gene trap element 
(Springer et al., 1995). 
1.2.3 Drosophila melanogaster 
Enhancer trapping has been particularly productive at detecting developmental 
control genes in Drosophila using the P-element system (reviewed in Spradling et al., 
1995). P-elements are transposons with terminal inverted repeats which transpose via 
DNA intermediates (reviewed in Engels, 1989). The first enhancer trap used a 3ga1 
reporter gene driven by a weak promoter placed within the P-element to detect cis-
acting regulatory sequences (O'Kane and Gehring, 1987). Of 49 transformed fly 
lines, 70 % showed restricted reporter expression patterns. Further refinement to the 
method has allowed the generation of tens of thousands of lines with about 65 % 
showing spatially and temporally restricted reporter expression (O'Kane and Gehring, 
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1987; Bellen et al., 1989; Bier et al., 1989; Wilson et al., 1989). As well as 
identifying valuable markers for tissues and organs, between 10 and 17 % of lines 
carrying P-elements insertions exhibit recessive lethal phenotypes (Cooley et al., 1988; 
Bier et al., 1989). Cloning the P-element insertion sites confirms that the reporter 
picks up genuine regulatory elements from neighbouring genes and importantly, 
insertions near known developmentally regulated genes display patterns of reporter 
expression similar or identical to those of the known genes (Wilson et al., 1989). 
The high frequency of reporter activation in P-element mutagenesis may reflect 
preferential integration into specific sites in the genome similar to that seen with 
retrovirus insertion in animal genomes (Jaenisch, 1988). In both cases insertions are 
generally found outside of heterochromatin, often in 5 untranslated regions. The 
more open chromatin confirmation of these areas is thought to make them more 
accessible to insertion. Sequence analysis of P-element integration sites has not 
revealed any biases, yet some genes represent hot spots for P-element insertions, 
whereas others are relatively refractory to insertion (Smith et al., 1993) From 68 
lethal lines which show an embryonic phenotype in the nervous system 5 of the P-
element insertions occurred in neuralized and 4 in master mind (Bier et al., 1989). 
Extensive analysis of a 1.8 megabase genomic region indicates that only one third of 
lethal loci which were identified by chemical mutagenesis can be functionally disrupted 
by P-elements. Another transposable element, hobo, has a different distribution of 
insertion hot spots (Smith et al., 1993) . This suggests that a hobo enhancer trap 
strategy may allow access to genes resistant to P-element insertion. 
1.3 Entrapment in mouse ES cells 
Early experiments in vertebrates revealed that the position a transgene 
integrates in the genome can influence its temporal and spatial expression pattern 
(Jaenisch, 1981). This observation, along with studies in Drosophila (O'Kane and 
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Gehring, 1987), laid the foundations for the first enhancer trap experiments in the 
mouse. Position effects were explored using truncated versions of HSV thymidine 
kinase (Allen et al., 1988) or the mouse hsp68 gene (Kothary et al., 1988) which 
acted as weak promoters driving lacZ expression. Constructs randomly integrated into 
the genome following injection into the male pronucleus of fertilized mouse oocytes. 
One out of 7 hsp68lacZ transgenic lines and 5 out of 20 HSVtk lacZ transgenic lines 
exhibited restricted patterns of reporter activity during development. These results 
indicated that enhancer trap constructs could be used in mouse to identify expression 
patterns of endogenous genes and to isolate the genes. However, as mentioned 
previously, transgenic mice generated by zygote injection often suffer large 
chromosomal abnormalities associated with insertions which make identification of the 
interrupted gene difficult (Section 1.1.3). Such was the case for the hsp68lacZ 
transgenic line where a 45 kb deletion accompanied the integration. Seven years 
passed between identifying the insertion as an allele of the classical mouse mutant 
dystonia musculorum (dt) and cloning the disrupted gene (Brown et al., 1995). As 
well as difficulties in cloning, another drawback making the transgenic approach 
unsuitable for large scale screening is that the expression of trapped genes cannot be 
assayed quickly, as this would require sacrificing valuable founder animals. 
A more efficient entrapment strategy utilizes ES cell technology and allows 
preselection for integration events and reporter activity in vitro before producing 
mouse lines (Gossler et al., 1989; Friedrich & Soriano, 1991). Mouse ES cells are 
derived by culturing the inner cell mass of pre-implantation mouse embryos under 
conditions which actively inhibit differentiation and/or promote stem cell self renewal 
(Evans & Kaufman, 1981; Martin, 1981). These cells, upon injection into host 
blastocysts, can colonize all embryonic lineages, including the germ line (Bradley et 
al., 1984). These properties, along with their ability to be maintained indefinitely in 
vitro, make ES cells one of the most powerful tools in mammalian genetics. DNA can 
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be introduced into ES cells in a number of ways, including electroporation, lipofection 
and retroviral infection, without compromising their ability to contribute to all lineages 
of the developing mouse embryo (Robertson et al., 1986; Thompson et al., 1989). In 
this way large numbers of mutations can be introduced into ES cells and then 
transmitted through the germ line of mice so that phenotypic consequences of 
mutations can be assessed in vivo. 
1.3.1 	Enhancer traps 
To overcome problems inherent with transgenic approaches, an enhancer trap 
vector was introduced into ES cells by electroporation and reporter activity was 
analysed in chimaeric embryos (Gossler et al., 1989; Korn et al., 1992). The 
construct consisted of a minimal hsp68 promoter driving the lacZ gene upstream of a 
neomycin gene under the control of the herpes simplex virus thymidine kinase 
promoter. Between 14 and 22 % of neomycin resistant lines exhibited lacZ expression 
in undifferentiated ES cells, and of these 40 % [6/15] showed distinct reporter gene 
expression patterns during early embryonic development (Gossler etal., 1989; Korn et 
al., 1992). Of the lines which showed no expression in undifferentiated ES cells 31% 
[16/51] gave rise to patterns during embryonic development. Many of the staining 
patterns were exclusively, or included in, the central nervous system. A similar skew 
towards CNS staining was seen in transgenic lines carrying a different design of 
enhancer trap (Allen etal., 1988) and is also reminiscent of the enhancer trap patterns 
obtained in Drosophila (Bellen etal., 1989). Together this data may reflect the large 
number of expressed genes in the developing nervous system. 
Genomic sequences flanking the insertion sites have been cloned for two 
enhancer trap lines and cDNA clones representing novel sequences were isolated from 
them (Soininen et al., 1992; Neuhaus et al., 1994). In both cases expression of the 
endogenous genes was more widespread than the corresponding f3gal activity, 
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suggesting that the reporter gene responded to only a subset of the regulatory elements 
of the endogenous gene. Both enhancer trap integrations were transmitted through the 
germline but neither showed an obvious phenotype when homozygous. The rate at 
which enhancer trap insertions yields mutant phenotypes is likely to be fairly low as 
the insertion is expected to leave the endogenous promoter and coding sequence intact 
(Table 1.1). 
1.3.2 	Promoter traps 
Numerous experiments have confirmed the feasibility of using the promoter 
trap approach to identify and mutate novel genes involved in development. Firstly 
promoter traps have been found to mutate the endogenous gene at the site of 
integration leading to a lethal phenotype in 37 % [23/63] of lines analysed (Friedrich & 
Soriano, 1991; Skarnes et al., 1992; Camus et al., 1996; Forrester et al., 1996; Hicks 
et al., 1997). This percentage of lethal loci is in keeping with the I in 3 loci essential 
for viability in yeast, worms and flies (Miklos and Rubin, 1996). Secondly the 
endogenous genes carrying insertions have been easily cloned from fusion transcripts 
or flanking genomic DNA (Table 1.2). Finally the expression patterns of reporter 
genes have been found to be similar to endogenous genes so that screens based on 
reporter activity can be used to pre-select for insertions which may play a role in 
development (Skarnes et al., 1992; Skarnes et al., 1995; Chen et al., 1996; Torres et 
al., 1997). The various promoter trap designs which have been used in ES cells are 
summarised in Appendix I and are discussed in the following sections. 
(a) Vector design 
In mice, exon trap vectors contain a promoterless reporter gene and are 
equivalent to the prototypical bacterial promoter traps (Casabadan & Cohen, 1979; 
Bellofatto et al., 1984). Reporter activity results from insertion of the vector into an 
exon in the correct orientation and reading frame (Friedrich & Soriano, 1991). Rather 
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Vector Insertion Gene Gene function 3gal acti vitya Homozygous phenotype Reference 
site 
Retroviral promoter trap 
5'UTR TEF- 1 transcription factor widespread embryonic lethal (Chen et al., 1994) ROSA3geo 
I. intron BTF-3 transcription factor res tricted* postimplantation lethal (Deng and Behringer, 1995) 
U33geo 5UTR Eck receptor tyrosine kinase restricted none (Chen et al., 1996) 
? ArMT arginine methyltransferase N.D. embryonic lethal (Scherer et al., 1996) 
U3neo 5UTR fugi unknown N.A. embryoinc lethal (Degregori et al., 1994) 
Plasmid promoter trap 
intron Gt4-1 unknown widespread perinatal lethal (Skarnes etal., 1992) pGT4.5 
intron Gt4-2 zinc finger trancsription factor restricted lethaib 
intron GtlO unknown (proline-rich) restricted N.D. 
? Gt2 N.D. widespread none 
intron Cordonbleu unknown restricted none (Gasca et al., 1995) 
pTl-ATG intron 1.23 N.D. restricted none (Forrester etal., 1996) 
intron 1.114 unknown restricted none 
intron 1.163 unknown restricted none 
intron 1.193 unknown restricted none 
intron R.140 unknown restricted embryonic lethal 
pGTl .8TM intron Netrin secreted axon guidance cue restricted postnatal lethal (Skarnes et al., 1995) 
intron PTPK protein tyrosine phosphatase restricted none 
intron LAR protein tyrosine phosphatase restricted none 
pGTl .8geo intron E-catenin cell-cell adhesion molecule restricted preimplantation lethal (Torres etal., 1997) 
TV2 intron Jumonji unknown restricted embryonic lethal (Takeuchi etal., 1995) 
Plasmid Poly A trap 
pPAT intron PAT-12 unknown N.D. none (Yoshida et al., 1995) 
* 	endogenous gene expression is not restricted 
RBP-2 	retinoblastoma-binding protein 
N.D. not determined 
N.A. 	not applicable as vector does not contain a reporter gene 
a gal activity during development 
b 	variable penetrance, some homozygotes viable with growth defect 
confusingly this vector design is sometimes referred to simply as a 'promoter trap', 
this nomenclature is based on the observation that retroviral exon traps tend to insert 
within 500 nucleotides of cellular promoters. Gene trap vectors contain a splice 
acceptor site upstream of the reporter gene (Gossler et al., 1989; Friedrich & Soriano, 
1991). Insertion into an intron of an active transcription unit leads to a fusion 
transcript between the endogenous gene and lacZ (Skarnes et al., 1992). 
Promoter trap insertions into the same gene have been found on several 
occasions. For example L29 and a-NA C were both disrupted three times in an 
analysis of 400 insertions (Chowdhury et al., 1997) and the protein tyrosine 
phosphatase Lar was disrupted twice in a sample of only six insertions (Skarnes et al., 
1995). There are a number of factors which could potentially influence the position a 
vector inserts into the genome. These include the presence of integration hot spots, the 
intron/exon structure of a gene and homology between the vector and areas of the 
genome which would increase the likelihood of homologous recombination. Genomic 
hotspots have been discussed in Section 1.2 and include regions with open chromatin 
structure which may offer easy access to vector insertion. The intron/exon structure of 
a gene will also influence its ability to be detected. Transcription units with large 
intronic targets are more likely to be targets for gene trap insertion. 
The reading frame of the endogenous splice donor must be compatible with the 
vector splice acceptor for reporter expression to be detected. There are two strategies 
to overcome reading frame constraints. The first uses the MoMuLV splice acceptor 
from the env gene which splices in all three reading frames (Schuster-Gossler et al., 
1994). Alternatively, including an internal ribosomal entry site (IRES) between splice 
acceptor and the reporter allows the reporter to be independently translated from the 
IRES irrespective of the reading frame of the transcript (Chowdhury et al., 1997). 
The number of G418R  colonies increased three fold when an IRES sequence was 
added to a SAI3geo gene trap vector (Chowdhury et al., 1997). 
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The final issue of vector homology is contentious as there is no hard evidence 
to suggest it exists. The repeat insertions into the same genes have been found using 
different vector designs. For example jumonji was originally identified using pTV2 
(Takeuchi et al., 1995) and has since been disrupted by pGT1.8TM (W.C. Skarnes, 
unpublished observations) and ROSAf3geo (Baker et al., 1997). It is possible that 
there is some degree of homology between the neo or n-gal sequences and the jumonji 
locus, particularly as the two plasmid vectors inserted into the same jumonji intron. In 
other repeat events the insertions occurred at different places in the gene (Skarnes et a!, 
1995; Chowdhury et a!, 1997; W.C. Skarnes, personal communication). 
I 	Selectable markers 
To allow direct selection of promoter trap events a reporter gene was developed 
in which the ORFs of lacZ and neomycin were fused in the same reading frame 
(Friedrich & Soriano, 1991). The encoded protein, I3geo, exhibits both Pgal reporter 
activity and neo selection activity. Therefore all G418R  colonies should express the 
I3gal protein. In the original promoter trap experiment using Pgeo 95 % of G418 
resistant pSAgeo colonies showed f3gal activity (Friedrich & Soriano, 1991). In a 
subsequent experiment (using pGT1.8geo) only 60 % of G418 resistant colonies 
showed Pgal activity (Skarnes et al., 1995). These colonies showed a variety of f3gal 
staining intensities in contrast to the uniform high levels of staining seen for pSAf3geo 
colonies. These anomalies were explained by the presence of a point mutation in the 
neo of pSA3geo which is known to reduce its enzyme activity (Yenofsky et al., 1990). 
Consequently, only pSAIgeo colonies expressing high levels of Pgeo can survive the 
selective pressure of G418. The different levels of pGT1.8I3geo staining patterns 
reflect the highly sensitive nature of its neo, such that low levels of expression are 
sufficient to confer drug resistance, yet much higher levels of lacZ expression are 
required to detect f3gal activity. The requirement for high levels of expression may also 
explain why far fewer G418 colonies were recovered with pSAf3geo compared to 
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pGT1.8geo (Skarnes et al., 1995). This increased sensitivity allows pGT1.8fgeo to 
detect insertions into genes expressed at very low levels in ES cells which may not be 
possible with pSAI3geo. 
II Poly A traps 
Novel promoter trap vectors called poly A traps have been designed to allow 
the identification of genes which are not expressed in ES cells by virtue of the selective 
gene within the vector being driven by its own promoter (Niwa et al., 1993; Yoshida 
et al., 1995). It is desirable to access insertions in this class of molecule as it is clear 
that some developmentally essential genes such as Wnt-] and En-] are not expressed 
in ES cells (McMahon & Bradley, 1990; Jeanotte et al., 1991). The first poly A trap 
vector consisted of a promoterless lacZ gene preceded by a splice acceptor with neo 
driven by its own promoter but lacking a poly A addition signal (Niwa et al., 1993) 
and Appendix I [26 & 25]. Insertions were required to trap an endogenous poly A 
signal for expression of neo selection. As neo is driven by the f3-actin promoter which 
is active in ES cells, endogenous genes can be tagged with lacZ even if they are not 
active in undifferentiated ES cells. Unfortunately, problems arose due to deletions 
from the ends of the electroporated vector which removed the splice acceptor site so 
that in 4 out of 5 cases the vector had inserted into the promoter region of the 
endogenous genes. The 3' end of neo fusion transcripts were amplified by 3' RACE 
and in three out of five lines the transcript had incorporated a poly A tail but curiously 
there was no poly A addition signal found in the sequences between neo and the poly 
A stretch. Products could not be amplified using 3' RACE in the other two lines. The 
authors postulated that on these occasions neo may be fused to the exon of a gene 
leading to the production of long mRNAs which could not be amplified. 
Another group further refined the poly A trap design by including a splice 
donor site downstream of the stop codon of neo (Yoshida et al., 1995) and Appendix 
It 
I [29]. This modification allows splicing of neo to downstream endogenous exons. 
Around 25 % of lines were successfully amplified with 3' RACE and in 5 out of 6 
fusion transcripts poly A sites were identified within novel endogenous sequences. 
The full length cDNA was isolated for a line called PAT-12 and was confirmed by 
southern and northern blot analysis to represent the endogenous gene carrying the 
insertion. Homozygous mice were generated but no overt phenotype was apparent. 
The poly A trap insertion occurred at the 3' end of the gene which raised the question 
whether the gene had been successfully disrupted. No transcripts were found in 
homozygotes so the authors postulate that the vector insertion possibly inhibits 
transcription or destabilises mRNA. Unexpectedly the endogenous PAT-12 locus is 
expressed in undifferentiated ES cells yet the reporter gene in PAT-12 ES cells is 
inactive. Although there is only minimal data regarding poly A trap vectors, they may 
be particularly useful for in vitro induction screens where genes are selected on the 
basis of their upregulation in differentiated cells in response to chemical or growth 
factor stimulation (Section 1.3.4 d). 
III 	Conditional promoter trapping 
Another novel entrapment strategy has been the incorporation of site specific 
recombination technology into a promoter trap screen (Russ et al., 1996). The authors 
developed a strategy to isolate genes that are transcriptionally activated during 
programmed cell death (summarised in Figure 1.3). A retroviral trap vector is used to 
bring the Cre recombinase under the control of cellular promoters. The vector was 
introduced into interleukin-3 (IL-3) dependent haematopoietic cells expressing a 
reporter plasmid that carries the PGK promoter driving expression of herpes simplex 
virus thymidine kinase, neo and IL-3. The neo gene is flanked by loxP sites and cells 
are neo resistant and require the addition of exogenous IL-3 for survival. Activation of 
Cre expression from promoter trap integrations within active genes results in Cre 
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Figure 1.3 Recovery of apoptosis genes using gene-trap mutagenesis 
and site-specific recombination 
Strategy used to identify genes that are transcriptionally activated during programmed 
cell death. Interleukin-3 (11D) dependent haematopoietic cells (FDCP1) expressing a 
reporter plasmid that encodes herpes simplex virus thymidine kinase, neo and murine 
IL-3 are transduced with a retroviral gene trap vector carrying coding sequences for 
cre recombinase (Cre). Activation of Cre expression from promoter trap integrations 
within active genes results in Cre mediated removal of neo activity and production of 
IL-3 which converts FDCP1 cells to factor independence. Because the expression of 
the marker genes is independent of the trapped cellular promoter, insertions into genes 
can be identified that are transiently induced by IL-3 withdrawal. 
promoter, thus converting cells to ganciclovir resistant and IL-3 independent state. 
Because the expression of the marker genes is independent of the trapped cellular 
promoter, insertions into genes could be identified that were transiently induced by IL-
3 withdrawal. The authors found that 1.7 x 10 insertions detected a promoter 
induced by IL-3 withdrawal. 50 % of the analysed fusion transcripts were also 
inducible by serum starvation, suggesting that the disrupted genes are associated with 
an apoptotic program or with growth arrest. This type of strategy could be used to 
identify transcriptional targets in many different signaling pathways. An alternative 
use for the site-specific recombination system would be to add loxP sites to a gene trap 
vector. This will allow the endogenous locus carrying the insertion to be manipulated. 
In this way it might be possible to produce revertants which would be useful in 
confirming that insertions were responsible for particular phenotypes. 
(b) Vector delivery 
Promoter traps have been delivered into ES cells by electroporation and 
retroviral infection (Gossler et al., 1989; Friedrich & Soriano, 1991; von Meichner, 
1992). Whilst retroviruses clearly provide an efficient method for introducing 
mutations in the genome without gross DNA rearrangement there are potential 
drawbacks to their use in promoter trapping. As alluded to earlier a concern is whether 
retroviral insertion is random. Three fold more G418 resistant colonies showed Pgal 
staining when a retroviral promoter trap was compared to the same ROSA3gal vector 
design electroporated (Friedrich & Soriano, 1991). This increase is thought to reflect 
specificity of proviral integration sites. Other studies have suggested that DNase I 
hypersensitive sites (Vijaya et al., 1986; Rohdewohld et al., 1987) and actively 
transcribed regions of chromatin (Mooslehner et al., 1990; Scherdin et al., 1990) are 
preferred sites within the genome for retroviral integration. It is clear that in some of 
these experimental systems a selection bias could have been introduced. Proviral 
insertions in tumours, and cell lines derived from them, may be selected for relatively 
subtle advantages to cell growth (Vijaya et al., 1986; Rohdewohld et al., 1987). A 
more recent report indicates that most regions of the genome are accessible to avian 
retroviral integration although a few sites are used up to 280 times the random 
frequency (Withers-Ward et al., 1994). However, the same group previously showed 
that approximately 20% of all integrations involve highly preferred sites (Shih et al., 
1988). The authors suggest that some unknown variable in cell culture conditions or 
in the target cells used could account for the contradictory results. Although 
controversial, the presence of integration hot spots would pose a problem when 
undertaking saturation scale screens. 
Another concern with retroviruses is the ability of the proviral reporter gene to 
accurately reflect the expression pattern of the endogenous gene carrying the insertion. 
Repression of transcription due to de novo methylation of the provirus which extends 
into flanking promoter sequences has been shown to occur in several retroviral 
transgenic strains (Jahner & Jaenisch, 1985). One of three published characterisations 
of retroviral gene trap lines describes an insertion of ROSAI3geo into the BTF3 
transcription factor (Deng & Behringer, 1995). The endogenous BTF3 gene is 
ubiquitously expressed but the expression of the 3gal reporter in BTF3 heterozygotes 
is restricted. 
A second report characterised an integration in the Eck receptor tyrosine kinase 
by the U3l3geo retrovirus (Chen et al., 1996). Although the retroviral vector is 
designed as an exon trap, the insertion occurred in an intron 8kb upstream of the 5' 
end of the published cDNA sequence, and 1.8 kb downstream of an alternatively 
spliced 5' exon. As the construct does not have a splice acceptor it is expected to be 
spliced from the primary fusion transcript along with the intron into which it has 
inserted. This does not appear to happen as adult mutant mice were shown to be 
severely deficient in Eck protein. As the transcripts were not analysed it remains to be 
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seen whether the protein deficiency is due to the insertion truncating the endogenous 
message or whether the provirus has silenced the Eck promoter. 
The final retroviral gene trap report describes an insertion of ROSA3geo in the 
transcriptional enhancer factor 1 (TEF-1) (Chen et al., 1994). On this occasion Pgal 
expression appears to accurately reflect the widespread expression seen with the 
human homologue of TEF-1. There are no reports of discrepancies in reporter 
expression with electroporated gene trap constructs suggesting that screens based on 
reporter expression may be more reliable using electroporated constructs than their 
retroviral counterparts. 
(c) Mutagenicity 
To work as an effective mutagen it is important that expression of the 
endogenous transcript is ablated at the locus carrying the promoter trap insertion. In 
six lines homozygous for gene trap insertions endogenous expression was absent or 
negligible as detected by Northern or RNase protection (Skarnes et al., 1992; Takeuchi 
et al., 1995; Skarnes et al., 1995). Northern analysis of a different promoter trap line 
showed that endogenous transcript was present in homozygotes (Gasca et al., 1995). 
The levels indicated that the gene trap insertion was spliced out of about 10 % of 
primary transcripts. The interrupted gene in this line was cordon-bleu and although it 
exhibited an exquisite spatially restricted expression pattern there was no obvious 
homozygous phenotype. The authors suggested that the low levels of wild type 
transcript could rescue any potential phenotype. In another gene trap line low levels of 
wild type transcript were seen in homozygotes carrying an insertion into the axon 
guidance molecule netrin (Serafini et al., 1996). However these homozygotes die at 
birth and exhibit defects in spinal commisural axon projections. 
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1.3.4 	Screens for genes of interest 
The major benefit of creating insertional mutations in ES cells by entrapment 
techniques is the ability to pre-select for insertions into genes of interest before the 
costly and time consuming production of germ line transmitting chimeras and 
subsequent breeding programs to look for phenotypes. ES cells lines can be selected 
on the basis of criteria which are discussed in detail in the next sections: sequence of 
disrupted gene, reporter gene expression during development and reporter gene 
expression in response to ES cell differentiation or other stimuli in vitro. 
(a) Sequence 
Genes disrupted by gene and poly A trap vectors can be identified from fusion 
transcripts by rapid amplification of cDNA ends (RACE). Genes carrying exon trap 
insertions can be identified using plasmid rescue of genomic DNA flanking the 
insertion site. To further facilitate the process of identification a solid-phase method to 
directly sequence 5'RACE products has been developed which eliminates the need for 
cloning (Townley et al., 1997). In the last year three groups have assessed the 
feasibility of large scale identification of endogenous genes carrying promoter trap 
insertions (Chowdhury et al., 1997; Hicks et al., 1997; Townley et al., 1997). Their 
results are summarised in Table 1.3. 
The identities of the previously cloned gene traps indicate that many classes of 
molecule are amenable to promoter trapping. Over 50 % of the trapped sequences 
represent insertions in novel genes and so provide a resource of novel mutations which 
are available for in vivo functional analysis. The sequence information allows lines to 
be selected on the basis of structural homology to known or novel gene families. 
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Table 1.3 Summary of genes disrupted by large scale promoter trap 
screens 
Vector 	 pSA3geo & pSAIRESgeo 	pGT1.8TM 	 U3neoSVlt 
(Chowdhury et al, 1997) 	(Townley et al, 	1997) 	(Hicks et al, 1997) 
Known genes 	 17(30%) 	 29(51%) 	 42(11%) 
Homology to ests 	 11(20%) 	 11(19%) 	 21(5%) 
Novel 	 28(50%) 	 17(30%) 	 337 (84%)* 
* The figures for the retroviral U3neoSVl originate from genomic sequences flanking the insertion 
site compared to the database. As a consequence it is likely that database matches will be missed 
because flanking DNA often lacks sufficient exon sequences to generate statistically significant 
matches particularly if insertions occur near promoters or splice acceptor sites or further within an 
intron. 
Vector does not contain a reporter gene 
(b) Reporter gene expression pattern in embryos 
Since lacZ activity has been shown to reflect endogenous gene activity in all 
electroporated vector insertions (Section 1.3.2), screening for reporter activity in 
chimaeric embryos can be a useful approach to identify candidate genes which 
function at particular developmental stages or during particular developmental 
processes. A large scale screen for insertional mutations into genes which are 
developmentally regulated during mouse development has recently been undertaken 
using pPT-1 (Wurst et al., 1995). Reporter expression was analysed in 8.5 dpc 
chimeras and approximately 33% showed widespread expression whilst 13 % 
[35/279] exhibited spatially restricted expression patterns. Of the lines which showed 
no expression at 8.5d more than 33% were found to express lacZ at 12.5 dpc. 
Therefore in total, roughly 66% of genes expressed in ES cells display 
developmentally regulated patterns of expression in embryos. The high percentage of 
restricted expression patterns clearly makes this type of screen an attractive approach 
to take. 
Although the pattern-hunting approach has identified genes important for 
development (Table 1.2) not all such genes can be identified this way. Genes which 
are widely expressed but play important developmental roles in specific regions or cell 
types would be missed in such a screen. For example notch plays an important role in 
the Drosophila embryo by allowing cells in the ventrolateral region of the embryo to 
make the choice between assuming epidermal or neuronal fate yet its RNA does not 
have a restricted expression pattern in the prospective neurectoderm (Hartenstein et al., 
1994). 
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(c) Reporter gene expression pattern in vitro 
In vitro strategies have been developed to pre-select for insertions which 
express the reporter gene in selected cell types or in response to inducers of 
differentiation. These approaches utilise the ability of aggregates of ES cells grown in 
suspension, called embryoid bodies, to give rise to a number of embryonic cell types 
(Keller, 1995). Co-localisation of cell-specific antibodies with f3gal expression has 
been used to pre-select for insertions in genes expressed in neurons, glia, myocytes 
and chondrocytes (Baker et al., 1997). To confirm that the regulation of gene 
expression in cultured embryoid bodies reflects expression during early development, 
changes in reporter gene expression in vitro were analysed in 191 lines carrying 
U3J3geo insertions (Scherer et al., 1996). 16 % exhibited alterations in pgal 
expression upon in vitro differentiation. Seven of these lines were passed into the 
germline and the expression during development was consistent with that seen in 
vitro. 
Another screen was designed to select integrations into genes which respond 
to retinoic acid (RA) (Forrester etal., 1996). Intriguingly, this selection was found to 
significantly enrich for integrations in genes which show restricted expression patterns 
during development. From 3600 integrations 20 lines showed a repression or 
induction of Pgal activity in response to retinoic acid. Of the 9 induced lines analysed 
56% displayed a restricted pattern of expression at 8.5d. In a previous screen where 
lines were selected solely on the basis of lacZ expression in undifferentiated ES cells 
over 4 fold less lines showed restricted expression at 8.5d (Wurst et al., 1995). In 
addition, eight of the RA-repressed integrations were expressed in the developing 
heart. This may reflect the proposed role of RA responsive genes in heart 
development, inferred from cardiac defects in RA-treated and RA-deprived embryos 
(Kirby, 1993). Similar types of pre-screens using growth factors, morphogens and 
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Figure 1.4 Two types of signal sequence target secretory proteins to 
the endoplasmic reticulum. 
The two types of signal sequence that target secretory proteins to the endoplasmic 
reticulum (ER) and determine their orientation within the membrane are the cleavable 
signal sequence (SS) and signal anchor (SA) sequence. All proteins encoding a SS 
are either secreted or if they have a stop-transfer (ST) sequence are placed in the 
membrane in a type I orientation. Such type I proteins have their amino-termini in the 
lumen of the ER while type II proteins have their amino-termini in the cytoplasm. The 
membrane orientation of proteins encoding SA sequences depends on the difference in 
charge between the 15 amino acids flanking the carboxy-terminal end of the signal 
anchor and the 15 amino acids flanking the amino-terminal end ([C-N]). If A[C-N] 
is positive the membrane protein is Type I, if [C-N] is negative then the membrane 
protein is Type H. Figure adapted from High, 1992 and Hartmann etal, 1989. 
growth substrates could be used to identify genes involved in other developmental 
programs. 
1.3.5 	Secretory trapping 
Cell-cell interactions play a crucial role in the determination of cell fate within 
the early embryo, and in the differentiation of specific cell types during embryogenesis 
and adult life. Many families of signalling molecules have been shown to mediate 
these interactions including the BMPs (Hogan, 1996), the Wnts (Moon, 1997), 
homologues of the notch receptor and its ligands (Robey, 1997) and the hedgehogs 
(Hammerschmidt et al., 1997). This section introduces the methods that have been 
used to identify novel receptors and ligands which mediate cell-cell interactions during 
development. 
(a) Secretory pathway 
To perform their function, secreted and transmembrane bound molecules must 
be trafficked to the extracellular environment through the secretory pathway (reviewed 
in Teasdale and Jackson, 1996). This pathway defines the route from the endoplasmic 
reticulum (ER) to the plasma membrane via the Golgi apparatus. The initial targeting 
of newly synthesized proteins to the ER occurs via a linear stretch of 7-20 apolar 
residues called the signal sequence. There are two types of signal sequence: cleavable 
signal sequences and uncleaved signal-anchor sequences (Figure 1.4). Cleavable 
sequences are found on both membrane and secreted proteins. They are present at the 
amino terminus of the nascent chain and their function is to target the protein to the ER 
and then initiate its translocation across the membrane. During the translocation 
process these signals are cleaved from the protein by the signal peptidase complex 
present at the luminel side of the ER membrane. A stop-transfer sequence on the 
carboxy terminal side of the signal sequence aborts translocation of the polypeptide so 
the carboxy terminus remains in the cytoplasm (type I orientation). In the absence of 
the stop-transfer sequences the entire protein is translocated across the membrane into 
the lumen of the ER. 
Membrane proteins with an uncleaved signal-anchor can expose either the 
carboxy (type I) or amino (type II) terminal to the cytoplasm. The difference in 
charges of the first 15 amino acids flanking the first signal anchor determines its 
orientation, with the more positive portion facing the cytosol (Figure 1.4; Hartmann, 
1989). In proteins that span the membrane more than once, the orientation of all 
subsequent transmembrane segments are determined by that of the most amino 
terminal one. Membrane proteins that have a cleavable signal sequence always have a 
type I orientation. Throughout this thesis the term secretory molecule will refer to any 
protein which contains either a cleavable signal sequence or an uncleaved signal-
anchor sequence. 
(b) Cloning secretory molecules 
Two expression cloning strategies have been devised to identify secreted and 
type I membrane proteins by exploiting the property of the signal sequence to direct 
secretory molecules to the ER (Tashiro et al., 1993; Klein et al., 1996). In the first 
example an expression vector containing the extracellular and transmembrane domains 
of interleukin-2 (EL-2) allowed cell-surface expression of fusion proteins when cDNAs 
encoding signal sequences are cloned into it. Fusion proteins expressed on the plasma 
membrane of cells can then be detected by antibodies to IL-2. Screening of 600 
colonies from a bone marrow stromal cell line cDNA library identified six positive 
colonies each of which was found to encode a signal sequence. However, only one 
was novel. This approach is both technically demanding and labour intensive and not 
amenable to large scale analysis. 
A more efficient method to identify genes containing signal sequences allows 
the simultaneous identification of many individual cDNAs in pools of a million clones 
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or more. The strategy is based on the ability of cloned cDNAs to provide a truncated 
secreted enzyme with a functional signal peptide (Klein et al., 1996). The system 
utilises yeast invertase as secretion of this enzyme is essential for survival on a sucrose 
medium. cDNAs are cloned upstream of the invertase gene without a signal sequence. 
Only transformants which have a signal sequence are able to grow on a sucrose 
medium. cDNA libraries from a variety of embryonic mRNAs were transformed into 
yeast and from about 2 X 10 7 transformants 583 survived on sucrose. 161 cDNAs 
represent unique genes and at least 86 % are secretory molecules of which around 50% 
are novel. Although this is obviously a highly efficient strategy to identify novel 
secretory molecules there are drawbacks. It is potentially biased in favour of 
abundantly transcribed mRNAs and it provides no functional information on the 
identified genes. More importantly, it will not identify secretory molecules with 
uncleaved signal sequences. 
(c) Secretory trap vector 
The protein sorting principle of the signal sequence has also been exploited in a 
gene trap approach to select for insertions into secretory molecules (Skarnes et al., 
1995). Unlike the expression cloning approaches, this strategy has the added 
advantage of allowing a functional analysis of the trapped genes. The rationale behind 
the approach is based on observations that f3gal activity can be detected in a variety of 
subcellular locations in promoter trap lines (Gossler et al., 1989; Wurst et al., 1995). 
As 3gal is normally distributed throughout the cytoplasm, the localisation to different 
subcellular structures presumably reflects the acquisition of endogenous protein 
domains that act as sorting signals. Experiments were performed to investigate 
whether insertions in secretory molecules could be identified by the subcellular 
localisation of 3gal activity. Surprisingly, 3gal activity is not detected if it is fused to a 
signal sequence Figure 1.5A; (Skarnes et al., 1995). Immunofluorescence using 3gal 
antibodies showed that such fusion proteins are translocated to the lumen of the ER 
W. 
Figure 1.5 	Insertions into genes encoding an N-terminal signal 
sequence are detected by the secretory trap vector 
(A) Localisation of enzyme activity and f3geo fusion protein in ES cells transiently 
transfected with CD4-3geo expression constructs. I The human 13-actin (act) promoter 
was used to drive f3geo alone or II, fused in frame with the SS of CD4 , or III, 
fused to the SS and TM of CD4. Enzyme activity was assayed using X-gal as a 
substrate and photographed under brightfield illumination. The subcellular localisation 
of 3geo protein was determined by immunoflorescence and photographed using a 
fluorescein epifluorescence filter set. (B) Model to explain the selective activation of 
3gal fusion proteins using the secretory trap vector. I Insertion of pGTI.8TM in 
genes that contain a signal sequence place f3geo in a type I orientation in the ER 
membrane. The TM of the vector retains 3geo in the cytosol where it remains active. 
II Insertion of the vector into genes which do not contain a signal sequence result in a 
fusion proteins with an internal TM domain. These proteins are inserted in a type II 
orientation in the ER membrane resulting in the 3geo being sequestered in the lumen of 
the ER where 3gal activity is lost. 
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where they are inactive. However, addition of a transmembrane (TM) domain 
downstream of the signal sequence restores Pgal activity presumably by placing 3gal in 
the cytosol. 
These results suggested that conventional gene trap vector insertions which 
occur downstream of a signal sequence but upstream of a TM domain would not be 
detected as 3gal would be inactive. To try to recover such insertions in secretory 
molecules a TM domain was added to the gene trap vector to make the secretory trap 
vector pGT1.8TM. Cloning data from the first six lines generated using pGT1.8TM 
supports the prediction that I3gal activity is dependent on acquiring a signal sequence 
from the endogenous gene carrying the insertion. A model to describe how the 
selection is thought to occur is presented in Figure 1.5B. In essence, the addition of a 
transmembrane domain upstream of fgeo in the vector confers a type II membrane 
orientation on 3gal fusion proteins which do not acquire signal sequences from the 
endogenous gene into which it has inserted. The type II orientation is thought to lead 
to the retention of the Pgal reporter in the lumen of the endoplasmic reticulum (ER) 
where the Pgal is inactive. In contrast signal sequences acquired by insertions in 
secreted and type I membrane proteins place the fusion protein in a type I orientation 
keeping the Pgal outside the ER lumen where it is active. 
1.4 Experimental approach 
The aim of this project was to use the secretory trap technology to identify 
and mutate novel secretory molecules involved in mouse development. Chapter 2 
describes the characterisation of lines generated from an electroporation of the 
secretory trap vector pGT1.8TM. To overcome the inherent bias of the pGT1.8TM 
gene trap design to insert into genes with large intronic targets an exon trap version of 
the secretory trap was designed. Chapter 3 describes the characterisation of lines 
generated by the new vector design. In Chapter 4 a detailed analysis of a secretory 
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trap insertion into a novel multiple membrane spanning gene required for lung 
development is presented. 
WE 
Chapter 2 
Secretory Trap Screen 
2.1 Introduction 
The secretory trap vector (pGT1. 8TM) has been shown to detect insertions in 
genes encoding secreted and membrane-spanning molecules (Skarnes et al., 1995); 
see also Section 1.3.5. This pilot study identified insertions in the extracellular 
domain of a novel cadherin-related gene, the secreted molecule netrin-1, the Sek 
receptor tyrosine kinase and two protein tyrosine phosphatases, LAR and PTPc. 
These initial results support the prediction that 3gal activity is dependent on acquiring a 
signal sequence from the endogenous gene at the site of insertion. 
This chapter describes the second more comprehensive screen using 
pGT1 . 8Th'I. Figure 2. 1 outlines the strategy employed to identify genes important for 
embryonic development. X-gal positive clones were subjected to two pre-screens 
before transmitting the insertion through the gerrnline. First, the insertion site was 
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Figure 2.1 Selection criteria for JST lines 
(A) Direct sequencing of 5' RACE products. (B) 3gal reporter expression in 10.5dpc 
JST19I chimera. (C) Strong coat-colour chimera shown to transmit a secretory trap 
insertion through its germ line. (D) Growth retarded JSTI85 homozygote alongside 
normal littermate. 
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characterised, and second, the expression pattern during early (8.5dpc) and late 
(10.5dpc) organogenesis was analysed in chimeras (Figure 2.2 and reviewed in 
Hogan et al., 1994). Only bone fide gene trap insertions which were expressed in 
chimeras were passed through the germline and intercrossed to look for recessive 
embryonic phenotypes. 
2.2 Isolation of JST lines and expression in ES cells 
The secretory trap vector pGT1 . 8TM was introduced into CGR-8 ES cells by 
electroporation. After 10 days in G418 selection 205 resistant colonies were picked 
into 24 well plates. Confluent wells were passaged into duplicate 24 well plates. One 
of these was maintained as a master whilst the other was stained for Pgal activity. 3gal 
activity was assayed using the chromogenic substrate X-gal and 57 (28%) lines 
showed varying degrees of expression. Most of the X-gal positive clones (77%) 
exhibited patterns similar to the characteristic secretory pattern' of Pgal staining in the 
pen-nuclear compartment of ES cells and multiple cytoplasmic dots described in the 
original report (Figure 2.3, A-D). This pattern is thought to reflect the targeting of 
fusion proteins to the ER/golgi apparatus. The remaining colonies showed either faint 
or strong staining in indistinct subcellular locations (Figure 2.3, E and F). Twenty-
four of the I3gal staining lines were expanded for further analysis and are referred to as 
JST lines. 
2.3 LacZ fusion transcript analysis 
Previous results from our lab have shown that a significant proportion of gene 
trap insertions fail to utilise the vector's splice acceptor properly and so produce fusion 
transcripts containing vector-specific intron sequences. Inefficient splicing of the 
reporter gene is predicted to occur if the vector inserts in polymerase I or Ill 
transcription units or into exons of polymerase II transcription units (Figure 2.4). 
This prediction was borne out when two insertions producing intron-containing fusion 
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Figure 2.2 Summary of mouse development 
(A) Reporter expression during the JST screen was analysed at 8.5 dpc and 10.5 dpc. The different lineages at 8.5d 
are coloured as follows, trophectoderm (grey); primitive endoderm (beige); epiblast (blue); mesoderm (red); notochon 
(brown); definitive gut endoderm (yellow) and neurectoderm (purple). Anterior is to the left and posterior to the right. 
8.5dpc embryo figure taken from Hoganet al 1994 and 10.5dpc embryo figure taken fromTheiler, 1972. (B) Time 
course of development. (0-5 days) Cleavage and blastulation; (5-10 days) implantation, gastrulation and early 
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Figure 2.3 3gal activity in JST ES cell lines 
ES cell lines containing pGTI.8TM stained for f3gal activity. (A) JST51 and (B) 
JST219 show intense dots of cytoplasmic expression amidst a background of lower 
level expression in the cytoplasm. The pattern is similar to the typical 'secretory 
pattern' of expression reported in Skarnes et al, 1995. In (C) JST85 and (D) JST 136 
patchy low level expression is detected showing a similar pattern to A and B. (E) 
JST71 shows very faint 3gal expression and (F) JST100 shows high level expression 
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Figure 2.4 	Predicted integrations producing intron-containing 
transcripts 
The 30% of secretory trap lines which produce intron-containing transcripts can arise 
in two ways shown in (A) and (B). An uncapped p01 I primary fusion transcript is 
produced. (I) Cis-splicing to a cryptic splice donor site within the En2 intron 
produces a transcript containing the 5 region of the intron. Such transcripts are 
predicted not to be translated as they are uncapped and the En2 intron contains stop 
codons in all three frames. (H) Trans-splicing of the En2 splice acceptor to the splice 
donor site produces a capped mRNA that can be translated to give a J3geo fusion 
protein. (B) Insertion of the secretory trap vector into an exon of a poi II would 
produce a primary transcript in which the introduced splice acceptor would compete 
for the endogenous splice donor with the endogenous splice acceptor. (I) Splicing of 
the endogenous splice acceptor to the splice donor would produce an intron containing 
transcript. A functional fusion protein would not he produced from this transcript due 
to the stop codons in the En2 intron. (II) Splicing of the vector splice acceptor to the 
splice donor would result in the removal of the partial endogenous exon from the 
transcript together with the En2 intron sequences. The transcript is capable of being 
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transcripts were characterised. Both clones contained vector insertions in rRNA genes 
which are transcribed by RNA polymerase 1 (J.E. Sleeman & W.C. Skarnes, 
unpublished results). Insertions into rRNA genes appear to participate in trans-
splicing as 5' RACE products contain not one, but several different endogenous gene 
sequences joined to the splice acceptor of the vector. It is thought that the uncapped 
RNA polymerase I transcripts are very poor substrates for cis-splicing, however the 
splicing machinery assembled at the splice acceptor of the vector is free to interact with 
other splice donors in trans (W.C. Skarnes, pers communication). Upon insertion 
into an exon of a polymerase II gene, the splice acceptor of the vector is expected to 
compete with the splice acceptor of the disrupted exon. Although this second class of 
event is likely to be mutagenic, it is likely that wild type transcript would be present 
and thus not represent a complete loss-of-function allele. 
Lines producing fusion transcripts containing vector intron sequences were 
eliminated from the screen using RNA dot blot analysis. Twenty-four JST lines were 
analysed and 7 (29 %) were shown to produce intron containing transcripts. To 
assess whether a unique fusion transcript was produced in the efficiently spliced lines, 
7 were analysed by Northern hybridisation using a Lac Z probe (Figure 2.5B and data 
not shown). A single major fusion transcript hybridised to LacZ in all lines analysed 
although the signal intensity varied between lines. Transcripts ranged between 4 kb 
and over 9 kb in size. Since the vector sequences compose 4kb of the fusion 
transcript, fusion transcripts included up to 5kb of the endogenous gene. 
2.4 Identification of endogenous genes carrying insertions 
5'RACE was used to clone cDNA sequences spanning the vector splice 
junction in 13 intron negative lines (outlined in Figure 2.6). To monitor the efficiency 
of 5' RACE an aliquot of the second round products were dot blotted and hybridised 
with a vector specific exon probe which spans the splice acceptor site of the vector and 
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Figure 2.5 Analysis of transcripts in JST lines 
(A) RNA dot blot analysis was used to eliminate lines producing intron containing 
transcripts. RNA dot blotted in duplicate and transferred to filters and hybridised to a 
LacZ probe or En2 intron probe (See map on Figure 2.7). All six lines hybridised 
with varying intensities to LacZ but only two, JST 100 and JSTI30, hybridised to 
En2 intron. To control for differences in amounts of sample loaded, both filters were 
stripped and rehybridised to a -actin probe. (B) The size of individual fusion 
transcripts, analysed by Northern hybridisation using a LacZ probe. Single fusion 
transcripts were detected in each line which varied in size from 4kb to over 9kb. 
Expression levels are very different between lines (compare JST 184 to J5T219). The 
contribution from the vector to the fusion transcript is estimated to be 4 kb (0.18 kb of 
En2, 0.68 kb of CD4 fused to 3.03 kb of lgeo and the 0.1-0.2 kb poly A tail). (C) 
Ethidium bromide staining of RNA samples showing 28S rRNA which acts as a 
loading control. 



















Figure 2.6 S'RACE used to identify endogenous genes 
Two routes to identify endogenous genes using a 5'RACE strategy. 
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is expected to be present in fusion transcripts (Figure 2.71). A strong exon-specific 
signal was present in all but one line (JST184; data not shown). Further analysis of 
JST184 is reported in section 2.6. 
Initially five lines were cloned into pBluescript IIKS+. The resulting clones 
gave between 73 and 515 bp of endogenous sequence (Table 2.1). At least two 
independent RACE clones from each line were sequenced. Subsequently the 
remaining 8 lines were sequenced directly from RACE PCR products using a protocol 
developed in the laboratory (Townley et al., 1997). Second round products for these 
8 JST lines were biotinylated and immobilised on streptavidin beads. Following 
denaturation, single stranded products were cycle sequenced using a 32P end-labelled 
En-2 primer. 
A single unique sequence ladder was obtained for each line except JST232. In 
this line there were clearly two sequences superimposed on each other. Careful 
scrutiny of the double sequence in line J5T232 revealed that one sequence 
corresponded to a properly spliced fusion transcript in which sequences from the 
RBP-Jx pseudogene were joined to the splice acceptor (Figure 2.7B). The second 
superimposed sequence was identified as vector CD4 sequence which was also joined 
to En-2 sequence but on this occasion the genuine splice acceptor had not been 
utilised. Separating the CD4 and En-2 sequence were 9bp of unknown sequence, 
upstream of CD4 were rRNA sequences (Figure 2.713). It is unclear how this product 
arose but the most likely explanation is the integration of, and splicing within, tandem 
copies of the vector. It remains possible that JST232 carries multiple insertion sites or 
represents a mixed colony. 
2.5 Sequence analysis of endogenous genes 
In 8 JST lines, the I3gal ORF continued upstream into novel endogenous 
sequence; however 4 lines demonstrated no upstream ORE continuity (Figure 2.7C, 
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No open reading frame 	 * E E G P R S R K P K K K 
A P Q D D S I G G 	S QV P KT K E E 
Figure 2.7 Endogenous genes utilise the vector splice acceptor site 
(I) Schematic of pGT1.8TM showing sites of RACE primers and probes. The 
primer numbers are based on Figure 2.6. (II) Structures of the two products directly 
sequenced from JST232. The top product is correctly spliced, the lower may be a 
result of splicing within vector sequences or may be a consequence of vector 
rearrangment. (III) Nucleotide and amino acid sequence of the secretory trap splice 
acceptor and the endogenous genes in two JST lines. (A) Sequence of En2 splice 
acceptor in pGT1 .8TM (intron sequences shown in lowercase and exon sequences in 
uppercase). The consensus splice acceptor nucleotides including the pyrimidine 
stretch are underlined. The splice site is marked with a vertical arrow. Nine amino 
acids of the En2 reading frame which are fused in-frame with the 3geo reporter are 
shown. (B) Eight out of twelve JST lines produce a fusion transcript with endogenous 
sequences encoding a protein in the same frame as the vector reporter gene. For 
example the endogenous cDNA cloned from JST203 is shown to encode a protein in 
the same frame as 3geo. (C) The lack of an open reading frame in the same frame as 
geo in three of the JST lines is due to the insertions having occurred in 5'UTRs. In 
the remaining line, JST85, the endogenous protein reading frame (in italics) is in a 
different frame to 3geo. The reporter activity seen in this line is thought to be a 
product of internal initiation of translation from one of the methionines within the 
vector. 
Table 2.1 5' RACE sequence information for JST lines 
Line 5RACE ORF Database BLAST score * Insertion site Gene 
sequence accession number 
(nucleotide) (amount 
in bp) 
Identified by cloning 
JST184 57 5'UTR no match n/a n/a novel 
JST185 448 in frame U40060 4.3 x l0- 1595** novel 
JST191 73 in frame AA 118295 (EST) 2.5 x 10-12 n/a novel 
JST197 51 5UTR U06939 3.6 x 10-08 162 non-muscle myosin heavy chain 
JST2I9 515 in frame X87241 3.6 x 10-135 3763 fat-like cadherin 
Identified by direct sequencing 
JST51 85 in frame Z19521 1.5 x 10-25 433 LDL receptor 
JST62 100 in frame D31887 1.6 x 10-22 575 myeloblast cDNA 
JST7I 120 in frame J04633 94 x 1749 heat shock protein 86 
J5T85 145 out of frame D28476 1.7 x 10-52 208 myeloid cDNA 
JST136 46 5UTR D21729*** 6.0 x 10-06 70 p23 
JST203 80 in frame M27917 2.0 x 10-23 1023 P 1,4-galactosyltransferase 
JST213 71 in frame U95727 8.0 x 10- 17 192 DNA-J2 homologue 
JST232 50 5'UTR M81871 5.5 x 10-10  236 RBP-Jic/Su(H) pseudogene 
* 	All are BLASTN scores except JST185 which refers to BLASTX score 
** Insertion site within J5T185 cDNA sequence (See Chapter 4) 
* * * Murine est which is 97 % identical to human p23 
n/a 	not applicable 
Table 2. 1 & Appendix II). The endogenous sequences were compared to the non-
redundant GenBank databases using the BLASTN and BLASTX algorithms (Altschul 
et al., 1990). The BLASTN program searches for stretches of nearly identical 
sequence, and matches are scored according to the probability of their occurrence by 
chance alone. BLASTX compares a nucleotide query sequence translated in all 
reading frames against a protein sequence database. Ten sequences were perfect or 
close matches to database entries (Table 2. 1). JST191 did not show any homology to 
any cDNA entries but closely matched a human and mouse expressed sequence tag 
(EST) in the DBEST GenBank database. JST185 did not show homology to any 
entries in either the non-redundant or DBEST databases but showed structural 
similarity to two hypothetical C. elegans proteins using the BLASTX algorithm. A full 
description of the JST185 sequence is presented in Chapter 4. 
Three of the 12 insertions occurred in known secretory molecules; the LDL 
receptor (JST51), the murine homologue of Drosophila fat (JST219) and f31,4-
galactosyltransferase (JST203). Using a program available on the world wide web, 
TMpred, (http ://ulrec3 .unil .ch/software/TMPRED_form. html) the predicted open 
reading frames of the novel set of JST sequences were analysed for hydrophobic 
sequences that might act as signal sequences or transmembrane domains. This 
program identifies putative membrane-spanning regions in the primary amino acid 
sequence and also predicts the possible orientation of these segments in the membrane. 
TMpred uses a combination of multiple weight-matrices that have been extracted from 
a statistical analysis of the annotated transmembrane proteins present in SwissProt. 
Another three sequences (JST62, 185 and 213) showed homology to cDNA sequences 
of unknown function that contain hallmarks of secreted gene products. 
JST62 shows 85% identity at the protein level to a human myeloblast cDNA 
and therefore may represent either the murine homologue of this gene or a closely 
related family member. The myeloblast cDNA is predicted to have 9 transmembrane 
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domains but there is no obvious signal sequence. The lack of the signal sequence may 
be genuine or may reflect the fact that the database entry for the myeloblast cDNA does 
not encode an initiating methionine, suggesting that the open reading frame is 
incomplete. Comparison between JST62 and the myeloblast protein predicts that the 
secretory trap insertion occurred after the second transmembrane domain. Similarly, 
the full-length JST185 coding sequence is predicted to encode 9 membrane-spanning 
domains upstream of the site of insertion (see Chapter 4). 
The gene interrupted in JST213 shows 95% identity over 23 amino acids to 
both a rat sequence, DnaJ homologue 2 (U95727), and a human sequence, Dnj3/Cpr3 
(AFO 11793). Over their entire lengths, the human and the rat proteins are 57% 
identical to each other. Such similarity suggests that these two genes and JST213 may 
be homologues. The human and rat sequences show 73% identity over a 73 amino 
acid motif (the J domain) that is conserved in proteins of the DnaJ family of 
chaperonins. The TMpred program predicts a strong transmembrane domain in the 
both the human and rat sequences upstream of the region of JST213 homology. 
The RACE sequence for JST191 does not show homology to any cDNAs in 
the database but shows 80 % identity to a murine EST isolated from a 13.5dpc embryo 
(AA 1 18295). The predicted open reading frame for the EST contains multiple proline 
residues. The I3gal staining pattern in JST191 ES cells suggests that it carries an 
insertion in a secretory molecule, however, the available sequence is too short to be 
informative. 
Unexpectedly, five of twelve insertions occurred in known or predicted non-
secretory molecules; heat shock protein 86 (JST7I), cytoplasmic p23 (JST136), non-
muscle myosin heavy chain (JST 197) and a pseudogene of a murine homologue of the 
Drosophila transcription factor Suppressor of Hairless, (JST232). The latter three 
insertions occurred in 5'UTRs. JST85 carries an insertion in a novel cDNA from 
36 
myeloid cells which has no hallmarks of a secretory molecule. However the myeloid 
protein coding sequence is fused out of frame with 3geo. In four out of five of these 
non-secretory insertions there is no endogenous open reading frame in the same frame 
as fgal. These results indicate that 3gal activity is detected in these lines via internal 
initiation of translation from one of the vectors methionines 
2.6 Vector deletion prior to insertion 
Dot blot analysis of second round amplified products revealed that JST184 
RNA could not be amplified with the primers routinely used for RACE. Northern blot 
analysis confirms the presence of a fusion transcript in the RNA prepared from 
JST184 ES cells (Figure 2.513). This suggests that the lack of amplification may be 
due to deletion of one or more of the primer sites in the vector prior to its insertion in 
the genome. The observation that the JST1 84 fusion transcript is only slightly larger 
than the 4 kb expected to be contributed by the vector is consistent with partial deletion 
of vector sequences. 
A second set of primers were designed which are located further 3' in vector 
sequences than the primers routinely used for 5' RACE of secretory trap lines (Figure 
2.8A). Several RACE clones of different sizes were obtained and sequencing revealed 
that each clone contained 160 bp of CD4 sequence and up to 60 bp of novel sequence. 
The novel sequence did not encode an open reading frame with 3geo. This suggests 
that either part of the vector has been deleted, or an alternative splice acceptor site in 
the CD4 sequence is being used. To investigate these alternatives the sequences 
flanking the insertion site were cloned from genomic DNA using ligation-mediated 
(LM) PCR (outlined in Figure 3.4). This is a single-sided PCR method that requires 
specification of only one primer hybridisation site, the second is defined by the 
ligation-based addition of a unique DNA linker. This linker, together with the vector-
specific primer, allows amplification of DNA fragments flanking insertion sites. 
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igure 2.8 Vector deletion occurs prior to insertion in JST184 
SJ.) The primers routinely used to amplify cDNAs from secretory trap lines are indicated on a map of 
3T1.8TM as open arrow-heads, (1st round synthesis, #92; 1st round PCR, #67; 2nd round PCR, #55; 
quencing, #98). These primers failed to amplify a product from JST1 84 RNA. Primers were designed 
rther 3' in the vector sequence to examine whether the failure to amplify was due to deletion of the primer 
tes. The new primers are indicated as filled arrowheads (1st round synthesis, #78; 1st round PCR, #79; 2nd 
'und PCR, #80; direct sequencing, #147). (B) RACE clones contained only 160 bp of CD4 sequence 
dicating that 2265 bp of vector sequence had been deleted. (C) A junction fragment was amplified using 
M-PCR (see Chapter 6 for details). The fragment contained the same amount of CD4 sequence as the RACE 
one confirming that 2265 bp of vector had been deleted prior to insertion. Immediately upstream of the CD4 
as 23 bp of sequence which was identical to that found in the RACE clone. The next 55 bp of sequence was 
fferent. Presumably the genomic clone extends into intron sequence and the RACE clone extends into further 
on sequence. (D) Representation of proposed insertion in JST184. 
RACE 
LM-PCR 
Genomic DNA prepared from JST184 ES cells was digested with a frequent 
cutter enzyme and denatured. Nci I was used for the digestion as it does not cut at the 
5' end of the pGT1.8TM vector and because its target site is made up of C and G 
nucleotides. Northern blot analysis suggested that the vector insertion had occurred 
towards the 5' end of JST184 possibly in the promoter region which may be expected 
to be rich in C and G nucleotides. DNA was synthesized using a primer directed 
against LacZ sequences and the adapter ligated. PCR was performed using primers 
directed against vector CD4 sequences and an adapter primer. The products were 
digested with XbaI which cuts within the linker and cloned into pBluescript IIKS+ 
digested with Xba and EcoRV. The sequence revealed the same amount of vector was 
present as observed with the RACE clone (Figure 2.8Q. This suggests that 2.3 kb 
of sequence, including the En-2 splice acceptor, had been deleted from the vector prior 
to insertion in the genome. 
In the genomic clone the first 22 bp of sequence fused to the vector CD4 was 
identical to that found in the RACE clone. This suggested that the vector insertion had 
occurred in an exon. A further 66 bp of sequence differing from that found in the 
RACE clone was fused to the exon in the genomic clone. This may correspond to 
intron sequence although there is no consensus splice site between the two sequences. 
In the RACE clone 35 bp of novel sequence is fused to the 22bp of exon sequence 
which may correspond to an upstream exon. The lack of an open reading frame in the 
RACE clone suggests the JST 184 insertion occurred in an untranslated exon. The 
small number of base pairs which contribute to the fusion transcript suggests that the 
insertion occurred in the 5' UTR (Figure 2.8 D). The JSTI 84 sequence did not match 
any entries in GenBank. 
2.7 Expression patterns associated with JST insertions 
To identify developmentally regulated genes the expression pattern of the 
reporter was monitored in chimeric embryos. Expression was analysed in 11 cloned 
lines between 8.5 and 10.5 dpc. To investigate the potential for active l3gal in 
inefficiently spliced lines, 3 additional intron -containing lines were analysed. 
Embryos were stained whole with X-gal to visualise lacZ expression. Different 
chimeric embryos produced from any particular cell line showed identical staining 
patterns. 
A variety of X-gal staining patterns were observed in chimeras generated from 
the different cell lines (Figure 2.9 and Table 2.2). Four of the lines, including the 
three lines which produce intron containing transcripts, did not express lacZ at the 
developmental stages analysed. In three lines, lacZ expression was detected in all 
tissues. Seven lines exhibited developmentally regulated patterns of expression. 
2.8 Germline transmission of JST insertions 
C57131/6 blastocysts injected with JST ES cells were allowed to develop to 
term within the uteri of pseudopregnant mothers. The ES cell contribution to offspring 
was estimated on the basis of coat colour. Male coat-colour chimeras were test bred to 
C57131/6 females and generation of agouti offspring indicated successful germline 
transmission. Offspring were genotyped by dot blotting tail biopsy DNA and 
hybridising with a neo probe. Offspring heterozygous for secretory trap insertions 
were back crossed to C57131/6 to dilute the CGR8 genetic background, which may 
have accumulated mutations during culture. The resultant F2 offspring were then 
intercrossed 'and offspring were genotyped by dot blotting. Clear differences in signal 
intensity were seen between heterozygotes and homozygotes as long as the protocol 
for tail biopsy size was strictly adhered to (data not shown). 
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Figure 2.9 Reporter expression in JST ES cell line derived chimeras 
Reporter expression was analysed between 8.5 -. 10.5dpc chimeras (A-E,G-I) or 
heterozygotes (F). (A) JST62. I Dorsal view of 8.5dpc embryo reveals LacZ 
expressed at high levels in the primitive streak (ps). II Lateral view of a late 9dpc 
embryo.. Expression in ventral half of the neural tube (nt). (B) JSTI84. I Lateral 
views of 9dpc and lO.Sdpc embryos. High levels of expression in the developing eye 
(e) and in the intermediate mesoderm (im). Expression is absent from the branchial 
arches (b). A day later expression is seen in the ventral neural tube (nt). (C) JST85. 
Lateral and dorsal views of 8.5dpc embryos. (D) JST197. Semi-lateral view of 
lOdpc thoracic regions show expression restricted to the developing heart (h). (E) 
JST203. I Ventral views of 8.5dpc embryos, expression restricted to the border of 
the closing yolk sac (ys). II Lateral views at lO.Sdpc show expression at high levels 
in the developing heart. Clusters of staining cells around somitic vessels in most 














Figure 2.9 cont 
(F) JST213. I Ventral view of 8.5dpc embryo shows high level of expression in the 
region of the foregut which corresponds to the liver diverticulum (id). II A dorsal 
view of the same embryo shows high levels of expression in the closing head folds 
(hf). III Lateral view of 10.5dpc embryo reveals expression throughout the 
neurectoderm with higher levels in the ventral neural tube (nt) and at the border of the 
hindbrain and midbrain, called the isthmus (i). The highest level of expression is seen 
in the liver (1). (G) JSTI9I. I Lateral view of 1 ldpc embryo. High levels of LacZ 
expression are seen in the nasal placode (np). the limb buds (lb) and between the first 
and second branchial arches. Low level staining in seen in the neural tube. Sections 
reveal high levels of expression in the spinal, trigeminal and facial ganglia (sg. tg & 
fg). II Dorsal view of forelimb bud with anterior at the top of the figure. Two 
regions of high expression are seen in the proximal region of the limb bud in both a 
posterior (P) and anterior (A) region. In more distal regions expression is absent from 
the apical ectodermal ridge but is seen in the mesenchyme (mes) surrounding forming 
digits. III Transverse section through the proximal limb bud shows the anterior and 
posterior regions of expression (dorsal, d and ventral, v). (H) JST51. Lateral view 
of 8.5dpc embryo showing widespread expression. (I) JST2I9. Dorsal and lateral 
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Table 2.2 Summary of JST expression patterns 
Line 	Gene 	 3gal expression pattern 
JST5 1 	LDL receptor 	 Widespread at 9dpc 
JST62 	novel 	 At 8.5dpc high levels of expression are seen in the primitive streak ectoderm, lower levels are present in anterior neurectoderm. Expression 
is absent from extra embryonic tissues. At 9.5dpc expression is restricted to the ventral half of the neural tube. 
JST85 	novel (myeloid cDNA) 	LacZ is expressed throughout embryonic but not extraembryoinc regions. In most chimeras the anterior neural folds failed to close. The 
severity of the head phenotype is proportional to the level of LacZ expression and therefore proportional to the contribution of ES cells to 
the chimera 
JST1 84 novel 	 At 9pc high levels of expression are seen in the developing eye and in the intermediate mesoderm. Lower levels of expression are seen 
elsewhere in the neurectoderm and brain but expression is absent from the branchial arches. A day later expression continues at high levels 
in the eye, the developing urogenital system and the ventral neural tube. 
JSTI85 novel 	 At 8.5dpc expression is restricted to lateral mesoderm which provides mesenchyme for the developing viscera. At 9.5 and 10.5dpc 
expression is seen in the mesenchyme surrounding endodermal epithelia. Lower levels of expression are seen in the ventral midline of the 
neural plate. (Further details in Chapter 4). 
JSTI91 novel 	 AT lldpc high levels of LacZ expression are seen in the nasal placode, the limb buds and between the first and second branchial arches. 
Low level staining is seen in the neural tube. Sections reveal high levels of expression in the spinal ganglia, the trigeminal ganglia and in 
specific cranial ganglia. Two regions of high expression are seen in the proximal region of the limb bud in both a posterior and anterior 
domain. In more distal regions expression is absent from the apical ectodermal ridge but is seen in the mesenchyme surrounding forming 
digits. 
JST197 non-muscle myosin 	At 10.5dpc expression is restricted to the heart. 
JST203 31,4 gal actosyl tran sferase At 8.5dpc expression is restricted to the border of the closing yolk sac. By lO.Sdpc expression is restricted to the developing heart. 
Sections show lower levels expressed in the liver. Higher magnification shows expression in isolated round cells of unknown origin 
throughout the embryo, they are often found clustered around blood vessels suggesting they may be blood or capillary cells. Most of the 
chimeras are severely abnormal. 
JST2I3 novel (DNA-J like) 	At 8.5dpc high levels of expression are found in the region of the foregut which corresponds to the liver diverticulum. Expression is also 
seen at the edges of the closing neural folds. By 10.5dpc expression becomes more widespread and is seen throughout the neurectoderm 
with higher levels in the ventral neural tube and at the border of the rhombencephalon and midbrain. The highest level of expression is 
seen in the liver. 
JST2I9 novelfat-like cadherin 	Widespread expression at 8.5 and 9.5 dpc. Some chimeric embryos are abnormal. 
Eight JST lines were injected into blastocysts and tested for germline 
transmission of which only three lines were successfully transmitted; JST51 (LDL 
receptor), JST185 (novel) and JST213 (DNA-i like) (Table 2.3). This rate of 
germline transmission compares unfavourably with a previous experiment using the 
same CGR8 ES cell line. 1 germline male was produced per 20 blastocysts injected 
and only 40% of lines contributed to the germline, whereas previously 1 germline male 
was produced per 10 blastocysts injected and 80% of lines contributed to the germline 
(W.C. Skarnes, unpublished results). This drop in germline efficiency is thought to 
result from the later passage ES cells used in this experiment than previously. Culture 
may bias towards the growth of a population of germline incompetent ES cells. This 
hypothesis is borne out by the fact that a clonal subline of earlier passage CGR8 cells 
gives a much higher efficiency; I germline male is produced per 5 blastocysts injected 
and 90% of gene trap lines contribute to the germline (W.C. Skarnes, unpublished 
results). 
The JST5 1 insertion was bred to homozygosity and, in agreement with 
published data for a null mutation in the LDL receptor, homozygous animals were 
viable and fertile (data not shown). JST213 homozygous animals were also found to 
be viable and fertile. The JST185 insertion results in neonatal lethality and is 
presented in Chapter 4. 
2.9 Discussion 
Insertions detected in type I, type II and multiple membrane-spanning 
proteins 
In the original report describing the secretory trap vector, 6 out of 6 insertions 
occurred in extracellular domains of secreted and type I membrane-spanning proteins 
showing that the vector selects for insertions in genes encoding N-terminal signal 
sequences (Skarnes et al., 1995). The results presented in this chapter now extend 
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Table 2.3 Summary of information on JST lines 
Line 	Insertion sitef 	Gene 	 Gene function 	 Expression 	Germline 	Phenotype 
pattern in transmission 
chimeras 
Secretory proteins 
JST5 I coding (intron) 
JST62 coding (intron) 
JSTI 85 coding (intron) 
JST191a coding (intron) 
JST203 coding (intron) 
JST2 13 coding (intron) 
JST2 19 coding (intron) 
Non-secretory proteins 
JST7 I coding (intron) 
JST85 coding (intron)C 
JSTI36 5UTR (intron) 
JSTI97 5UTR (intron) 
JST232 5UTR (intron) 
Unknown protein 
JSTI 84 	5UTR (exon )e 
LDL receptor uptake of lipoproteins into cell widespread yes viable 
myeloblast cDNA unknown (multiple TM domains) restricted no rd 
novel unknown (multiple TM domains) restricted yes perinatal lethal 
novel unknown (proline rich protein) restricted no rd 
31,4-galactosy1transferase multiple (inc. cell adhesion) restricted not tried neonatal lethald 
DNA42 homologueb molecular chaperone restricted yes viable 
fat-like cadherin cell adhesion molecule widespread no rid 
heat shock protein 86 unknown rid not tried rd 
myeloid cDNA unknown (contains ubiquitin ligase domain) widespread no rd 
p23 complexes with progesterone receptor rid not tried rd 
non-muscle myosin heavy chain mediates actin-based motility restricted no rid 
RBP-Jrc/Su(H) pseudogene transcription factor pseudogene no stain not tried rid 
novel unknown restricted not tried rd 
a 	3gal staining in ES cells exhibits a typical secretory pattern 
b predicted to have a transmembrane domain 
C 	endogenous gene in a different frame to reporter 
d reported in Lu et al., 1997 
e 	2.3 kb of vector deleted prior to insertion 
' coding intron signifies an insertion into an intron within the open reading frame 
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Figure 2.10 Membrane topology of JST fusion proteins 
Fusion proteins which place the vector CD4 TM domain in a type I orientation in the ER membrane are 
thought to expose f3gal to the cytosol where it is active. In single membrane spanning proteins insertions 
are detected if they occur downstream of a signal sequence (A) or downstream of a type II transmembrane 
domain (B). If the insertion occurs in a multimembrane spanning molecule it must occur downstream of a 
type II domain to allow I3gal to be detected (C). 
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Figure 2.11. Membrane topology of CD4 fusion proteins 
(A) The difference in the charge between the first 15 residues flanking a transmembrane 
domain can be used to predict its orientation, with the more positive portion facing the 
cytosol (Hartmann etal, 1989). Arginine (R) and lysine (K) are given a value of +1, 
histidine +0.5, and aspartatic acid (D) and glutaniic acid (E) -1. The charge differential, 
A(C-N), for CD4 is +2.5. This positive value predicts that CD4 is a type I transmembrane 
domain. However, the highly charged N-terminal portion of the vector, which includes 23 
charges from En-2 and 34 charges from CD4, makes the transmembrane domain behave in 
a type II manner. Inframe fusions to non-secretory genes will result in the I3gal reporter 
downstream of the TM being placed in the lumen of the ER where it is inactive. (B) 
Fusions to secretory molecules containing a signal sequence are always placed in a type I 
orientation which places Pgal in the cytosol where it is active. (C) Fusions to 5'UTRs or 
those which are out of frame with the reporter can only be detected if translation is initiated 
within the vector. A Kozak consensus methionine upstream of the transmembrane domain 
produces a truncated fusion protein which only contains 3 charges in its N-terminus. The 
paucity of charges allows the N-terminus of the fusion protein to be translocated across the 
ER membrane leaving I3gal in the cytosol where it is active. In this manner insertions into 
non-secretory molecules can be detected. 
the range of secretory molecules to include type II membrane receptors as well as 
multiple membrane-spanning proteins (Table 2.3). As was predicted for N-terminal 
signal sequences, insertions downstream of a type II membrane-spanning region are 
also expected to place Bgeo in the cytosol where it is active (Figure 2. 10). The same 
holds true for multiple membrane spanning proteins if the vector inserts downstream 
of a type H membrane-spanning region. 
Insertions detected in non-secretory proteins 
My results also indicate that the secretory trap vector enriches but does not 
absolutely select for insertions in secretory molecules. Five out of twelve JST 
insertions were associated with non-secretory molecules. It is noteworthy that three 
insertions had occurred in 5' untranslated region of the target gene and a forth was out 
of frame with the target gene. This suggests that BgaI protein is produced via internal 
initiation of translation from one of the 7 in frame methionines within the CD4 
sequences of the vector. One of the methionines located upstream of the CD4 
transmembrane domain has an excellent Kozak consensus (Kozak, 1987). Although 
internal initiation of translation at this site offers an explanation for how the reporter 
might be made such a product should be inactive. 
To investigate this apparent anomaly the CD4 transmembrane domain of the 
vector was re-examined. The Hartmann charge-difference rule predicts that CD4 
should in fact adopt a type I orientation in the membrane (Figure 2. 11 and Hartmann, 
1989). This contradicts the entire basis of the selective property of the vector as the 
CD4 transmembrane domain is thought to place fusions that do not acquire a signal 
sequence in a type II orientation by default. However, not all transmembrane domains 
fit the charge-difference rule: analysis of 126 proteins revealed 7 proteins that do not 
fit the rule (Hartmann, 1989). All 7 proteins were predicted to be type I but in reality 
behaved as though they were type II. Most of the exceptions contained a total of 17 or 
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more charged residues in their N-termini. These highly charged segments are thought 
to prevent the translocation of the amino terminus across the membrane thus placing 
the protein in a type II orientation. Indeed the addition of positive charged residues to 
the type I membrane protein cytochrome P-450 has been shown to convert it to a type 
H protein (Szczesna-Skorupa et at., 1995). In the secretory trap vector both CD4 and 
En-2 contribute highly positively charged segments to the N-terminus of the fusion 
protein (Figure 2. 11 A).  The presence of this charge may account for the fact that the 
CD4 transmembrane domain behaves as a type II domain within the context of the 
vector. 
Internal initiation of translation would lead to the production of a truncated 
fusion protein which lacks positive charges encoded by the N-terminal part of the 
vector (Figure 2. 11). Removal of these positive charges may cause the CD4 
transmembrane domain to revert back to type I behaviour. Similar types of reversion 
have been documented but they were only partial. For example inversion of the 
charge difference between the segments flanking the membrane spanning domain of 
the asialoglycoprotein (ASGP) from -3 to +5 yielded mixtures of type II and type I 
topologies (Beltzer et al., 1991). Thus internal initiation of translation allows 
insertions into non-secretory molecules to be detected as 3gal activity no longer 
depends on the acquisition of a signal sequence. The I3gal activity in such lines tends 
to be expressed at very low levels and may reflect a mixture of active and inactive 
enzyme topologies (Figure 2.3). Only those lines showing a clear "secretory" pattern 
were selected in the preliminary study, explaining why no insertions were detected in 
non-secretory molecules (W. C. Skarnes, pers. conmi). 
It is unclear why the in-frame insertion in the heat shock protein (hsp) 86 in 
line JST7 1 produces detectable 3gal activity. However, TMpred predicts a type II 
membrane-spanning domain in hsp86 upstream of the insertion site which would place 
the fusion protein in an active type I orientation. Alternatively there is evidence to 
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indicate that the orientation of the transmembrane domain can be affected by the 
folding state of the N-terminal domain (Denzer et al., 1995). Tightly folded N-
terminal domains hinder and can prevent translocation whereas destabilisation or 
unfolding facilitates translocation. It is possible that the fusion to Jgeo may somehow 
destabilise the N-terminus of hsp 86 allowing it to be translocated. 
Developmental regulation of reporter activity in JST lines 
All the JST lines which show detectable levels of expression in ES cells were 
expressed in either a widespread or restricted pattern in embryos during early 
gestation. The four JST lines which did not express in the embryo include the three 
intron containing lines and J5T232. The latter carries an insertion in a pseudogene of 
RBP-JK/Su(H). Although the endogenous RBP-JK/Su(H) is expressed during 
development the pseudogene is expected not to be expressed as promoter elements are 
usually missing from pseudogenes. It is not clear why the three lines which produce 
intron containing transcripts express pgal activity in ES cells, yet do not express in the 
early embryo. Either the level of expression is higher in ES cells than embryos or the 
staining method is less sensitive in embryos. However it is clear that these events 
always represent very low levels of I3gal activity. 
A number of novel genes associated with interesting developmentally regulated 
patterns of reporter gene expression were identified in the JST screen. For example, 
JST62 carries an insertion into a novel multiple membrane spanning molecule which is 
expressed at high levels in the developing nervous system. JST191 carries an 
insertion in a novel proline rich protein which is expressed at high levels in the limbs, 
various ganglia and the nasal placode. JST1 84 is expressed almost exclusively in the 
developing eye. 
JST213 carries an insertion in a membrane spanning DnaJ-like protein. The 
prototypical bacterial DnaJ protein is a molecular chaperone which is involved in 
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protein folding and translocation across biological membranes (Ziegeihoffer et al., 
1996). The gene interrupted in JST213 shows 95% identity to a rat and human 
sequence. Unlike bacterial DnaJ both these sequences are predicted to have 
transmembrane domains. JST213 also shows 61% identity to a murine EST, Nedd-7 
(accession D10917), which was isolated on the basis of its high expression in the 
mouse neuronal precursor cell (NPC) and its down-regulation in adult brain (Kumar et 
al, 1992). Two human homologues of Dna-J have also been isolated which show 
restricted expression patterns in the brain, both are preferentially expressed in neurons 
(Cheetham et al., 1992). Interestingly, the expression of the f3gal reporter in 8.5dpc 
JST213 embryos is detected in the anterior closing neural folds. The JST213 insertion 
was transmitted through the germ-line and homozygous animals are viable and fertile. 
JST203 carries an insertion in f1,4-ga1actosyltransferase (GalTase). Several 
studies have suggested that GalTase acts as a surface receptor for extracellular ligands 
during a variety of cellular interactions (Hathaway & Shur, 1996 and references 
within). To date, the 3gal reporter in JST203-derived chimaeric embryos is expressed 
solely in the developing heart. Studies have shown that GalTase is expressed in 
individual cells of the morula before compaction and later in migrating neural crest 
cells (Bayner et al., 1988; Hathaway and Shur, 1992). Intriguingly, mice carrying a 
targeted mutation in GalTase die a few weeks after birth due to a pituitary insufficiency 
(Lu etal., 1997). Unfortunately the JST203 insertion was not transmitted through the 
germline. Further studies should address whether Pgal is also detectable in the 
pituitary. 
JST219 carries an insertion in the murine homologue of the Drosophila tumour 
suppressor fat which is essential for controlling cell proliferation during Drosophila 
development (Mahoney et al., 1991). The gene encodes a large transmembrane 
protein with 34 tandem cadherin repeats, five EGF-like repeats, and a laminin A-G 
domain. JST219 is 88% identical to the human homologue of FAT which is expressed 
in epithelia and in some mesenchymal compartments (Dunne et al., 1995). Higher 
levels of human FAT expression were observed in fetal, as opposed to adult tissue, 
suggesting that its expression may be developmentally regulated in these tissues. 
Surprisingly, the reporter in JST219 was expressed ubiquitously and at very high 
levels in embryos analysed between 8.5 and 10 dpc. Line ST519, which was 
identified in the original secretory trap screen, carries an insertion in another Fat-like 
cadherin (Skarnes et al., 1995). ST5 19 is 81% identical to FAT. Unlike JST219, the 
reporter in ST5 19 is not expressed in ES cells, suggesting that these lines carry 
insertions in different but related genes. Several attempts have been made to transmit 
both these insertions through the germline but none have been successful. This failure 
may reflect the compromised germline transmission rate of the particular ES cells used 
in the electroporation, or may reflect a role for these Fat-like molecules in early 
development which is sensitive to a gene dosage effect. Alternatively the mutant Fat-
like molecules carrying the secretory trap insertions may be exerting a dominant 
negative effect on the endogenous molecules. 
In summary, the results presented in this chapter validate the secretory trap 
approach as a means to identify novel secretory molecules involved in mouse 
development. In future screens, secretory trap lines which do not show a clear 
secretory pattern of Pgal activity should not be analysed, as these often represent 
insertions in non-secretory genes. An alternative approach to eliminate non-secretory 
insertions would be to remove internal methionines from within vector sequences. 
This may prevent the detection of insertions into 5'UTRs which make up the majority 
of non-secretory insertions. 
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Chapter 3 
EXON TRAP SCREEN 
3.1 Introduction 
The requirement for pGT1.8TM to insert into introns is likely to favour 
insertions into genes composed of large intronic regions. Consequently, the vector 
will be biased against detecting insertions in genes containing few or no introns. 
There are several reports in the literature of intronless genes which play roles in cell 
signalling. Many of the genes encoding G protein-coupled receptors including 
members of the somatostatin receptor family (Patel, 1995) and serotonergic receptor 
family (Li et al., 1995) are intronless. Coding sequences of the recently discovered 
olfactory multigene family of serpentine receptors lack introns although members do 
contain introns in untranslated regions (Drutel et al, 1995). A recent report suggests 
that imprinted genes, including the secreted growth factor IGF2, contain fewer and 
smaller introns than non-imprinted genes (Hurst et al., 1996). Since genes composed 
of few or no introns represent a class of molecule that cannot be accessed with the 
Eno 
intron targeting vector, a new vector was designed to access insertions in these genes. 
This chapter describes the construction and preliminary experiments with an exon 
trapping version of the secretory trap vector, pET1 .8TM, which relies on insertion into 
the exons of secreted genes. 
3.2 Construction of exon trapping vector, pET1.8TM 
The pGT 1 .8TM vector contains the En-2 splice acceptor site upstream of the 
CD4 transmembrane domain and the Ogeo reporter. To construct the exon trap version 
of pGT1.8TM the En-2 sequences were deleted by digestion with Hind III and Bgl H. 
The vector backbone was gel purified and circularised by ligating adapters which re-
introduce a unique Hind III site. The new vector, pET1 .8TM, now relies on inserting 
into the exons of genes in the correct orientation and reading frame to generate a fusion 
transcript (Figure 3.1). 
3.3 Comparison between pGT1.8TM and pET1.8TM electroporations 
To compare the efficiency of the original and derivative vectors, pET 1.8TM 
and pGT1 .8TM, parallel electroporations were carried out under identical conditions. 
Vectors were electroporated into 5 x 10 CGR-8 ES cells. As expected, the 
pET 1 .8TM electroporation resulted in a reduction in G418 resistant colonies compared 
to pGT1.8TM (123 versus 205). Similar to previous observations 28% of pGT1.8TM 
colonies stained for pgal activity whereas 47% of pET 1.8TM colonies stained (Table 
3.1). Most of the I3gal positive pGT1.8TM lines showed the characteristic secretory 
pattern of pgal expression, in multiple cytoplasmic inclusions and in the pen-nuclear 
compartment of the cell. Surprisingly, only 4 pET! .8TM colonies showed this 
pattern, the remaining 54 displayed a variety of subcellular localisations (Figure 3.1). 
Roughly equal numbers of colonies showed nuclear, cytoplasmic, single dots and dots 
with cytoplasmic staining patterns (Figure 3.2). The different patterns of Pgal. activity 
are thought to reflect the differential sorting properties of the endogenous genes 
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Figure 3.1 Comparison of the structures of gene trap and exon trap vectors. 
The exon trap vector, pET1 .8TM, is derived from pGT1 .8TM by removal of the En2 splice 
acceptor sequences. 
SA 	 Genomic target 
pGTI.8TM 	 Intron 
En2 CD4 	3-geo 	pUC13 
pET! .8TM 	 Exon 
Table 3.1 Colony numbers generated with pGT1.8TM and pET1.8TM 
Number of colonies pGT1.8TM pET1.8TM 
neoR 205 124 
f3-gal staining (27%) 58(47%) 
secretory pattern 44(21%) 4(3%) 
other patterns 13(6%) 54(44%) 
Figure 3.2 Pgal activity ES cell lines carrying pET1.8TM insertions 
ES cell colonies carrying insertions of pET1.8TM show 3gal activity in a variety of 
subcellular localisations. (A) 'Secretory' pattern (ET74) (B) Nuclear (ET71) (C) 
Cytoplasmic (ET95) (D) Single dots per cell (ET50). (E) Shows small patches of 
expression (ET1 13) and (F) shows larges patches of stain with a tight border seperating 
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carrying insertions. Such a variety of patterns was unexpected and suggested that the 
selective property of the transmembrane domain in pET1 .8TM has been lost, so that 
insertions were possibly being detected in non-secretory molecules. Unfortunately, 
the 4 colonies showing the secretory pattern were lost to contamination and could not 
be studied further. 
3.4 ET lines produce fusion transcripts to endogenous genes 
Total RNA was prepared from 16 ET lines expressing detectable I3gal and 
analysed by Northern blot hybridisation with a Lac Z probe. A single major fusion 
transcript of varying size hybridises to lac Z in 11 out of the 16 lines analysed. Short 
auto radiographic exposures of Northern blots reveal that in the remaining 5 lines a 
complex array of minor transcripts hybridise as well as the major transcript (Figure 
3.3 and data not shown). Such a pattern of transcripts is often seen when gene trap 
insertions occur in rRNA genes and undergo trans-splicing (Figure 2.4). The 
complex array of transcripts may reflect a variety of trans-spliced fusion transcripts 
(J.E. Sleeman & W.C. Skarnes, unpublished results). 
Fusion transcripts varied in size from 3.5 kb to> 12 kb, although most (9 out 
of 16) were around 5 kb. The contribution from the vector to the fusion transcript is 
estimated to be 3.8 kb (0.68 kb of CD4 fused to 3.03 kb of fgeo and the 0.1-0.2 kb 
poly A tail). In ET93 over 7 kb of endogenous sequence contributed to the fusion 
transcript confirming that Pgal activity can be detected in the presence of large N-
terminal fusions. In most cases, less than 700 bp of endogenôus sequence 
contributed, suggesting that insertions tended to occur towards the 5' ends of genes 
(Table 3.2). In ET105, the transcript was estimated to be 3.5kb. As this is 300 bp 
less than the minimum contribution expected from the vector, this suggests that 
sequences were deleted from the vector prior to insertion in the genome. 
W.  
Figure 3.3 Northern blot analysis of ET lines 
2Opg of total RNA was separated on a denaturing agarose gel and analysed by Northern 
blot hybridisation to a LacZ probe. (A) 24 hour exposure to autoradiographic film. Three 
out of the seven lines contain a complex array of fusion transcripts (B) Seven day 
exposure. The remaining four lines contain a single fusion transcript between 4.5 and 6kb 
in size. (C) Loading control. Ethidium bromide stained gel. 













Table 3.2. Summary of information on pET1.8TM lines 














ET 2 dots & cytoplasm restricted 0.528 8 3.70 L 5'ETS 
ET 8 cytoplasm widespread nd nd nd nd nd 
ET 50 dots nd 0.521 5 0.7 L novel 
ET 80 nuclear nd 0.300 5 0.5 R novel (ORF) 
ET 82 nuclear widespread nd nd nd nd nd 
ET 94 dots & cytoplasm nd 0.496 >12 >7.7 L 28S rRNA 
ET 105 dots restricted 0.365 4.5 0.1 L + R novel (5'UTR) 
ET 111 dots & cytoplasm no stain nd nd nd nd nd 
ET 119 nuclear widespread nd nd nd nd nd 
ET 124 dots & cytoplasm nd 0.559 6 1.8 R 28S rRNA 
ET 138 cytoplasm nd 0.449 5 0.6 L + R novel (5'UTR) 
ET 143 dots restricted 0.565 4.8 0.6 R novel (5'UTR) 
a Determined by sequencing LM-PCR products except for ET 80, 124 and 143 where amount deleted is estimated from RACE sequence 
b 	Estimated from Northern blot by plotting the migration of the rRNAs against molecular weight and extrapolating 
C 	Calculated by subtracting the amount of vector deletion (a) from the 4.8 kb expected to be contributed by the exon trap vector and then 
subtracting this value from the size of the fusion transcript (b) 
d 	Insertion sites identified by LM-PCR (L) or 5'RACE (R) 
nd not determined 
3.5 Identification of insertion sites reveal vector deletions 
Initially 5'RACE was used to identify the endogenous genes in 4 lines using a 
lacZ first strand primer. However, none gave rise to second round PCR products. 
Indeed, only one, ET80, gave rise to first round products. Use of a more 3' primer 
gave rise to 2nd round RACE products for ET80 which were cloned. Sequencing 
confirmed that vector sequences were missing from the amplified cDNA. The absence 
of 5' vector sequences may be due to the use of a cryptic splice acceptor within the 
vector in ET80, or may reflect a deletion from the vector before it inserted into the 
genome. To investigate these possibilities insertion sites in exon trap lines were 
identified from genomic DNA. 
A ligation mediated PCR approach (LM-PCR, Garrity & Wold, 1992) was 
adapted to allow direct sequencing of junction fragments which span the insertion site 
(Figure 3.4). Sequence information should reveal whether or not deletions occurred 
from the vector before insertion in the genome. In addition, owing to the requirement 
of pET1.8TM to insert into exons, it should be possible to identify coding sequence of 
interrupted genes directly from junction fragments. 
Before attempting LM-PCR, ET lines were confirmed to carry single vector 
insertion sites. Genomic DNA was digested with Hind III, which does not cut within 
the vector, and analysed by Southern hybridisation with a neo vector probe. A single 
band whose size varied between lines hybridised to the probe suggesting that each line 
carried a single insertion site (Figure 3.5A). A frequent cutting restriction enzyme, 
NlaIII, was then used to generate junction fragments for amplification. N1aIII was 
chosen as it cuts within the 5' region of lacZ but does not cut in CD4 sequences. 
Digested genomic DNA was analysed by Southern blot hybridisation using a lacZ 
probe located 5' to the NlallI site. Junction fragments between 0.5 and 3 kb, which 
Figure 3.4 Ligation mediated PCR. 
Genomic DNA is digested with a frequent cutter enzyme to produce a junction fragment 
that spans the secretory trap insertion site. Digested DNA is denatured and blunt ended 
molecules are synthesised. A unidirectional adapter is ligated and the DNA denatured. As 
the adapter is non-phosphorylated only the top adapter strand (5'-3') is bound to the DNA. 
A nested vector primer is used to synthesize DNA which forms the template for a first 
round of PCR amplification. The second round PCR uses a biotinylated vector primer so 
that amplified products can be bound to magnetic streptavidin coated beads, denatured and 
directly sequenced without the need for cloning. 
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Figure 3.5 Ligation mediated-PCR on ET lines 
(A) Schematic representation of primers and probes used for LM-PCR, numbering of 
primers is based on Figure 3.4. (B) Genomic DNA prepared from ET ES cells digested 
with Hind Ill, an enzyme which does not cut within the vector. Southern hybridisation 
with a neo probe reveals a unique fragment containing the vector in each line. (C) 
Genomic DNA digested with Niaffi and analysed by Southern hybridisation using a LacZ 
probe. Hybridising bands indicate the size of NlaIII junction fragments which span the 
insertion site. (D) First round LM-PCR products were re-amplified using nested primers 
(P2-P4 shown on the diagram). Products were analysed by Southern hybridisation with a 
CD4 probe. In ET105 all three primer sites are present in the vector whereas in ET  lithe 
p4 primer site has been deleted from the vector. The larger second band seen in ET105 2nd 
round PCR products is due to re-amplification of the junction fragment with the first round 
primer pair which are present in the reaction. 
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are a suitable size for amplification, were produced (Figure 3.5C). Two fragments 
hybridised in some lines suggesting that multiple copies of the vector had inserted. 
LM-PCR was performed on Nialli digested genomic DNA using the primers 
indicated in Figure 3.5. A primer against lacZ sequence was used to generate the first 
round products. These were further amplified using one of a set of three diagnostic 
primers. The presence or absence of products hybridising with CD4 on a Southern 
blot was used to estimate the amount of CD4 sequence that had been deleted from the 
vector prior to insertion (Figure 3.5C). This enabled a suitable primer to be selected 
for direct sequencing from second round products (Figure 3.6). In two lines carrying 
multiple copies of the vector, ET2 and ET50, single endogenous sequences were 
identified from the junction fragment, suggesting that one or more of the LM-PCR 
primer sites were absent from subsequent copies of inserted vector. However, 
multiple copies in ET  11 precluded the identification of endogenous sequences, only 
sequence corresponding to the 3' end of the exon trap vector could be read upstream of 
CD4. This indicated that at least two copies of the vector had inserted in a head to tail 
arrangement. 
Sequence information from 5 ET lines revealed that between 365 and 528 bp 
had been deleted from the 5' end of the vector prior to its insertion in the genome 
(Table 3.2). Endogenous sequences are recorded in Appendix III. They were 
compared to the non-redundant GenBank database using the BLASTN program. Two 
of the insertions occurred in rRNA genes. Sequence from the remaining three lines 
failed to generate a significant match with any database entry. The lack of homology 
may be due to the vector having inserted towards the 5' end of an exon. In this 
situation the sequence flanking the insertion site would mostly be composed of intron, 
this would result in insufficient coding sequence to generate a match to any database 
entries. The observation that the endogenous gene sequences from 3 lines lack open 
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Figure 3.6 Direct sequencing of LM-PCR products 
Direct sequencing of ET2 and ET50 LM-PCR products. Length depends on the position of 
the Nialli site within genomic sequences. Various amounts of vector CD4 sequence are 
deleted before insertion. In ET2 528bp has been deleted whereas in ET50 521bp was 
deleted. The novel sequence upstream of vector CD4 corresponds to genomic sequence 
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reading frames in the same frame as 3gal may likewise be explained by insertion at 
5'ends of exons. 
3.6 S'RACE confirms pET1.8TM inserts into exons 
Coding sequence from endogenous genes carrying vector insertions were 
identified by cloning cDNAs generated from fusion transcripts using 5' RACE. 
Comparison between the sequences generated by 5' RACE to those generated by LM-
PCR from genomic DNA should indicate whether insertions occurred in introns or 
exons. Identical sequence would suggest an insertion into an exon. 
Total RNA was prepared from five ET lines and first strand cDNA was 
synthesized using a primer complementary to lacZ. In the lines where the extent of 
vector deletion had not been determined by LM-PCR, a series of PCR amplifications 
were performed on cDNAs using the same approach as that for LM-PCR. Direct 
sequencing of second round RACE products revealed that in the two lines where 
genomic sequences flanking the insertion site were novel, the RACE products gave 
identical sequence. This suggested that the insertions had occurred in exons. In 
addition, the lack of an open reading frame suggests that the insertions occurred in 
UTRs. The 5'RACE sequences are recorded in Appendix 3 and summarised in Table 
3.2. 
3.7 Expression in ES cell derived chimeras 
To identify developmentally regulated genes, the expression patterns of trapped 
genes were determined by monitoring reporter activity in chimeric embryos. Seven ET 
lines were selected for analysis on the basis of high levels of 3gal expression in ES 
cells. Chimeric embryos were dissected between 8.5 and 9.5d of development and 
reporter expression was monitored by staining for Pgal activity. Of the 7 lines 
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analysed, 3 showed restricted expression patterns, 3 were widespread and 1 failed to 
express (Figure 3.7). 
Out of three lines where chimeras were generated, ET105, was the only one 
successfully transmitted through the germ line. Heterozygous intercrosses were set up 
after one backcross to C57B1/6 males. Offspring were genotyped by dot blotting tail 
DNA and hybridising to a neo probe (data not shown). Five suspected homozygotes 
were identified whose DNA hybridised to neo with twice the intensity of the suspected 
heterozygotes. To confirm the genotype of the homozygous animals a restriction 
fragment length polymorphism (RFLP) was identified to distinguish between the wild 
type and the disrupted ET105 alleles (Figure 3.8). The probe used to identify the 
RFLP was cloned from LM-PCR products which flank the genomic insertion site. 
The Southern blot genotypes were identical to the dot blot results confirming that 
homozygous animals are viable (Figure 3.8C). 
3.8 Discussion 
The results in this chapter demonstrate the feasibility of using an exon trap 
approach to screen for developmentally regulated genes. In two published reports the 
efficiency of detecting insertions into transcription units was 12-50 fold lower using an 
exon trap vector compared to a vector designed to insert into introns (Gossler et al., 
1989; Friedrich and Soriano, 1991). The decrease in efficiency is thought to reflect 
the smaller exon target size in the genome compared to the intron target. The recovery 
of similar numbers of colonies for both types of vector in our screen was therefore 
unexpected. Molecular characterisation of 8 pET 1.8TM insertions revealed that 
between 300 - 600 bp of sequence had been deleted from the 5' end of the vector prior 
to its insertion into the genome. Deletions from the ends of electroporated DNA that 
destroy reporter activity may explain the poor frequency of gene trap events in 
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Figure 3.7 Reporter expression of ET lines during development 
LacZ expression was monitored by staining for I3gal activity in whole mount embryos. 
Lateral views of 8.5dpc (A and B), 9.5dpc (D) and 10.5dpc (C) embryos. (A) ET2 
chimera. LacZ is expressed in the allantois (arrow). (B) ET82 chimera. Widespread 
expression is observed with greatly reduced levels in the heart (h). Higher levels are seen 
in the otic vesicle (o), intermediate mesoderm (im) and the neural crest (nc). (C) ET105 
(heterozygote). Fairly widespread expression although absent from the dorsal neural tube 
(dn) and the anterior/midbrain junction (j). Highest levels of expression are seen in the 
yolk sac (ys). (D) ET143. LacZ expression restricted to the vascular system (v), otic 
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Figure 3.8 Characterisation of ET105 insertion 
The probe used to identify the RFLP was cloned from the LM-PCR products and 
contains 130bp of ETI05 genomic sequences (black shading) flanking the secretory trap 
insertion site and 155bp of vector CD4 (hatched shading). In ETI05, 365bp of vector has 
been deleted, including one of the PvuII sites. This makes PvuII a suitable enzyme to 
digest genomic DNA with to look for restriction fragment length polymorphisms (RFLPs). 
A single fragment of 5kb hybridises in the wild type DNA which corresponds to the 
ET 105 locus. An endogenous CD4 fragment does not hybridise because the vector CD4 
sequence originates from rat DNA which does not cross-hybridise to mouse DNA. The 
wildtype ET105 band is eliminated due to the vector insertion and two bands of 
approximately 2.5 and 3.0kb arise. One of these bands corresponds to the PvuII fragment 
flanking the insertion site and the other corresponds to an internal PvuII vector fragment. 
The internal fragment is generated as a consequence of multiple copies of the vector having 
inserted at the ETI05 locus. (C) Genotype data of ETIOS weaning age offspring. (minus 
(-) signifies that no homozygotes are expected from that particular cross). 
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previous attempts at exon trapping. The improved efficiency of pET1.8TM is likely 
due to the buffering property of the CD4 TM domain upstream of the reporter. 
The pET1.8TM exontrap vector was designed to detect insertions in secretory 
molecules yet it is clear that deletion of CD4 sequences abolishes its selective property. 
This was first suspected when the subcellular localisation of 3gal activity was analysed 
in ES cells. Rather than colonies showing the secretory pattern of staining which is 
indicative of fusion proteins having been targeted to the secretory pathway, exontrap 
colonies exhibited a variety of localisations. Similar to observations with the 
pGT1.83geo gene trap vector, this variety probably reflects differential sorting of 
various classes of endogenous genes fused to 3geo. Sequence information from 
exontrap lines confirmed the deletion of transmembrane sequences from the vector 
accounting for non-secretory patterns. 
These results highlight the importance of protecting the 5' end of a vector from 
deletion if exon trapping is to be successful. The ends of electroporated DNA are 
thought to be deleted by the action of endogenous exonucleases (Kumar & Simons, 
1993). This exonuclease activity causes problems with positive/negative gene 
targeting constructs where the TK negative selection cassette is often damaged prior to 
or upon integration, leading to a background of non targeted events (Mansour, 
Thomas & Capecchi, 1988). A recent report shows how the addition of a nucleic acid 
hairpin structure to the end of a targeting vector increases the enrichment for targeted 
events, presumably by protecting the TK gene from exonuclease activity (Nehis et al., 
1996). Alternatively, random integration of these protected vectors may have been 
prevented by the absence of a free end. We are exploring the possibility of ligating a 
similar hairpin structure to the end of pET 1.8TM to protect the CD4 sequences from 
deletion and thus preserve the selective property of the vector. An alternative strategy 
to protect the vector's selection is to include buffer sequences upstream of CD4. 
These sequences would need to contain an open reading which does not interfere with 
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the type II property of the transmembrane domain. It is difficult to know how much 
buffer to include as deletions of up to 2.3kb have been observed with gene trap vectors 
(Chapter 2). A drawback to this approach is that deletions will still occur within the 
buffer, and to some degree within the CD4, so that the extent of deletion will need to 
be mapped by RT-PCR before endogenous genes can be identified by T RACE. 
Another way to overcome the problems associated with deletions is to use a 
retroviral based exon trap vector. However, retroviral promoter traps have been 
shown to insert mostly in the 5'UTRs of genes (Friedrich & Soriano, 1991; von 
Meichner et al, 1992). For the purpose of secretory trapping, it is essential that there 
be no bias towards inserting in the 5'UTRs as the selective procedure is dependent on 
insertions occurring downstream of a signal sequence. 
Three out of the five insertions identified from fusion transcripts by RACE 
occurred in 5'UTRs (Table 3.2). The evidence for such insertions comes from the 
observation that fusion transcripts do not encode open reading frames in the same 
frame as 3gal, suggesting insertions in untranslated regions. Northern data indicates 
that the contribution of endogenous genes to fusion transcripts is on average less than 
500bp suggesting that the insertions occurred in 5'UTRs rather than 3'UTRs. 
Conceivably the RACE products may represent insertions in non-translated RNAs but 
it is unlikely this is the case for all the insertions. As the endogenous gene does not 
provide a translation start site when insertions occur in 5'UTRs, it is likely that 
reporter activity is detected as a result of internal initiation of translation from within 
vector sequences as discussed in Chapter 2. 
It is not known why pET1.8TM insertions seem to preferentially occur in 5' 
UTRs particularly as 5' exons are often the smallest exons within transcription units 
(Hawkins, 1988). The same unknown mechanisms which cause retroviral gene trap 
insertions to occur in 5' UTRs (Friedrich & Soriano, 1991; Jonsson etal., 1996), may 
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be operating with plasmid based vectors. Evidence for preferred retroviral integration 
into 5'UTRs comes from data showing that the number of colonies generated with a 
promoter trap construct containing an ATG translation start codon in frame with a lacZ 
gene was 5-10 times greater than the same construct lacking an ATG (Brenner et al, 
1989). Both constructs had a splice acceptor site and they only differed in the ability 
of the construct containing the ATG to detect insertions into introns downstream of 
untranslated exons. Previous analysis of insertion sites generated by electroporation 
of an exontrap construct showed a similar preference for 5UTRs in that 6 out of 7 
integrations occurred within, or adjacent to, CpG islands (Macleod etal., 1991). The 
authors proposed that DNA of CpG islands has a more open chromatin structure 
which allows a high level of recombination with exogenous DNA. However, the 
construct used in this experiment may be intrinsically biased towards detecting 
insertions which generate short fusion transcripts. The results may not reflect a bias 
towards insertions in 5' regions but rather the fact that the neo selection gene in the 
construct cannot tolerate large 5' fusions. A more convincing argument that 
electroporated DNA may preferentially integrate into 5' UTRs comes from a 
comparison between two gene trap constructs in which an initiating ATG in lacZ is 
either present or absent (Gossler, 1993). As with the retroviral experiment, addition 
of the ATG allows insertions into 5' UTRs to be detected. In both constructs the neo 
selection gene is driven by its own promoter. Four times as many blue colonies were 
recovered with the construct which included the ATG indicating a preference for 
inserting into 5'UTRs. 
The 3 lines carrying insertions in rRNA genes are predicted to produce 
chimaeric fusion transcripts, comprised of the rRNA polymerase I transcript and the 
vector polymerase II transcript. The production of functional 3gal activity from such 
non-polymerase II transcripts could be due to promiscuous activity of RNA 
polymerase II which produces a capped transcript capable of being translated (Palmer 
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et al., 1993). Alternatively there are precedents for translation from uncapped 
transcripts (Gunnery and Matthews, 1995). 
There are a number of potential advantages of exon trapping over the 
more widely used gene trap approach. Firstly, insertions that occur in exons are 
unlikely to be spliced around, such that the insertion will completely abolish the 
production of endogenous transcripts. In contrast, splicing around intronic gene trap 
insertions which gives rise to wild type transcripts, has been observed in a number of 
homozygous lines (Chapter 1). Secondly, insertions into exons allow sequences 
flanking insertion sites to be directly cloned from genomic DNA by PCR. These 
junction fragments allow the simple identification of RFLPs associated with vector 
integrations. RFLPs can be used to unequivocally genotype offspring and, more 
importantly, can prove that the cloned sequence represents the gene carrying the 
insertion. In contrast, identifying RFLPs in gene trap lines can be a lengthy process. 
This is because gene trap insertions often occur in large introns, therefore cloned 
5'RACE products are unlikely to contain DNA which recognises a polymorphism due 
to the insertion. 
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Chapter 4 
DETAILED ANALYSIS OF LINE JST185 
JST185 is a novel multiple membrane spanning molecule which was identified 
in the secretory trap screen presented in Chapter 2. In this chapter the cDNA cloning 
and structure of the disrupted gene is described as well as its expression pattern during 
embryogenesis. Animals homozygous for the insertion die shortly after birth due to 
respiratory failure. However, a few homozygous animals survive beyond weaning 
and display a striking lung pathology. The following introduction provides a brief 
background to lung development. 
4.1 Introduction to lung development 
Lung development starts around 9.5d with an outgrowth of epithelial cells 
from the foregut endoderm into mesenchyme, the splanchnic mesoderm, generating 
the lung primordium. Shortly after its appearance, the primordia develop into the 
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Figure 4.1 Lung development 
(A) The two lung buds derive from the primitive foregut at around 9dpc. During the 
pseudoglandular stage of development the primordial tubes undergo a defined pattern of 
branching morphogenesis to form the bronchial tree which consists of a proximal conducting 
system and a distal respiratory system. The circled structure shows a terminal bronchiole which 
has terminated close to the pleura and goes on to form the pulmonary acinus (respiratory portion 
of lung). (B) Shown is a schematic representation of the growth of the pulmonary acinus. The 
last generation of airway at the pseudoglandular stage shows a thinned epithelium and forms the 
first respiratory bronchiolus (RB). These respiratory bronchioles branch further and eventually 
form the transitional duct (TD) which in turn gives rise to two primitive saccules (S). By birth 
the terminal sacs are established. No true alveoli are present although indentations representing 
future alveoli are found. During post-natal development the alveoli develop in the walls of the 
respiratory bronchioli, transitional ducts and saccules, which change these last two into alveolar 
ducts (AD). By about 2 weeks of development the architecture of the adult lung is acheived in 
which the terminal sac has formed the adult atrium (At) which has given rise to a number of 
alveolar sacs (AS). (Adapted from Hislop and Reid, 1974). (C) Schematic of adult lung 
histology. (Taken from Freeman and Bracegirdle, 1966) 
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branching tubular system which eventually forms the proximal conducting system and 
the distal respiratory system (reviewed in Ten Have-Opbroek, 1991; Hilfer, 1996). 
Lung development is described in four stages based on characteristic morphological 
changes: the pseudoglandular, canalicular, terminal sac and alveolar stages (Table 4. 1 
and Figure 4. 1). During the pseudoglandular stage, the epithelial tissue proliferates 
and branches into the surrounding mesenchyme to form the bronchial tree (Figure 
4. 1A). This process is known as branching morphogenesis and relies on epithelial-
mesenchymal interactions. In the absence of bronchial mesenchyme the epithelium 
fails to branch (Rudnick, 1933). Grafting experiments have shown that branching 
morphogenesis and differentiation of the proximal tracheal epithelium can be induced 
by interaction with distal mesenchyme, while the mesenchyme around the trachea 
inhibits the growth and branching of the distal epithelium (Alescio & Cassini, 1962); 
Wessels, 1970). During this stage molecular markers specifying proximal and distal 
epithelium are first expressed in distinct populations of cells (Hackett & Gitlin, 1997). 
By the end of the pseudoglandular period the conducting airways including the 
trachea, bronchi, bronchioles and terminal bronchioles have been established (Figure 
4.1B). 
Table 4.1 Chronology of stages in murine lung development. (Based on Minoo and King, 1994; 
Thuribeck, 1996)) 
Stage 	 Age * 
Embryonic 	8.5 - 10.5d 
Pseudoglandular 	10.5 - 16.Od 
Canalicular 	16.0 - 17.5d 
Saccular 	16.5 - P0 
Alveolar 	P0 - P14 
Physiological events 
Development of trachea and primordial bronchi 
Branching morphogenesis 
Development of vascular bed and framework of respiratory 
acinus; flattening of epithelium 
Increased complexity of saccules 
Development of alveoli 
* d = day of gestation, P = days after birth 
The canalicular stage is characterised by the development of the vascular 
system, the airways divide further, the epithelium thins, and the proportion of 
mesenchyme decreases. Distal to the terminal bronchioles, respiratory bronchioles 
develop containing both type I and II epithelial cells. The thin flat type I cells 
eventually facilitate gas exchange from airspace to capillary whereas the alveolar type 
II cells synthesise pulmonary surfactant. The surfactant spreads over a thin layer of 
liquid that normally coats the wall of the alveoli. In doing so, it lowers the surface 
tension at the air-liquid interface and thereby reduces the tendency of the alveoli to 
collapse at the end of expiration. 
The terminal sac stage involves a dramatic increase in gas-exchanging surface 
area. Further thinning of the mesenchyme brings the pulmonary capillary bed in close 
apposition to the distal epithelium. Transitory ducts branch from the respiratory 
bronchioles into several saccules which end in terminal saccules. At this stage the 
intersaccular septa are thick. Deposits of elastin are found in regions where future 
alveolar structures will appear (Noguchi et al., 1989). It is also during the saccular 
period that increased production of surfactant components yields a potentially 
functional lung should birth occur prematurely. 
The alveolar stage begins on post-natal day 5 with a rapid rate of increase of 
surface area of both the airspaces and the capillaries. Secondary septa subdivide 
saccules and transitory ducts into alveolar sacs and alveolar ducts, respectively. The 
septa thin by a reduction in the volume of interstitial tissue. After about two weeks of 
restructuring, the mature lung histology is achieved (Figure 4.1C). 
4.2 Sequence analysis of JST185 
Cloning of the JST 185 fusion transcript from heterozygous embryos revealed 
that the secretory trap insertion occurred in a novel multiple membrane spanning 
protein. RNA was prepared from 8.5dpc embryos derived from crosses between a 
JST 185 heterozygous male and wild type C57131/6 females. The RACE protocol was 
used to amplify cDNA sequences spanning the splice junction from the fusion 
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transcript. The sequence of the longest RACE clone (480bp) was compared to the 
non-redundant GenBank database using the BLASTN program and no significant 
homology to any entry was seen (Appendix II). The RACE cDNA was used to 
screen a random primed D3 ES cell cDNA library (gift from Dr Hitoshi Niwa). One 
positive clone containing an insert of 1.8 kb was identified. Two probes 
corresponding to the 5' and 3' ends of this cDNA were used to re-screen the same ES 
cell library and two further cDNAs were isolated. The 3 overlapping cDNAs span 
3510bp of JST185 sequence. The cDNAs encode the complete coding sequence of 
JST185 as both 5' and 3' UTRs were identified. Two in-frame methionines are 
encoded within the first 7 residues. The sequence preceding the second methionine 
fits the Kozak consensus for vertebrate initiation perfectly suggesting it represents the 
initiating methionine (Kozak, 1987). There is no polyA addition signal (AATAAA) or 
a polyA stretch, therefore sequences are missing from the 3' end of the cDNA. 
Conceptual translation revealed a single open reading frame encoding a protein 
of 963 amino acids (Figure 4.2). BLASTP was used to compare the JST 185 protein 
sequence to the GenBank protein sequence database. Two genes located on 
chromosome III of C. elegans, called F38136.6 and F21) 1, are both 3 1% identical to 
JSTI85. The C. elegans genes are 30% identical to each other. No information 
regarding structure or function of these two genes is available. Multiple alignments 
reveal that all three genes shared conserved blocks of sequence identity, particularly in 
the amino termini (Figure 4.3). Hydropathy profiles of all three proteins also reveal 
clear similarities (Figure 4.4A). Multiple membrane spanning domains appear to 
reside within the 400 amino-terminal most amino acids of the three proteins. TMpred 
predicts 9 TM domains in JST185 and 11 in the two C.elegans genes. The first 
hydrophobic stretch is predicted to be an uncleaved signal sequence which takes a type 
II orientation in the membrane. As the secretory trap insertion occurred downstream 
US 
Figure 4.2 Sequence of JST185 cDNA 
The JST 185 nucleotide sequence is derived from three overlapping eDNA clones and is shown on 
the upper line. The conceptual translation of the JST 185 open reading frame is shown on the 
lower line. Nine putative transmembrane domains are underlined and TPR domains are in red 
and underlined. The site of the secretory trap insertion is marked with an arrow. 
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Figure 4.3 Amino acid alignment of JST185 and nematode homologues 
Sequences were aligned using the ClustaiW algorithm from MacVector (version 5. 1 
software). JSTI85 protein sequence aligned with two C.elegans genes, F38136.6 
(accession number U40060) and F32D1 (accession number AFO 10427). 
ClustaiW Formatted Alignments 
JST185 	 N A U 	S 	N ---------F 	K 	E V T 	I 	
"I 
 V V N 	N 	C C S FV F0 B VS A I L SN 	U H P 	CT? LKTL 	Q N - D F 	5 5 	P S E 	E P. H SC S I K 	P 	T V L 
F)85 6 .KMKKHLHHKVSGSCDPGIRSPKEEGR 	SQGIRNLLIS 15L51 IPCLS 
CV 	C MsL 
GUFVFBDAESIVNNPI NGKDPLLQI S-- -VS 	S SSSNI6 KSYR PVTTF 
P3201 	MKKEKRKQKS--VEPTILS- 	------HIPYQYL VA LFASIV FI AIPVYDDRPAILTN U LSRTPWRSL VHNDFWG p GLQQISHXSIP FLITS 
1ST1S5 	T P H L 	S E 	L F 	P N S TN L I N 	 V 	SV I L 	V 	F - 	 - - 	 - L FL BE 	S S S I IA AL L P 	AV H P I H YE A V 	TG 	2 N AK L L 	S 	V F L A 	Ft SN T K S K B P ON 	S I V N P 
TFS ? 	HETSTLGYHIVNII 	V 	TLV 
ENY 
V 	L 	K 	LEHIPBFFNI SAStLPAVNPVHTEAVANtPAELLM 	I FtC LILHVKNR 
F32D1 	5FF A'HGLKAELFH 	VN 	I I 	OWL L 	S 	R--QMRIS4GNEFS LSALIFAFCHPITSEAVCISI 	NAULLS 	
N ILL ITCHTSBP --------- 
J5T3SPIVLTVFA 	ATLCXE 	GI 	V 	CCVY FGGPPVHLAUVN C 	AVSAREGSIPLSNLQT VP. 	I 	LMLSTLLLVV NV 	V 555 PV?TR 
F 38 N 5 . 6 INCFFVL 
EV 
ILSTLSKESGL P P AICI LA 	--------- N C SNFVP. -----------IC 5 SIC ------ FLRM V GFE AKFTK P111 
P 3201 STFPTIV SILAVTAKEGIIL P ITLI LFETSN----TK F DVTVV ------------ OS S LCY 	-------- LRL I SF5 PEPSE 
JST185VSPT?T 	TFN 	LLPVN 	WLLL 	P FYPSD--S5 	TVLMALCL 	ALPFI 	NSNL 
F3886.HF L 55 	K 	F 	1 	MI 	N V T 	I W L V H 	V L S V 	P 
E 	C 	H3I 	L~ E RLB 	K 	ATFAFFCFLGALG ---IFS 
N 	C F B 	N 	G - I 	S 	 PV 	B 	N S 	P V LI 	FT 	I V -------I I G 	N 	F 5 N - 	 - - 	 K C 	A FT 535 N 	I 	I 	SF L 	A S N I 
P3201 	HEPNSLT 	A 	TFM 	LPVFH 	NLIV 	P P 	550 MD 	I 	KESB 	N 	ILTPIVIGVGEHVLLELLLG RNSENSHENRSLLFLFNL 	TTPHI 	SSNLL 
JST185 	F P 	V V}N F F V L TV P 	S F C I tY 	SW 5 K IK S V 	L K 	S W V C L S 	N T N A L 	L 	N 	- 	 C 	 A 	K 	N K 	N 	S N N A L N N E K N 	F E K A L 
F 3886,6 FTVGFSIINERVLYLPS 	GFCLL IFEKL 
E ll 
----VNFK 	ABVLSIT 	I 	LLIS 	P5.5 	3KW 	5 	LV 	SC 	CC? 	55(561 KVLG 
F H 
P3201 	THVGFVAAERILYLNT 	AVCIL 	LAEMC - ENS 	SPE 	VLPLYIL 	L 	LFTIRTMRSDDW ESLFSA 	K 	NPT 	-KAHN VVYTT 
JSTSRSKYPLQATHVQPDOIGANNNVGRTYENLNNTREAEA SSNLAKSLNP 	QIIPGKKVAAFIAPNNLNVY 	I N L A N L I R A N 	ESELEE 	CL 	 SNRPDFEQC 
F3886.6 ----------------------------------------------- N ---------------------------- G 	L 	S 	D K N 	 K 	LOPS 	NE 	QL 
P3201--------------------------------------------------------------------------- 
JST1BSISP 	K 	St 	- 	 K P 	L K 	EAVLS( LDRNN LISY 	- 	 YIELKE?NE 	LKNFNX 	LNPK -----------NFL 	L VI 	 EVKLRPEAR 
FSBNSKNVL OLSEN -GOSKY ESLLA?TLRPSF 
F E 
SAWN 	L- 	SQMNLEEYYEESKSLKNSLLIRPN -----------SAN 	
[1.
.CVL 	5 	.N 
CNL ILTIK SNNSNG IHCSQMQSFST'CA 
-
F2C AWL 	L 	LLHDAGHNMKAFSHLDKCLNNTGEFLEFYHVSSRXTQAT 3RL 	QSGNFNVAIENF 
JSTSHNKRLLNNVNEEPQDAEGYFNLGMLAMU 
PJBB6.6 ------------------------N 	I - - 	 - 	 - 	 N A N NW EN A T RI 	P 	S H 55 
EW 
N C 	L 	V LB 
EKDSEA MKEAIK 	?IFRS 	SF 	L 	S 	CS 	TARLEALPILEEL 	KIS 	DHTKGLILEGDILNNQKKDIP 
L SS 	Q V ID S 15 A CS V N E SR 
P 3201 ELALKLGGPHFEHrFSVLNSMGTCVN LCD-EQS EKFPGKAI 	ENHVNVL N 	H KIRON F 	EVEN LREA PLC ESVI- ----------------- 
55 T 185 GAEECPEKISENDPSNVQSKLCVVYFEEEELLKAEP.CLVE S 	P 	EEYIQRH 	SI 	RD 	ISSSGIVEQPLNPADEIPGTEEREEIPSEDVK 	IS 
F38R6,6---------VHMQISSCHNK ---------
EN 
SNFPAVENHIKS I 	tSP 	SVLFHAN S 5 	SR ----------------------------SF EVE 













JSTI8S 	PPQILETNNNRNSK 	SKQSTENABQDAPHKTTKIIKEIEKKRVAALKRSEEI RIFKWRISS 	LHHVPNFARPSVSINRLLVLEPEKCQEYII.VPQEL 
P 366,6YRIVLALBSSN-IVAK LQ3CL 	EHNCYNST 
P3201 	SRKVNEA5PNS-YAAH. 
---------------------------------- 
-------------------------------- YGAIL 	LNQKYDLA 	EYEISLILDPTSIVAR ------ENREEVIR 	SLEEK 
JSTS85 C K V L S I B S K 
F) 8B6 .6 
F32D1 RN L 




Figure 4.4 Hydropathy profiles of JSTI85 and nematode homologues 
(A) Hydropathy values were calculated using Mac Vector version 5.1 software according to the Kyte-Doolittle algorithm with a window 
size of 12 amino acids(Kyte and Doolittle, 1982). The first solid line indicates an uncleaved signal sequence. Following lines indicate 
putative transmembrane domains. Only the first 600 amino acids for each protein are shown because no transmembrane domains are 
predicted to occur in their carboxy termini. (B) Cartoon structures of JST 185, F38B6.6 and F32D1. Each contains between 9-11 
transmembrane domains (black numbered boxes) and 4-10 TPR repeats (green boxes). 
of all the TM domains, the vector CD4 TM domain will be placed in a type I 
orientation thus exposing Pgal to the cytosol where it is active. 
The carboxy-termini of the three proteins differ in length but they all show a 
high degree of similarity to proteins containing tetratncopeptide repeats (TPRs). 
These 34 amino acid motifs are found in proteins that function in diverse processes, 
including cell cycle control, transcriptional repression, protein transport and protein 
dephosphorylation (reviewed in Goebl & Yanagida, 1991). TPRs contain 8 
consensus residues whose size, hydrophobicity and spacing are conserved, yet the 
absolute identity of each residue is flexible. Secondary structure studies predict that 
TPRs form a pair of amphipathic cc-helical domains, punctuated by proline-induced 
turns, that have been proposed to mediate TPR-TPR interactions (Figure 4.5B). 
Domain A (W-LG-Y) is predicted to form a hydrophobic pocket into which the bulky 
phenylalanine (or tyrosine) side-chain of domain B (A-F-A) is predicted to fit. While 
there is as yet no evidence that TPR motifs interact directly with each other, they have 
been shown to participate in interactions between TPR-containing proteins. For 
example, the TPR-containing proteins CDC23 and CDC27 form part of a complex that 
promotes anaphase; a mutation in the TPR region of CDC27 impairs its ability to 
interact with CDC23 (Lamb et at., 1994). There is also evidence that TPRs mediate 
interactions with non-TPR containing proteins: the transcriptional repression protein 
SSN6 (Cyc8), for example, interacts with specific DNA-binding proteins by means of 
its TPR region (Tzamarias & Struhi, 1995). 
Careful scrutiny of the JST 185, F38B6.6 and F2D1 sequences revealed that 
V. 
they each contain between 4 and 10 TPR domains within their C-termini (Figure 
4.4B). J5T185 contains 10 TPRs some of which are separated by short stretches of 
between 3 and 15 amino acids (Figure 4.2). F38B6.6 contains 7 tandemly arranged 
TPRs and F2D1 contains 4 TPR tandemly arranged domains. Comparison between 
the individual TPR motifs of JST 185, F38B6.6 and F2D1 reveals they are more 
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closely related to each other than to the consensus (Figure 4.5A). The 185 consensus 
differs from the canonical TPR consensus sequence in that tryptophan is not well 
conserved at position 4, this is replaced by histidine or leucine in 10/17 cases. This 
tryptophan differs in a number of other TPR-containing proteins including a 
mammalian protein, p150, which also binds to SH2 containing proteins (Malek et al., 
1996) and Tg737 which is mutated in polycystic kidney disease (Moyer et al., 1994). 
A Drosophila EST (Accession nos. AA540614 & X92653) has recently been 
identified with 51% identity to JST185 over 420 amino acids spanning the 
transmembrane region. There are also two human ESTs (Accession nos. T66249 & 
AA540614) with 50% identity to JST185 nucleotide sequence. It is unclear how 
many genes these represent since they match different parts of the JST 185 sequence. 
4.4 Analysis of JST185 endogenous and fusion transcripts 
RNase protection was used to confirm that the RACE clone, and thus the 
cloned cDNA, represents the interrupted gene in line JST185. Total RNA was 
prepared from wild type, heterozygous and homozygous 12.5dpc embryos. A 200bp 
fragment was released from the RACE clone and used as a template for riboprobe 
synthesis. The riboprobe contains the En2 exon from the vector which acts as an 
internal loading control. In wild type RNA only the 120bp endogenous En2 band was 
protected (Figure 4.6A). In the heterozygous and homozygous lanes endogenous 
En2 was protected and also a fragment of I 8Obp which corresponds to the sequence 
from the fusion transcript which spans the splice acceptor. Unfortunately the 40bp 
endogenous JST 185 fragment which is expected to be protected in the wild type and 
heterozygous RNAs, and absent from homozygous RNA, was too small to be 
detected. 
The expression of JST185 was analysed by RNase protection during 
development and in adult tissues using a probe prepared from the JST185 cDNA 
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Figure 4.5 	Alignment of JST185 tetratricopep tide repeat (TPR) 
domains 
(A) Sequence comparison between TPR domains of JST 185 and C.elegans 
F38B6.6 and F2D1. Consensus TPR residues are highlighted in yellow. Conserved 
amino acids within the repeats of the same proteins are in red. The canonical TPR 
consensus sequence as defined in (Lamb, 1995) is shown at the bottom. The 185 
consensus represents the consensus residues between the repeats in JST 185, F38B6.6 
and F32D1 (B) Surfaces for TPR-TPR and TPR-non-TPR interactions. Domains A 
and B of a canonical TPR are shown as a-helices. TPR-TPR interactions are probably 
mediated by the hydrophobic surfaces formed by the seven consensus residues (short 
arrows). TPR-non-TPR interactions need not be limited to the consensus residues but 
could involve any face of the cc-helix (long arrows). 
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Figure 4.6 JST185 transcript analysis by ribonuclease protection 
(A) Ribonuclease protection analysis (RPA) to detect the fusion transcript in 
heterozygous and homozygous RNA from 8.5d embryos. The RNA probe was 
digested from the JST 185 RACE clone. The protected RNA species corresponding to 
the fusion and endogenous En2 loading control are marked. (B) Endogenous 
JSTI85 transcript levels were examined during development and in the adult. A 
fragment of the JST 185 cDNA was used as a template for riboprobe synthesis. The 
protected RNA species is 410 bp. The last panel shows an RPA used to confirm that 
the synthesis of normal wild type transcripts is undetectable in homozygote RNA. 
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which flanks the secretory trap insertion site (Figure 4.6B). At 8. 5dpc expression is 
undetectable by RNAse protection. A day later expression is detected and its level 
increases up to 12.5 dpc. Transcripts were analysed in total RNA prepared from 
isolated lung buds at various stages of development. JST1 85 is expressed at high 
levels during the pseudoglandular stage at 14.5dpc but by the canalicular stage at 
16.5dpc expression is down-regulated. By birth and in the adult no expression is 
detected. Expression was not detected in any of the other adult organs tested except 
very low levels in the heart, gut and testis. Thus the expression pattern of the 
endogenous gene is consistent with that of the reporter gene. 
RNase protection was used to determine whether splicing around the insertion 
could lead to the production of wild type transcript. Total RNA was prepared from 
12.5dpc embryos, the stage at which the highest level of JST185 transcripts are 
expressed. This should ensure that even very low levels of wild-type transcripts will 
be detected. A GAPDH loading control probe was also added to the RNA samples. A 
single band is protected in the wild type and heterozyote (Figure 4.613). In the 
homozygote no band is detected therefore no splicing around the insertion occurs to 
produce wild type transcript. 
The sizes of the endogenous JST1 85 transcript and the fusion transcript were 
investigated by Northern blot analysis with a JSTI 85 probe which hybridises to 
sequence 5' to the insertion site. Total RNA from a wild type 12.5d embryo and two 
homozygous embryos were analysed (Figure 4.7A). A single wild type band of 
approximately 7.5kb was detected. In the homozygous RNA the wild type band was 
absent confirming the RNase data that no splicing occurs around the insertion. A 
fusion transcript size of 8.0kb was detected in both homozygous samples. In a 
duplicate Northern blot a LacZ probe confirms the size of the fusion transcript (Figure 
4.7B). The vector contribution to the fusion transcript size is predicted to be 5.3kb 
(Chapter 2), 1.6kb of JST185 cDNA sequence has already been cloned 5' of the 
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Figure 4.7 LacZ fusion and endogenous transcript in JST185 
Northen blot analysis of 20j.ig of total RNA prepared from a wild type 12.5dpc 
embryo and two homozygote embryos hybridised to 5' JSTI85 probe (A) and LacZ 
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secretory trap insertion site, indicating that an additional 1. 1kb of 5' UTR sequences 
have yet to be identified. In total, 3.5kb of JST185 cDNA sequence has been cloned, 
considering the pA tail is 1 50-200bp, approximately 2.7-2.75kb of 3' UTR sequences 
have yet to be identified. 
4.5 Expression during mouse development 
The developmental expression pattern of JST185 was analysed between 
gastrulation and birth by staining embryos from heterozygous backcrosses with X-gal. 
The appearance of the primitive streak at around 6.5dpc marks the beginning of 
gastrulation, when the bilaminar egg cylinder is transformed into a trilaminar, three-
chambered conceptus. JST1 85 is expressed in the cells which have delaminated from 
the streak and formed the mesodermal layer between the epiblast and visceral 
endoderm (Figure 4.8A). Lower levels of expression are seen in the epiblast. At 
around 8.5dpc JST185 is expressed at high levels in two strips of lateral mesoderm 
which extend around the lateral edges of the posterior half of the embryo (Figure 
4.8B). The lateral mesoderm provides much of the mesenchyme for the developing 
viscera. Around 9.Odpc, JST185 is expressed at high levels throughout the 
mesenchymal component of regions undergoing epithelial-mesenchymal interactions 
(Figure 4.8C). Dissecting through the embryo at the level of the hind limb reveals 
expression restricted to the splanchnic mesenchyme and excluded from the closely 
associated gut which is derived from the endoderm. Low levels of expression are 
seen in the ventral midline of the neural plate (Figure 4.81)). 
At 12.5dpc expression is seen at high levels in the developing lung, the gastro-
intestinal tract, the brain and in some cranio-facial regions (Figure 4.9A). Higher 
magnification of the lung and gut reveals JST 185 is expressed at very high levels in 
mesenchyme surrounding the endoderm (Figure 4.9B &C). By 1 6.Sdpc expression 
levels are down regulated (Figure 4. 10D). Expression remains in a sub-population of 
Figure 4.8 JST185 expression at early gestation 
Heterozygous embryos were stained with X-gal during early gestation. (A) Lateral 
view of 8.Odpc embryo. (B) Dorsal view of early 8.5dpc embryo showing 3ga1 
activity in the lateral mesoderm (lm). Lower levels are also seen in the head folds (hf). 
(C) Lateral view of late 8.5dpc embryo showing I3gal activity in the mesoderm. (D) 
Crude section cut through the posterior third of the embryo shown in (C) confirms 
expression restricted to the splanchnic mesenchyme (sm) and the somitic primordia 
(sp). No expression is seen in the gut (g) but low levels are seen along the ventral 
















Figure 4.9 JST185 expression during mid to late gestation 
(A) Sagital section through 12.5dpc embryo. High levels of i3gal activity are seen in 
the lung (L), throughout the gastrointestinal tract (GI), cranio facial regions (CF) and 
in the brain at the edge of the striatum (s). (B) High magnification view of a section 
through the lung showing high levels of expression in the mesenchyme, particularly 
surrounding the branching epithelium. Expression is excluded from the airway 
epithelium in proximal terminal bronchioles (b) but is seen in the epithelium of more 
distal respiratory bronchioles. (C) Part of the gastro-intestinal tract showing high 
levels of expression in the mesenchyme surrounding the endodermal derived 
epithelium. (D) Sagital section through 16.5dpc embryo. Levels of expression are 
down-regulated. Expressing regions include the lung, gastro-intestinal tract, 
submandibular gland (SMG) and the forth ventricle of the brain (FV). (E) High 
magnification view of a section through lung. Highest levels of expression are seen 
surounding the bronchioles. Lower levels are seen in subsets of cells which could be 
either mesenchymal or epithelial. (F) High magnification view through a region of 
the gastrointestinal tract showing high levels of expression in a ring of cells 
surrounding the epithelium. 
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mesenchymal cells in the lung (Figure 4.9E). Expression is also seen in a ring of cells 
surrounding the developing gastrointestinal tract (Figure 4.9F). The morphology and 
location of these cells suggests they may represent smooth muscle cells. Expression is 
also seen in the submandibular glands and in a small region of the brain. 
JST 185 is expressed in a restricted pattern throughout lung development. At 
9.5d it is expressed in the splanchnic mesoderm. It is into this region that the 
pharyngeal pouch from the foregut endoderm first protrudes. Sections through 
pseudoglandular stage embryonic lungs reveal JST 185 expression at high levels in the 
mesenchyme surrounding the airway epithelium which is undergoing branching 
morphogenesis. Lower levels of expression are seen in other regions of mesenchyme. 
During the canalicular stage of development expression is downregulated. Expression 
remains highest in mesenchyme surrounding the airway epithelia. In more distal 
branches of the bronchial tree JST185 expression is seen in the epithelial layer as well 
as the mesenchyme (data not shown). During the saccular stage JST 185 is expressed 
in isolated cells throughout the lung parenchyma and at birth there is no detectable 
expression in either heterozygotes or homozygotes. 
4.6 Homozygous lethality 
Genomic DNA prepared from JST 185 heterozygotes and wild type offspring 
was digested with a panel of enzymes and analysed by Southern hybridisation using a 
probe derived from the J5T185 RACE clone. An RFLP was detected in DNA 
digested with Pvu II which resulted in a shift in size from a 14 kb wild type band to a 
12 kb mutant band (Figure 4.10). Pure C57B1/6 and 129/OLa DNA show only the 
14kb band, therefore the RFLP is a consequence of the vector insertion and not due to 
a strain difference. 
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Figure 4.10 RFLP used to genotype intercross offspring 
Genomic DNA digested with PvuII analysed by Southern hybridisation with a probe 
made from the JST 185 RACE clone. A restriction fragment length polymorphism 
(RFLP) is seen as a consequence of the secretory trap insertion in JST 185. The 
polymorphism is not due to a genetic strain difference as the same sized wild type 
band is seen on a C57B116 and 129/ola background. The probe contains the En2 exon 
so background En2 bands hybridise as well as JST 185. 
B16 129 WT HET HOM 
-04 Wild type JST185 
Mutant JST185 
'I 
JST185 RACE clone 
e 4.2 Summary of JST1 85 heterozygous intercross breeding 
Genetic St rai n a 	Wild Type 	Heterozygote 	Homozygote 	Expected 
Homozygote' 
k adult mixed 129/C57b 63(35%) 115(63%) 4 (2%)f 59 
k adult C57C 32(39%) 50(61%) 0 27 
:k adult 129d 28(34%) 52(63%) 3(3%)g 27 
:k adult MF1 28(37%) 43(57%) 4 (5%)h 24 
18.5d embryo mixed 129/C57 31(26%) 56(48%) 30(26%) 29 
ivared analysis on the number of 3 week surviving pups indicates the difference between the expected and actual values 
itistically different (P<0.01) 
57 = C57B1/6, 129 = 1290La and MFI = outbred 
1 [129XC57]; offspring of first backcross to C57 
Fl X C571F4; Fl offspring crossed to C57 four times 
Fl X 129}F3/4; Fl offspring crossed to 129 three/four times 
Fl X MF1]F4; Fl offspring crossed to MF1 four times 
unted, laboured breathing, died at 4 and 9 weeks (2 culled at 4/5 weeks) 
unted, laboured breathing, died at 6 weeks and 6 months (I culled at 6 weeks) 
unted, laboured breathing, died at 6 weeks, 16 weeks and 5 months (1 culled 9 weeks) 
alculation based on normal Mendelian segregation. (no. of wild type + no. of heterozygotes) divided by 3 
Almost 400 intercross offspring on a variety of genetic backgrounds were 
genotyped at weaning (Table 4.2). Only 11 homozygous animals survived until this 
stage indicating that 88% of homozygous pups die before weaning. All the 
homozygotes which survived were slightly runted and exhibited breathing difficulties 
which worsened with age. All homozygotes died between 3 weeks and 6 months of 
age, as compared to heterozygous littermates which typically survive over two years. 
Preliminary results suggest that genetic background may be influencing the survival 
rate of homozygotes. In particular the C57131/6 genetic background appears to 
increase the penetrance of the mutation, while 129/OLa and MF1 backgrounds 
decrease it (Table 4.2). 
To investigate at what stage the majority of mutant mice were dying a number 
of intercross matings were set up, mothers were sacrificed at various stages of 
pregnancy and embryos were examined for abnormalities or lethalities. The expected 
Mendelian ratio of genotypes was observed up to 1 8.5dpc (Table 4.2), suggesting that 
homozygotes were dying at birth and being cannibalised. Five intercross litters were 
delivered from their mothers at 1 8.5dpc by Caesarean section. All pups had 
intercostal retractions shortly after birth. Most pups established a regular breathing 
pattern within 15 minutes and turned a healthy pinkish red colour (Figure 4.11). 
Three newborns remained pale, immobile and sporadically gasping for air for up to 
2.5 hrs before they died. All three pups were genotyped as being homozygotes and all 
the surviving pups were heterozygous or wild type. The lungs from homozygous 
pups were smaller than controls although there was no difference in weight (Figure 
4.11). Homozygous lungs sank when placed in a dish of media, whereas control 
lungs floated. These observations suggest that JST 185 post-natal lethality is due, at 
least in part, to a failure of newborn pups to inflate their lungs. 
The potential airspaces of the lung are filled with liquid during development. 
At birth, the lung must be rapidly cleared to allow aeration of the lung. To examine 
M. 
Figure 4.11 Homozygous caesarian section pups fail to inflate their 
lungs 
18.5dpc pups were delivered by Caesarian section. Homozygous pups failed to 
establish a regular breathing pattern, remained pale compared to littermates and died by 
2.5hrs post-delivery. The lungs of hornozygotes were slightly smaller and more dense 
than control litternates. (Horn, homozygote; Wt, wild-type). 

whether the JST 185 mutant lungs were water saturated at birth, the wet to dry weight 
ratios was calculated for two intercross litters (data not shown). There was no 
difference in weight ratios suggesting that water is effectively cleared from mutant 
lungs. 
4.7 Analysis of homozygote lung development 
Two homozygotes were culled at 5 and 9 weeks of age, when their breathing 
difficulties had become very severe. Internal organs were dissected and compared to 
wild type and heterozygote littermates. All organs appeared normal except for the 
lungs. The homozygote lungs were reduced in size and, rather than being a uniform 
pink colour like the control lungs, had patches of brown/yellow tissue. These patches 
fail to inflate when fluid was injected down the trachea. 
Lung sections were compared between JST185 homozygotes and 
heterozygous littermates. The epithelial walls of the air spaces in the mutant lungs 
were much thicker and highly disorganised compared to the heterozygous lungs 
(Figure 4.12). The architecture of the mutant lungs resemble that of the terminal sac 
stage of development. The transition from the terminal sac to the alveolar stage occurs 
post-natally and involves the production of secondary septa from the terminal sacs 
followed by thinning of the septal walls to form the alveoli, which greatly increase the 
surface area of the lung. This transition has occurred normally in the heterozygotes 
where the thin walled alveoli are clearly seen (Figure 4.12 A & Q. 
Alveogenesis depends on the presence of mesenchymally derived alveolar 
myofibroblasts which provide the contractile components which keep alveoli expanded 
(Bostrom et al., 1996). As JST185 is expressed in isolated cells of the saccular stage 
lung newborn lungs were examined to see whether the myofibroblasts are missing or 
defective in JST185 mutants. Immunohistochemistry was used to examine the 
distribution of a-smooth muscle actin (a-sma) which marks myofibroblasts, and 
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Figure 4.12 Abnormal histology of JST185 homozygote adult lungs 
Histological lung sections are shown from a 5 week JST 185 heterozygote (A) and (C) 
and homozygote (B) and (D). Lungs were fixed in Bouins reagent and 
counterstained with haematoxylin and eosin. At high magnification the thin walled 
septa of the alveoli (arrows) are seen in the heterozygote (A). There is a complete 
lack of alveolar structure in the mutant (B). In the heterozygote at lower 
magnification (C) a respiratory bronchiole is seen lined with simple cuboidal epithelia 
with an artery containing blood next to it, in the homozygote (D) the walls of both 
bronchioles and arteries are disorganised . The lumen in many of the respiratory 
bronchioles in the homozygote are reduced in volume by the presence of either 
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Millers solution was used to stain the elastin fibres produced by the myofibroblasts. 
In sections through lungs from 18.5dpc pups there is no difference between the levels 
of a-sma in mutants and controls. As expected the a-sma is located in the smooth 
muscle layer surrounding the bronchioles and in the arterial walls (Figure 4.13 A & 
B). Lower levels are seen in the epithelia surrounding the terminal sacs. At lower 
magnification the histology of the mutant lung is subtly different from the controls. 
The mesenchyme separating the terminal sacs is thickened in the mutants (Figure 4.13 
C & D). There are also fewer distal terminal sacs in the homozygotes suggesting that 
branching may be retarded (Figure 4.13 E & F). The elastin levels were also similar 
in both mutant and control newborn lungs (data not shown). 
Staining for cx-sma and elastin was repeated on sections through homozygous 
and control lungs taken from 5 week old animals. Unlike the 18.5dpc lungs, there is a 
slight background of cx-sma staining in the adult sections. However low level 
background staining is clearly distinct from bona fide antibody signal. As expected, in 
the control lungs a-sma is seen in cells lining the arterial walls and in isolated cells at 
the tips of alveolar septa which are thought to correspond to myofibroblasts (Figure 
4.14 A & Q. However, in the homozygous lungs the distribution of (X-sma is 
drastically altered; it is found ectopically in cells throughout the distal airways (Figure 
4.14 B & D). In the inflated mutant lung airways are distended but the highly 
muscularised alveoli are not expanded (Figure 4.14 D). Elastin levels are markedly 
increased in homozygous lungs compared to controls (Figure 4.15 A & B). Rather 
than being localised to the matrix and tips of the alveolar septa as in the controls, 
elastin in the homozygotes completely surrounds the sac-like airway epithelium 
(Figure 4.15 C & D). 
In addition to aberrant marker expression homozygous lungs contain regions 
containing excessive numbers of cells which occlude entire airways in places (Figure 
4.15 B & D). The identity of these cells is unknown although some regions show 
Figure 4.13 Smooth muscle actin expression in 18.5dpc lungs 
Lungs dissected from pups delivered by Caesarean section were analysed by 
immunohistochemistry for the presence of a-sma antibody and counterstained with 
haematoxylin and eosin. Control lungs (A, C and E) were compared to homozygote 
lungs (B, D and F). Staining is seen in the arterial (a) walls and surrounding the 
respiratory bronchioles (b) in both control and mutant lungs (A) and (B). Lower 
magnification shows that the mesenchyme (arrows) between the airways is thicker in 
the mutants (D) than in the control (C). There are many more distal terminal sacs 
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Figure 4.14 Smooth muscle actin expression in adult lungs 
Lungs taken from 5 week old control mice (A, C & E) and JST 185 homozygotes 
which were suffering with severe breathing difficulties (B, D & F). Lungs were either 
fixed immediately overnight (A, B, E & F) or inflated with fix prior to overnight 
fixation (C & D). a-sma (brown) was detected in arterial walls (filled arrows) in both 
controls and homozygotes (A) and (B). High levels of a-sma is seen throughout the 
lung parenchyma in the homozygote lung (open arrowheads, B and D). Isolated cells 
expressing c-sma are seen in the control at the tips of the alveolar septa (open 
arrowhead, C). The homozygous lung can be inflated with fix (D) however the 
surface area for gas exchange is greatly reduced compared to the control (C). Bar 
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Figure 4.15 Elastin expression in adult lungs 
Lungs were dissected from a 5 week old control mouse (A & C) and a JST 185 
homozygous littermate (B, D. E & F). Lungs were stained with Millers and Van 
Geisons which stains elastin black. In the control lung (A) elastin deposits are 
predominantly seen at the tips of the alveoli septa (arrows), in the mutant lung (B) 
elastin is seen surrounding the alveoli (arrows). At lower power elastin levels are 
drastically increased in homozygotes (compare C and D). Regions of the 
homozygous lungs contain large numbers of cells of unknown identity (E), often 
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high levels of a-sma expression so may correspond to myofibroblasts (Figure 4.14 
B). The adult lungs also show evidence for an inflammatory response in that there are 
larger numbers of alveolar macrophages in the mutant lung compared with controls 
(data not shown). There also appears to be an abundance of phagocytic and 
neutrophil-like cells but confirmation of their identity awaits specific histological 
stains. 
4.8 Identification of a processed pseudogene homologous to JST185 
To allow rapid genotyping of animals before processing samples for histology 
a reverse transcriptase PCR (RT-PCR) strategy was developed. JST 185 primers were 
designed to amplify across the insertion site and downstream of the insertion site 
(Figure 4.16A). A third set of primers were designed to amplify the insertion site 
from the fusion transcript (Figure 4.16A). HPRT gene primers were used for each of 
the RT reactions as positive controls. RT-PCR was performed on wild type, 
heterozygous and two homozygous RNA samples from 16.5d lung buds and the 
expected products were observed on an ethidium bromide gel (Figure 4.1613). 
However, Southern hybridisation with a JST185 probe spanning the insertion site, 
detected low level wild type bands in the homozygous lanes which were not seen on 
the ethidium bromide gel (Figure 4.16B). A genomic southern had previously 
confirmed the genotype of the RNA source and previous data had confirmed splicing 
around the insertion does not occur. 
Potentially the faint bands could result from contamination of the PCR reaction 
with amplified product, or could result from residual genomic DNA in the RNA being 
used as a template. To distinguish these, DNase I was added to RNA samples before 
the reverse transcriptase reaction to eliminate gDNA. In the presence of DNAase I, a 
band failed to amplify in homozygous RNA, showing that gDNA was the source of 
the previous faint band (Figure 4.16C). As the primer pair (P1 and P2) spans the 
Figure 4.16 Identification of JST185 pseudogene 
RT-PCR strategy to allow rapid genotyping of JST 185 intercross offspring. 
(A) Arrangement of primers used to amplify wild type and fusion bands. (Triangle 
marks position of secretory trap insertion). (B) Ethidium bromide gel reveals the 
expected bands in RNA prepared from wild type, heterozygous and homozygous 
16.5dpc lung buds. Southern hybridisation of the RT-PCR samples with a JST 185 
probe which flanks the insertion site is shown. Bands which were not observed on 
the ethidium bromide gel are now detected in the homozygous samples. The bands are 
the size expected to be amplified from wild type transcripts. However, wild type 
transcripts have previously been shown to be absent from the samples. (C) DNase 
treatment of RNA samples prior to the RT-reaction prevents amplification of the band 
from homozygous samples. This suggests that the band in the non-DNase treated 
RNA sample is amplified from gDNA. (D) Confirmation that the RT-PCR primers 
amplify a product from genomic DNA. As the primers reside on exons which are 
seperated by intron sequences the data suggests there is a processed JSTI85 
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secretory trap insertion site, they are expected to reside on a separate exons. This 
suggests that amplification from a JST185 processed pseudogene, which lacks intron 
sequences, may be responsible for the band. Further evidence for the presence of a 
pseudogene was obtained by performing PCR on genomic DNA using the same 
primer set and seeing the expected band amplified (Figure 4.16D). 
Pseudogenes are DNA sequences that bear significant homology to functional 
genes, yet they lack promoter sequences for their transcription or contain other 
mutations that preclude formation of a functional product. They are thought to arise 
by rare retroposition events and they have no known function. 
4.9 Mapping of JST185 
JST185 was mapped by fluorescent in situ hybridisation (FISH) by Muriel Lee 
at the MRC Human Genetics Unit, Edinburgh according to the protocol in Fantes et 
al., 1992. Metaphase chromosome spreads and interphase nuclei were prepared from 
JST185 heterozygous spleens. The vector pGTI.8TM was labelled with digoxigenin, 
hybridised to the samples and visualised using a texas red detection system. A single 
vector integration site was localised to chromosome 10 by its G-banding pattern. To 
confirm the chromosomal allocation, paints (using a digoxygenin label and fluoroscein 
detection system) which are specific for chromosome 10 were hybridised to the 
spread. The vector and paint were seen to co-localise confirming that JST185 is 
positioned towards the telomere on chromosome 10 (Figure 4.17). 
4.10 Discussion 
JST185 carries an insertion in a novel multiple membrane spanning molecule 
which has been conserved during evolution. It is strongly expressed during the 
pseudoglandular stage of development, predominantly in the mesenchymal layer, and 
is down-regulated during the canalicular stage. During the saccula stage, expression is 
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Figure 4.17 Chromosomal location of JST185 
Fluorescent in-situ hybridisation (FISH) to metaphase chromosome spreads localises 
the secretory trap vector insertion in JST 185 to close to the telomere on chromosome 
10. The location was confirmed using paints specific to chromosome 10. 
at" 
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observed in isolated cells throughout the lung parenchyma. Most homozygotes die at 
birth due to respiratory failure. A few survive to adulthood but these have 
progressively worsening breathing problems which lead to premature lethality. 
Structure of JST185 
JST185 represents the first report of a membrane spanning molecule 
containing TPR motifs. The presence of two structurally related C.elegans sequences 
and a number of human and Drosophila ESTs suggests this structure has been 
evolutionarily conserved. Furthermore, it is likely that more JST 185 family members 
exist in the mouse. JST 185 contains blocks of homology which are conserved across 
species, degenerate primers can be made to these regions to identify other mouse 
genes. 
It is possible that related molecules functionally compensate for JST185 in the 
homozygous mutants. The expression pattern of JST 185 at mid-gestation suggests it 
may be involved in signalling between the mesenchyme and epithelium which instructs 
branching to occur. Histological analysis of new-born lungs at the saccular stage 
indicates that JST185 homozygotes have fewer terminal branches compared to 
controls. The role of JST185 in branching morphogenesis may be partially 
compensated for by a related family member. 
The TPR domains may be important in relaying signals from the membrane. 
To examine this the TPR domains can be used as affinity reagents in a yeast two-
hybrid screen to identify interacting proteins. This may allow a convenient entry point 
to studying any potential signalling pathways mediated by JST185. The TPR domains 
of JST 185 are predicted to be positioned in the intracellular domain. Recently an 
intracellular SH-2 binding protein was discovered which contains 15 TPR motifs 
(Malek et al., 1996). The authors speculate that the protein may function as a linker 
molecule between TPR-containing and SH-2 containing proteins. 
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RNase protection and Northern analysis confirms that splicing does not occur 
around the secretory trap insertion to produce wild type transcript in JST 185 
homozygotes. The secretory trap insertion occurred just before the end of the first 
TPR domain, thus producing a 3geo reporter protein containing all the JST185 
transmembrane domains. Such a structure could act as an interfering mutant by 
binding ligand at the cell surface but failing to transduce a signal as it contains only 
one complete TPR domain. 
Subcellular localisation studies of several l3gal fusion proteins have previously 
shown that they remain sequestered in the ER and do not reach the surface of the cell 
to perform their function (Skarnes et al, 1995). JST 185 antibodies can be raised to its 
N-terminus to examine the subcellular localisation of the wild type and fusion 
proteins. The multimembrane spanning nature of JST185 suggests that it might 
normally be targeted to the ER membrane. Interestingly, a multiple membrane 
spanning molecule in Drosophila, called porcupine, has been localised to the ER 
membrane where it acts as a pore involved in processing or secretion of the wingless 
signalling molecule (Kadowaki et al., 1996). The Wnt gene family are the vertebrate 
homologues of wingless and in the lung at least one family member, Wnt-2, is 
expressed in the distal mesenchyme of the terminal buds (Bellusci et al., 1996). 
JST185 phenotype 
The majority of JST185 homozygotes fail to make the transition to air 
breathing at birth. Analysis of the lungs of newborn pups indicate they fail to expand 
and fill with air. Homozygote pups attempt to breathe as indicated by their costal 
movements at birth, also, sections through their diaphragms suggest no structural 
abnormalities. The failure of the lungs to inflate does not appear to be due to an 
inability to clear the lungs of fluid at birth as there is no difference between the dry and 
wet weights of mutant and control lungs. Sections through new-born lungs observed 
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under a light microscope show that the airways are not blocked and that, at a gross 
morphological level, they are correctly formed. However, there are subtle 
morphological differences in the airways. Most obvious is their failure to taper into 
terminal sacs, instead the distal most airways have a diameter similar to the more 
proximal respiratory bronchioles (Figure 4.13 C & D). 
The respiratory problems seen at birth in the JST 185 mutants could be due to 
developmental retardation, over-proliferation of mesenchyme or a block in epithelial 
cell differentiation. The paucity of distal branches in mutant lungs compared to 
controls constitutes evidence for retardation. The lung has the appearance of a late 
canalicular lung rather than a lung at the terminal sac stage. Retardation of lung 
development would explain the lethality seen at birth, as retarded lungs produce lower 
levels of pulmonary surfactant. With diminished surfactant, surface tension is 
elevated, the alveoli are unstable and so collapse. 
Alternatively, the abnormal appearance of new born lungs could be due to an 
excessive production of mesenchymal tissue surrounding terminal airways compared 
to the controls. Excessive mesenchyme would explain why there is no difference in 
lung weight between homozygotes and controls although the homozygous lungs are 
smaller. The abnormal alveogenesis seen in the few homozygous survivors may be a 
consequence of mesenchymal over-proliferation which prevents the septal walls of the 
distal airways from thinning out to form the alveoli. 
A mesenchymal over-proliferation phenotype is observed in Hoxa-5 mutants 
of which over 50% show a pen-natal lethality (J. Aubee, pers communication). 
Similar to JST185, Hoxa-5 is expressed at high levels in the mesenchymal 
components of the trachea and lung primordia. This may suggest that JST185 and 
Hoxa-5 are part of the same pathway. It will therefore be interesting to see whether 
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Hoxa-5 expression is altered in JST185 mutants or vice versa as this may provide 
insight into which is upstream of the other. 
Transgenic mice over-expressing Shh in the entire lung epithelium also show a 
similar phenotype to the JST185 lungs (Bellusci et at, 1997). Shh is normally 
expressed in the distal tips of the epithelium but in transgenic mice the surfactant 
protein C promoter drives its expression throughout the distal epithelium of the lung, 
but not in the proximal airway. Histological defects becomes apparent at the 
canalicular stage where there is an increase in the relative proportion of mesenchyme to 
epithelial tubules, however, the organisation of the epithelia looks normal. In the 
transgenic lung during the saccular stage the architecture of the lung is similar to the 
JST1 85 mutants, in that expansion of the airway occurs but the mesenchymal 
component is much thicker than normal. At birth the transgenic lungs fail to inflate. 
In the transgenic mice in vivo BrdU labelling indicated that Shh overexpression results 
in increased mesenchymal and epithelial cell proliferation at 16.5 and 17. 5dpc. It will 
therefore be interesting to examine Shh expression in JST185 mutants and vice versa, 
and use BrdU labelling to demonstrate whether over-proliferation occurs in JST1 85 
mutants. 
It is possible that the early expression of JST185 in the mesenchyme is 
required to promote the differentiation of respiratory cells in the pulmonary epithelium. 
A failure of type H epithelial cell differentiation would account for the failure of mutant 
JST185 lungs to inflate at birth, as these cells provide the lung with pulmonary 
surfactant. During the pseudoglandular stage, when JST185 is expressed at its 
highest level, the type II cell precursors, which stain for apoprotein A, are present 
(Thurlbeck, 1996). Loss of surfactant protein B by type II cells has previously been 
shown to lead to respiratory distress syndrome and pen-natal lethality (Clark et al., 
1995). 
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Further evidence to suggest that JSTI85 animals might be suffering from 
surfactant insufficiency comes from the phenotype of the few adult survivors. The 
pathology of the mutant adult lungs is similar to the chronic lung condition, 
bronchopulmonary dyplasia (BPD), the most common cause of chronic lung disease 
in infants (reviewed in Horowitz & Davis, 1997). Most of the pathological hallmarks 
of this disease are seen in JST185 mutant lungs, including impaired alveolar 
development, oedema, fibroblast proliferation and inflammatory cell infiltration. 
There is no single cause for BPD in all infants but it often occurs in prematurely born 
infants with respiratory distress syndrome which have been treated for surfactant 
deficiency. Similar to the JST185 mutants, in the early stages of BPD there is 
increased pulmonary resistance which increases the work of breathing. This increased 
resistance is thought to be due to the surfactant deficiency causing significant alveolar 
collapse. 
One of the mechanisms proposed to contribute to the pathology of BPD is a 
protease-antiprotease imbalance which interferes with the layout of elastin leading to 
growth without proper alveolarisation (Robertson, 1989). Histological staining of 
JST 185 mutant lungs reveals drastic changes in the distribution of elastin. Mechanical 
ventilation of premature neonates is often associated with BPD, as the high pressures 
required to open collapsed alveoli cause significant damage to the terminal bronchioles 
and alveolar ducts. A recent model for ventilation induced BPD in preterm lambs 
found an excessive production and accumulation of elastin in alveolar walls (Pierce et 
al., 1997). 
Immunohistochemistry reveals marked changes in the level and distribution of 
a-sma in the homozygous lungs. The increased levels indicate there may be an over-
proliferation of mesenchymally derived lung fibroblasts. Abnormal distribution of a-
sma has also been observed in the lungs of transgenic mice over-expressing TGF-131 
(Zhou et al., 1996). These animals show severe defects in sacculation. The authors 
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suggest that TGF-131 influences myofibroblast differentiation and that the abnormal 
distribution of myofibroblasts tethers the distal airways and inhibits the expansion of 
terminal lung buds leading to abnormal sacculation. 
To further investigate the role of developmental immaturity in the JST 185 
homozygotes, pregnant females of heterozygous intercrosses can be treated with 
dexamethasone and progesterone. Dexamethasone promotes epithelial cell maturation 
and progesterone delays parturition by one day, prolonging in utero development time. 
In this way we may increase the proportion of JST 185 homozygotes which survive. 
Examination of the levels of surfactant proteins in JST 185 new born animals may also 
indicate whether the lung epithelium is either immature or lacking type II epithelial 
cells. Ultrastructural studies can also be used to differentiate between these two 
possibilities as the type II cells are easily recognisable by the presence of large 




The results presented in this thesis demonstrate that the secretory trap approach 
provides a highly efficient means to screen for novel membrane spanning molecules 
essential for mouse development and also allows rapid identification of the mutated 
genes by direct sequencing of 5'RACE products (Townley et al, 1997). Using this 
approach, 58% [7/12] of insertions were shown to occur in secretory genes. Based on 
the analysis of the remaining insertions, a pre-screen has been developed which should 
ensure that up to 100% of insertions occur in secretory molecules. This involves only 
selecting lines which show the secretory pattern of 3gal activity in ES cells. 
Detailed analysis of secretory trap line JST 185 shows that gene function is 
disrupted since splicing does not occur around the secretory trap insertion. This 
demonstrates that the vector can act as an effective mutagen. The developmental 
importance of JST 185 is clear, given the recessive lethal phenotype of homozygotes. 
Recent results from ongoing experiments in this laboratory have shown that 30% 
[10/28] of secretory trap insertions into secretory molecules cause recessive lethal 
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phenotypes (S.J. Monkley, J.Brennan, D. Townley, B.J. Avery and W.C. Skarnes, 
unpublished data). 
71% [5/7] of JST insertions which disrupted secretory genes are expressed in a 
restricted pattern. JST185 exhibits one such pattern in the developing lung and results 
in aberrant lung development. This indicates that, if used in conjunction with a screen 
for tissue specific expression patterns, the secretory trap approach can be used to 
identify novel genes involved in particular developmental pathways. However, other 
genes with restricted expression patterns, such as JST213, do not result in abnormal 
phenotypes. Results from the ongoing experiments mentioned above, indicate that 
disrupting genes with restricted expression patterns gives rise to recessive lethal 
phenotypes at a frequency similar to those exhibiting widespread expression patterns. 
This may reflect the fact that in signalling pathways the ligand or receptor can often be 
widely expressed, whilst its partner exhibits a more restricted expression profile. 
In a previously conducted pilot screen using pGT1 .8TM, two of the six lines 
examined had mutations in the same gene (Skarnes et al, 1995). This raised the 
possibility that the secretory trap vector would be unable to detect insertions in more 
than a subset of secretory genes. None of the 13 JST lines analysed here were repeat 
events indicating that this may not be a real problem. 
Data from our lab and others suggests that electroporated constructs are biased 
towards inserting into particular genes, as multiple independent insertions have been 
detected in the same gene using different vectors (Chapter 1). Therefore the best way 
to achieve a saturation screen would be to use a combination of vector constructs with 
different integration preferences. The results presented in Chapter 3 confirm the 
feasibility of an exon trap approach and also indicate ways in which such an approach 
might be improved. For example, if a random promoter trap screen is to be performed 
on a large scale, a retroviral based vector would be advisable. Such a vector would 
not suffer deletions from its 5' end and would thus reduce the effort required to 
identify disrupted genes. However, a selective screen for secretory molecules requires 
insertions to occur in coding regions, so a plasmid based vector must be used. In such 
a screen it is vital that the selective property of the vector is protected from deletion. 
This may be achieved by the inclusion of either buffer sequences or a hairpin loop at 
the 5 end of the vector. 
In summary the data described in this thesis has shed new light on the selective 
mechanism of the secretory trap vector and has indicated ways in which the selective 
properties may be improved. More importantly this data shows that the secretory trap 
approach is an efficient way to generate a resource of mutants carrying insertions in 
novel secretory molecules that are immediately accessible to molecular characterisation 
and functional analysis. 
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Chapter 6 
MATERIALS AND METHODS 
6.1 Materials 
Unless stated otherwise, all chemicals were of analytical grade and supplied by BDH 
Laboratory supplies or Sigma, restriction and modifying enzymes were from 
Boehringer Mannheim. All bacterial media constituents were supplied by DIFCO 
laboratories and electrophoresis grade agarose was supplied by GIBCO BRL. 
Synthetic oligonucleotides were supplied by Oswel, University of Southampton. 
Radioisotopes were supplied by Amersham and X-ray film was supplied by Kodak. 
Computer software packages used for DNA analysis were MacVector (V. 5), 
University of Winconsin Genetics Computer Group (1994), GCG package (V.7). 
ME 
6.1.1 	DNA vectors 
Commercially available: 
pBluescript KS II (-) (Stratagene) 
pBluescript SK II (-) (Stratagene) 
Constructed/provided: 
pGT1.8TM (W.C. Skarnes, Figure 6.1) stock #78 
pET1 .8TM (J. Brennan, Figure 6.2) stock #114 
pl.8HX (W.C. Skarnes, Figure 6.3) stock #95 
pSAib (W.C. Skarnes, Figure 6.4) stock #106 
pSAgeoAEK (W.C. Skarnes, Figure 6.5) stock #94 
pGTbTM1 (W.C. Skarnes, Figure 6.6) stock #90 







RACE probe (genotyping) 520bp XbaIJAsp7 18 
5' cDNA (library screen) 	190bp NotJJXbaI 
3' cDNA (library screen) 170 BamHI 
200bp RACE (RPA) 	200bp HindIIIBsshII 
480bp cDNA (RPA) 	480bp NcoIJBsshII 
Hindifi/SacI 
J5T185 RACE clone #2 
Original JST185 cDNA 
Original JST 185 cDNA 
JST185 RACE clone #2 
PvuIJJXba 650 (subcloned 
from original cDNA) 
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BgiI!/ 	 Cia! 
Nac! 
Probe Restriction fragment Plasrnid 
Neomycin 1.1kb XbaIBamHI pGTATM1 
LacZ 0.8kb ClaIJSacI pSAflgeoAEK 
En2 exon 0.5kb BamHTJBg1II pl.8HX 
En2 intron 1.5kb HindIlTfBglll pSAib 
ET105 330bp Xballllindffl ET105 RACE clone #13 
6.1.4 	Primers 
pGT1.8TM RACE primers (Primer numbering based on Figure 2.6, see also 
Figure 2.7 for position of primers within vector sequences) 
















pET1.8TM LM-PCR primers (Primer numbering based on Figures 3.4 and 3.5) 
Unidirectional adapter was made by ligating the following primers: 
#144 	5' gctagtctagagggcccagatctgaattc 3' 
#145 	5' gaattcagatc 3' 
EX 
Primer 	Stock# 	Sequence (5-93') 
P4 	146 	gctagtctagagggcccagat 
P5 	155 	gctagtctagagggcccagat (5'biotinylated) 
The positions of the nested primers designed against pET1.8TM sequences are 
illustrated in Figure 6.7. The primer numbers refer to the following nested primers: 
Located within LacZ sequences: 
#78 	5' taatgggataggttacg 3' 
#79 	5' agtatcggcctcaggaagatcg 3' 
#80 	5' attcaggctgcgcaactgctgttgg 3' 
#166 	5' cgccagggttttcccagtcacgac 3 '  
Located within CD4 sequences: 
#147 5' aataggatgcagagccccgt 3' 
#148 5' cagcacgacagccaggaacat 3' 
#93 5' ccttcactcagtagacattgcc 3' 
#149 5' agacattgccacacccctgct 3' 
#150 5' aggtcaaagtgttgctgtcgg 3' 
The same nested primers were used to RACE from ET lines. 
420 
310 	1 431 
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CD4 II I LacZ 
#150 	#1493 #148 #147 	 #166 #80 #79 #78 
Figure 6.7 Primer sites in pET1.8TM 
Primer number is indicated below arrowhead. Position in nucleotides within pET1.8TM vector is indicated above the map. 
6.1.5 Escherichia coli strains & culture media 
Escherichia coli strains 




Luria Broth (LB), per litre (in H20) 
Tryptone (Difco) 	log 
Yeast extract (Difco) 	5 g 
LB plates 
1 litre LB 




LB Top Agarose 
250 mis LB 
1.79 g Agarose 
SM 
lOOniM NaCl, 10mM MgSO4, 50mM TrisCi (pH7.5), 0.01% gelatin 
Antibiotics (Stock solution) 
Ampiciiiin (100mg/mi in H20) 
Kanamycin (10mg/mi in H20) 
Tetracycline (5mg/mi in ethanol) 
6.1.6 	Embryonic stem cells, culture media & solutions 
CGR-8 ES cells (derived from 1 29/OLa mice by J Nichols) 
CGR-8 ES cells are feeder-independent and rely on an exogenous source of 
differentiation inhibitory activity, DIA (also known as leukocyte inhibitory 
factor, LIF). These cells are karyotypically male and were derived from the 
129/OLa strain of mice as described in (Nichols et al., 1990). 
Cell culture medium: (per 400 ml) 
lOX Glasgow MEM/BHK12 (Gibco), store 4 0C 	 40 ml 
7.5% sodium bicarbonate (Gibco), store 4 0C 	 13.2 ml 
IX MEM non-essential amino acids (Gibco), store 4 0C 	4 ml 




0.1M 2-mercaptoethanol (Sigma), store 4 0C for 1 month 	0.4 ml 
foetal calf serum (Globepharm, Surrey), batch tested, 
store -200C 	 40 ml 
sterile, deionised water 	 340 ml 
(Store up to I month at 4°C) 
Differentiation inhibiting activity (DIA) 
DIA was prepared by D. Colby and D. Rout at the CGR by transient expression 
of murine or human DIAJLIF expression plasmids in COS-7 cells using the 
method described in (Smith, 1991). Serial dilutions of the supernatant were 
tested on ES cells plated in 24-well plates. A 100-fold higher dilution than the 
minimal dilution required to keep ES cells undifferentiated was typically used. 
Serum batches were tested for their ability to sustain the growth, differentiation 
and viability of ES cells grown at clonal density in the presence and absence of 
DIA. 
Phosphate Buffered Saline (PBS) 
One PBS tablet (Dulbecco A; Oxoid BRO14G) was dissolved in 100 mis water 
to give a PBS solution pH 7.3 which was filter sterilised. 
Trvpsin solution 
Dissolve 250 mg of trypsin (Difco) and 372 mg EDTA disodium salt (Sigma) in 
1 litre of PBS. Add 10 ml of chicken serum (Flow Labs) and filter sterilise. 
Store in 20 ml aliquots at 200C. 
1% Gelatin 
Add 1 g of gelatin (Sigma,) to 100 ml dH20, autoclave and store in 20 ml 
aliquots at 40C. For a working solution of 0.1%, add 10 ml of 1% gelatin to 90 
ml of PBS. 
0. 1M 2-mercaptoethanol 
Add 100 ml 2-mercaptoethanol (Sigma) to 14.1 ml PBS. Store up to 1 month at 
4°C. 
Geneticin (G 418; Boehringer-Mannheim) 
200 mg/ml dissolved in dH20. 
Freezing solution 
1 ml of DMSO to 9 ml of cell culture medium (made fresh). 
	
6.1.7 	Miscellaneous solutions 
Standard solutions were made according to (Maniatis et al., 1982). 
Th 
10 mM Tris HC1, pH 8.0 (200C);  1 mM EDTA, pH 8.0 
DEPC HQ prepared in a fume hood by adding 1 ml of diethyl pyrocarbonate 
(Sigma) to 1 litre of dH20, shake thoroughly and leave overnight before 
autoclaving 
NaP buffer (1 M sodium phosphate) 
Dissolve 70.5 g of anhydrous Na2HPO4 in dH20, add 4 ml of phosphoric 
acid and make up to 1 litre with H20. Filter sterilise. 
TEN 
25mM Tris Cl (pH7.4), 24mM EDTA, 75mM NaCl 
6.2 Molecular biology methods 
Many of the methods described in this section are based on those described in 
Sambrook et al., 1989. 
6.2.1 	General cloning techniques 
Restriction fragments and PCR products required for further analyses were routinely 
subcloned into the plasmid Bluescript II KS (-) This typically involved the following 
steps. 
(a) Gel purification. 
Restriction digests and PCRs were fractionated by electrophoresis on agarose gels 
(usually cast in lx TAE) of the appropriate concentration containing ethidium bromide 
(0.5 pg/ml). Bands of interest were excised with clean scalpels under long 
wavelength ultraviolet illumination and DNA recovered using the QIAEX II kit 
[QIAGEN] according to the manufacturer's instructions. DNA is bound to a silica 
resin, subjected to a series of washing steps which eliminate non-nucleic acid 
impurities and finally eluted in TE or water. 
Ligation. 
Ligation reactions were usually set up with a vector to insert ratio of 1:3 by molarity. 
Reactions were performed in 10 tl volumes to include 1 pl each of T4 DNA Ligase (1 
Weiss unit) [Boehringer] and a 10 x ligation buffer (containing ATP) [Boehringer]. A 
control reaction containing vector alone was always set up to determine the 
background number of colonies due to self-ligation of vector. A successful ligation 
reaction usually produced an enrichment of more than 100-fold colonies over the 
vector-alone ligation. Cohesive-end ligations were performed at 16 0C for a minimum 
of 8 hours while blunt-end ligations were allowed to continue overnight at room 
temperature. 
Transformation. 
Electrocompetent cells were prepared according to the following procedure: 
Inoculate a single colony of the required bacterial strain, usually DH5ot or 
XL1-Blue (from a recently streaked plate), into 25 ml LB broth. Incubate at 
370C overnight with vigorous shaking. 
Inoculate 500 ml LB broth with 5 ml of the overnight culture. Incubate at 
370C with vigorous shaking until 0D600=0.3. 
Chill on ice for 15 minutes. Centrifuge at 4000 x g for 10 minutes at 4 0C. In 
this and all subsequent steps, rotors, centrifuge bottles, tubes and pipettes must 
be kept cold. 
Discard supernatant and resuspend bacterial pellet in 10 ml cold water. Bring 
volume to 500 ml with cold water. Centrifuge at 4000 x g for 10 minutes at 
4°C. 
Repeat step 4 but reduce volume of water to 250 ml. 
Repeat step 4 but resuspend pellet in 10 ml ice-cold 10% glycerol. 
7. 	Discard supernatant and resuspend the bacterial pellet in a final volume of 1 ml 
with 10% glycerol. 
8. 	Dispense into 40 j.tl aliquots. Quick-freeze in liquid nitrogen and store at 
-80°C. 
1-2 j.tl of the ligation reaction was mixed with 40 111 of electrocompetent cells and 
incubated on ice for 1 minute prior to electroporation in a prechilled cuvette [Biorad]. 
The electroporation conditions using Biorad's Gene Pulser were 25 mE, 200 ohm and 
2.5 kV (for 0.2 cm electrode gap) and usually resulted in a time constant of 4.5. 
600ml of LB was immediately added to the cells following electroporation and were 
allowed to recover for 1 hour at 37 0C with gentle shaking. Appropriate amounts were 
plated onto LB-Ampicillin plates. Transformation efficiencies of 2 x 10 10  
transformants per mg of supercoiled plasmid are typical with fresh electrocompetent 
cells. This was found to fall 10-fold upon freezing. 
6.2.2 	Isolation of nucleic acids 
(a) Small scale preparation of plasmid DNA 
A single colony was picked with a sterile gilson tip and used to inoculate 5m1 of L 
broth, containing 10mg/mi Ampicillin (Sigma). This culture was shaken at 37 0C 
overnight and DNA prepared according to the following protocol: 
Cells were harvested by centrifugation for 3 minutes at 13,000 rpm in a 1.5 ml 
Eppendorf tube. 
The pellet was resuspended in 200 i1 of TGE (24mM Tris-HC1 pH 8.0, 50 m 
glucose, 10 mM EDTA). 
400 p1 of freshly made lysis buffer (0.2 M NaOH/1 % SDS) was added, mixed 
by inversion and stored on ice for 5 minutes. 
200 j.tl of solution III (3 M Potassium Acetate/5 M acetic acid; 100 ml = 60 ml 
5M KAcetate, 11.5 ml glacial acetic acid, 28.5 ml water) was added, mixed by 
vortex and stored on ice for 10 minutes. 
Th.e resulting precipitate was removed by 10 min centrifugation at 13000 rpm 
and 700 111 of supernatant was transferred into a clean Eppendorf tube. 
The DNA was phenol/chloroform extracted and then precipitated by the addition 
of 360 j.tl of propanol. 
After 10 minutes on ice the DNA was pelleted by centrifugation at 13000 rpm for 
10 minutes, washed in 70 % ethanol and then air dried. 
The DNA was resuspended in 50 pJ of TE containing 20 pg/m1 of RNase A 
(b) Large scale preparation of plasmid DNA 
Plasmids required for electroporation into cells were prepared according to the 
following protocol. 
A 10 ml overnight culture of the appropriate colony was used to seed a 250 ml 
culture. 
The cells were harvested by centrifugation at 4000 rpm for 15 minutes at 4°C. 
The bacterial pellet was then resuspended in 9 ml of lysis buffer (see above). 
1 ml of freshly prepared lysozyme (10 mg/ml in 10 mlvi Tris-HCI, pH 8.0) was 
added. 
20 ml of 0.2 M NaOH/l% SDS was added, mixed by inversion and stored at 
room temperature for 5 minutes. 
10 ml of ice cold 3 M KAcetate/5 M acetic acid was added and mixed by 
shaking. 
The bacterial lysate was then centrifuged as before and the rotor allowed to stop 
without braking. 
The supernatant was removed and filtered through glass wool. 
The plasmid DNA was then precipitated with 0.6 volumes of isopropanol. 
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The DNA was recovered by centrifugation at 4000 rpm for 15 minutes at room 
temperature, washed with 70% ethanol and then resuspended in 10 ml TE 
buffer. 
The plasmid DNA was then purified by CsCl-ethidium bromide gradient. 
To the above DNA preparation 10.8 g of CsC1 was added and dissolved 
followed by 650 j.tl of 10 mg/ml ethidium bromide. 
This mixture was then centrifuged at 4000 rpm for 15 minutes and the 
supernatant loaded into an ultra centrifuge tube and sealed avoiding air pockets. 
Centrifugation was performed at 55,000 rpm overnight at 20°C in a Beckman 
NVT65 rotor. 
The band corresponding to plasmid DNA (see (Maniatis et al., 1982) was 
removed and the ethidium bromide removed by extraction with CsC1 saturated 
isopropanol. 
TE buffer was added to 4 ml and the DNA precipitated with 8 ml ethanol. 
The pellet was collected by spinning and washed in 70% ethanol, resuspended in 
4m1 TE buffer, phenol/chloroform extracted twice, chloroform extracted and 
reprecipitated. 
The pellet was collected by spinning and washed in 70% ethanol and 
resuspended at 1 1g/ml in TE buffer. 
(c) Preparation of genomic DNA from ES cells 
10' cells were harvested by trypsinization, washed in PBS and pelleted. 
The cells were resuspended in 700 p1 TEN buffer and transferred to a 
microcentrifuge tube. 
SDS was added to 1% and mixed by inversion to iyse cells and nuclei. 
0.2 mg of proteinase K (Sigma) was added and the solution incubated at 56 0C 
for at least 2 hours. 
DNA was phenol/chloroform extracted. 
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The DNA in the supernatent was precipitated by adding one tenth of a volume of 
0.3M sodium acetate and 2 volumes of cold ethanol. The DNA was spooled out 
with a heat sealed pasteur pipette, rinsed in 70% ethanol and air dried for a few 
minutes. 
The DNA was transferred to a fresh microcentrifuge tube containing 200-500 jil 
TE and dissolved overnight at 4 0C. 
(d) Preparation of RNA 
RNazol B (Biogenesis Ltd) was used to prepare RNA from cells and tissues. The 
method used is based on that recommended by the manufacturer. 
Preparation from ES cells: 
A confluent tissue culture well of ES cells was rinsed twice with PBS. A 
volume of RNazol was added to the cells (I ml RNazol per 6-well; 250p1 RNazol 
per 24-well). 
The lysate was passed up and down in a gilson pipette several times and 
transferred to a microcentrifuge tube and placed on ice. 
One tenth of a volume of chloroform was added and the mixture vortexed for 15 
seconds. The sample was left on ice for 5 minutes. 
The mixture was spun for 15 minutes and the aqueous phase transferred to a 
new tube. 
One volume of ice cold isopropanol was added to precipitate the RNA and the 
sample left on ice for 15 minutes. 
The RNA was pelleted by spinning for 15 minutes. 
The pellet was washed with 75% ethanol, air dried and resuspended in DEPC 
water. 
RNA was stored at -20 0C. 
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6.2.3 	Dot blot analysis of nucleic acids 
(a) Tail biopsy dot blot 
A one tube method for preparing genomic DNA from tail biopsies was used. To 
obtain uniform signals, it was important to apply enough DNA to saturate the 
membrane. This was determined empirically using a BioRad 96-well dot blot 
apparatus and Amersham Hybond N+  membrane. 
Tail biopsies (1.5 cm in length) were taken at weaning age and digested 
overnight at 55-65 0C in 0.4 ml of tail buffer (recipe below). 
While tubes are still warm, 0.1 ml SM NaCl was added and vortexed at high 
speed for 5-10 sec. 0.5 ml of chloroform was added and vortexed again for 5-10 
sec. Samples were spun in a microfuge for 5 mm. 
50 tl of the top aqueous phase was transferred to a 96-well plate. DNA was 
denatured by adding 150 tl of 0.53 M NaOH and incubating at 37°C for 30 
mm. 
The dot blot apparatus was prepared by cutting a piece of Hybond N+  membrane 
and a piece of Whatman paper to fit the apparatus. The membrane was pre-wet in 
H20 then soaked in 0.4 M NaOH for 10 mm. The Whatman was pre-wet in 0.4 
M NaOH and placed underneath the membrane on the apparatus. 
Samples were applied to the dot blot apparatus and left for 30 min before 
applying a vacuum. 
Samples were drawn through with gentle vacuum. Apparatus was disassembled 
and the membrane washed with 30 mM NaP buffer/0.1% SDS buffer. The 
membrane was hybridised to a neo probe. 
Tail buffer (made up fresh): to 10 mM Tris-HC1 (pH 8.0)/100 mM NaCl/ 50 mM 




Second round RACE products were analysed in essentially the same way as the tail dot 
blot above. 3pi of second round products were denatured in lOOp! of 0.4M NaOH for 
30 minutes at 37°C. The dot blot was performed as outlined in 4-6 above. 
RNA dotbiot 
20pg of total RNA was resuspend in 40u1 DEPC water. The following were added: 
80j.il formamide 
28i.l formaldehyde 
176pA 1M NaP buffer 
Samples were left at 55°C for 15 minutes and then applied to the dot blot as above 
except for using Hybond N rather than N+. 
6.2.4 	Southern blot analysis 
Southern blots were performed according to the following 'dry blot' protocol. 
1. 
	
	Following electrophoresis, the gel was photographed and shaken for 45 
minutes in 0.4M NaOH. 
2. 	Hybond N+  (Amersham) was pre-wet in distilled water for 5 minutes and then 
transferred to 0.5M NaP buffer. 
3. 	The transfer sandwich was set up as follows: 
Gel was inverted on a glass plate. 
Hybond N+ was laid on top, making sure all air bubbles were removed. 
3 sheets of Whatman 3MM paper (pre-wet in 0.5M NaP buffer) were laid 
on top. 
3 sheets Whatman 3MM paper (dry) was laid on top. 
A stack of hand towels was added on top. 
4. 	Next morning the sandwich was disassembled and the filter rinsed briefly in 50 
mM NaP buffer followed by UV cross linking the DNA to the filter (1 auto 
cross link cycle in Stratalinker). 
MI 
Southern hybridisation of genomic DNA included a 20 minute treatment of the agarose 
gel in 0.25M HC1 prior to the alkali treatment in step 1. 
6.2.5 	Northern blot analysis 
The JST Northern in Figure 2.5 was run by Julie Moss. 
Solutions: 
lox MOPS Buffer Loading Buffer 	(lOmis) 
(store 40C in dark) 5m1 formamide 
400mM 	1 M MOPS* I .58m1 formaldehyde 
100mM 	Sodium Acetate (pH 5.5) imI 10 X MOPS buffer 
10mM 	EDTA (DH 8.0) 2.42m1 water 
*1M MOPS (acid) pH to 7 with 2M 
NaOH, filter sterilise and store 4 0C in 
dark 
RNA was separated on a 1% denaturing agarose gel containing 0.37M 
formaldehyde. 
Loading buffer was added to 10-20ig RNA samples (3 parts buffer: 1 part 
RNA). 
Samples were incubated at 650C for 15mins then 1/100th of a volume of 
10mg/mi ethidium bromide was added. 
The gel was electrophoresed in 1X MOPS. 
Once run, the gel was incubated with shaking under the following conditions: 
1 -5hrs 	water (water changed a couple of times) 
45 mins 50 mM NaOH, 10 mM NaCl 
30 mins 	0.5M NaP buffer 
RNA was blotted onto Hybond N 
95 
RNA was transferred to Hybond N pre-soaked in 0.5M NaP buffer in a similar 
'sandwich' as with the Southern hybridisation above. After transfer the filter was 
baked at 80°C for 2hrs. 
RNA molecular weight standards were usually separated on the Northern gel, failing 
this, transcript size was estimated from the size of 18SrRNA (6333 nucleotides) and 
28SrRNA (2366 nucleotides). 
6.2.6 	Preparation of radiolabelled probes 
The DNA template was released by digestion of plasmid DNA with an 
appropriate restriction enzyme. After separation through a low melting point 
agarose gel the probe template was excised and the concentration was adjusted to 
5 ng /pl with TE. 
5 tl of melted template (25 ng) was added to 5 il of water and denatured for 5 
minutes at 95-100°C. The DNA sample was collected at the bottom of the 
eppendorf tube by a brief pulse in a microfuge. 5 p1 of DNA labelling mix, 5 p1 
of 32P dCTP (10 .iCi/ml;3000Ci/mmol, Amersham) and 1 p1 of Klenow (2 
units/pt) were added and the reaction incubated at 37 °C for at least 30 minutes. 
Unincorporated nucleotides were removed by spinning the reaction through a 
G-50 sephadex column. Probes were stored for up to 1 week at -20 °C. 
6.2.7 	Hybridisation conditions 
RNA and DNA blots were hybridised using a technique based on that of (Church and 
Gilbert, 1984). 
Hybridisations were performed in rotating glass cylinders (Techne oven). 10 ml 
of hybridisation buffer was routinely used per filter in each glass cylinder. 
Pre-hybridisation and hybridisation were carried out at 65 °C for DNA blots and 
60 °C for RNA blots. 
Filters were pre-hybridised for 10 minutes during which time radiolabelled 
double stranded DNA probes were denatured at 95-100 °C (5-10 minutes). The 
probe was placed on ice for 2 minutes before being added to fresh buffer at a 
concentration of approximately 10 6 cpmlml. Hybridisation proceeded overnight. 
The first post-hybridisation wash was performed in the glass cylinder for 15 
minutes at the same temperature as hybridisation. Two further 15 minute 
washes were performed in a Tupperware box on a shaker at the same 
temperature as before. 
Filters were placed in Saran wrap and exposed to X-ray film between 
intensifying screens at -70 °C. 
To re-hybridise filters, the bound probe was stripped by placing the filter in 
boiling 0.1% SDS and then left to cool. 
DNA hybridisation buffer 	RNA hybridisation buffer 
0.05 g Marvel milk powder 	 0.2 g bovine serum albumin (Sigma) 
10 ml 1M NaP buffer 	 7 ml 1M NaP buffer 
7 mls 20 % SDS 
	
6 ml formamide 
3 mls water 	 7 ml 20 % SDS 
DNA wash buffer 
	
RNA wash buffer 
30 mM NaP buffer 	 150 mM NaP buffer 
0.1 % SDS 
	
0.1 % SDS 
6.2.8 	RNAse Protection Assay 
Based on the protocol of King and Melton, 1987). 
Probe Templates 
Probe templates were made by restriction digest of pBluescript plasmid containing 
RACE cloned products. In each case, the T7 polymerase site 3' of the sequence of 
interest was retained. The digests were then run on a 1.2% agarose gel, and the 
fragments representing the probe templates excised. The DNA was extracted from the 
agarose by spinning the gel slice through synthetic wool at 40°C and then ethanol 
precipitated and resuspended in DEPC treated water at approximately 250ng/ml. 
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Probe synthesis 







lox transcription buffer 
polymerase (usually T7) 








For GAPDH loading control probe, 0.25 j.il of [a32P] CTP was used, together with 
6t1 of 1mM unlabelled CTP. 
The reaction mixtures were then incubated at 37°C (40°C for GAPDH) for Mr. 
imi of RNase free DNase was then added to each reaction to remove the probe 
template, and incubation at 37°C continued for 10 minutes. A further 1il of DNase 
was added, followed by a further 10 minute incubation to ensure maximum 
degradation of the probe template. 
The volume of each probe was made up to lOOjil with sterile water, and each probe 
extracted once with phenol/ chloroform and spun through a sephadex G-50 column to 
remove unincorporated nucleotides. 
Gel Purification of Probes 
12tl of each probe was mixed with 8jil of loading dye, denatured briefly, and run on a 
6% polyacrylamide sequencing gel for lhr at 60W. 
The wet gel was wrapped in Saran wrap and orientation marks made. A piece of x-ray 
film was then placed on the gel, and the same orientation marks made on the film. 
After developing the film, the two sets of marks were aligned, and the area of the gel 
containing the probe band carefully excised and removed to a microfuge tube. A 
further piece of X-ray film was then placed on the gel and developed to ensure that the 
correct region of the gel had been removed. 100.tl of probe elution buffer (0.5M 
ammonium acetate; 1mM EDTA; 0.2% SDS) was then added to each gel slice, and the 
gel crushed with a disposable spatula. The probes were then shaken at 37°C for 2hrs, 
at the end of which time the gel was spun to the bottom of the tube and the 
supernatant, containing the probe, removed. To ensure maximum yield of probe from 
the gel, a further 5Opi of elution buffer was added to the gel, vortexed briefly, and the 
supernatant pooled with the previous lOOil. 1il of each probe was then added to 
scintillation fluid and the incorporation of each probe measured. 
Hybridisation 
10pg samples of target RNAs were precipitated, spun down and resuspended in 2jil 
DEPC water. A volume of eluted probe containing 350 000cpm was added to each 
sample (50 000cpm for GAPDH loading control) and the volume made up to lOOj.tl 
with DEPC water. These mixtures were then precipitated at -70°C using 250j.il of 
ethanol, with ipi of glycogen as carrier. The precipitated RNA and probe mixtures 
were then spun down, air dried and resuspended in 3lil  of DEPC water, 3p1 of lOX 
hybridisation buffer and 24pl of deionised formamide. The samples were then 
denatured at 85°C for 15 minutes and hybridised overnight at 55°C. 
RNase Digestion 
Digestion buffer was made up as follows: 
2M Tris pH7.5 	30p1 
500mM EDTA 	60jil 
5MNaC1 	 360pi 
dH2O 	 5.55pi 
25mg/mi RNase A 9.6pi 
RNaseTl 	2.1jil 
350p1 of digestion buffer was added to each sample. The samples were then put at 
30°C for 30 minutes to digest unhybridized RNA. 
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20tl of 10% SDS and 5p1 of 10mg/mi proteinase K were then added to stop the 
digestion, and the samples incubated at 30°C for a further 10 minutes. 
The samples were then extracted once with phenol/chloroform and precipitated at 
-70°C with lml of ethanol using 5jig of tRNA as carrier. 
The precipitated RNAs were then spun down, air dried and resuspended in lml of 
DEPC water and 4tl of loading dye, denatured briefly at 95°C and run on a 6% 
polyacrylamide gel. 
6.2.9 	DNA sequencing 
(a) Dideoxy- termination method 
Double-stranded sequencing of plasmids was carried out using the Sequenase Version 
2.0 DNA Sequencing Kit {USB-Amersham] and 35S-dATP as label according to the 
recommendations of the manufacturer with the following modifications: 
Termination mixes were pre-diluted with DMSO to a final concentration of 
10% DMSO. 2.5 jil aliquots were transferred to tubes and kept at room 
temperature until the labelling reaction, whereupon they were transferred to 
37°C. 
1-5 jig of plasmid was added to 1.8 pmol of the sequencing primer (17-mer) in 
a volume of 8.75 p1 and denatured for 5 minutes. 
After chilling samples were chilled on ice for 3 minutes. 1.25 p1 of DMSO 
was added to samples. 
2.5 p1 of Sequenase 5x reaction buffer was added and the labelling and 
termination reactions were performed according to the manufacturers 
recommendations. 
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(b) Direct sequencing 
Preparation of Streptavidin coated beads 
20 pi (200 jig) of beads were prepared for each template (Dynabeads M-280). 
Supernatent was removed from the beads with the aid of a specially designed magnetic 
tube holder (Dynal). 
2X B&W buffer was made (10mM Tris-HC1 pH 7.5, 1.0 mM EDTA, 2.0 M NaCl) 
Beads were resuspended in 20 jil of 1X B&W buffer and mixed gently. 
Supernatant was removed with the beads on the magnet and they were 
resuspended in 40 jil of 2X B&W buffer (Beads were now at 5jig/p.l). 
Immobilisation of PCR products 
Buffer was removed from beads on magnet and 40 jil of washed beads were 
added to 40 jil of diluted biotinylated PCR products (in general 5ji1 of second 
round PCR products from both RACE and LM-PCR reactions were adequate for 
sequencing, these were diluted in 35pJ of H20). 
Samples were incubated for 15 minutes at room temperature with frequent 
mixing to keep beads suspended. 
Denaturation of DNA and removal of unbound strand 
Supernatant was removed with beads on magnet which were then washed with 40 jil of 
lx B&W buffer (samples could be stored at 4°C at this stage for several weeks). 
Supernatant was removed with beads on magnet and resuspended in 8 pA of 
fresh 0.1M NaOH and incubated at room temperature for 10 minutes. 
Supernatant was removed from beads on magnet and the beads were washed 
twice with 50 pA 0.1M NaOH and once with 40 pA 1X B&W buffer, followed 
with a final wash with 50 pi TE. 
TE was removed with the beads on the magnet and they were resuspended in 
12.5 p1 H20. 
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End labelling sequence primer 
The following were made up to a total volume of 20 il: 
10 pmol sequencing primer 
2 p1 lox polynucleotide kinase buffer (Boehringer-Mannheim) 
50 jiCi ['y- 32P] ATP (3000-6000 Ci/mM) 
10 units polynucleotide kinase (Boehringer-Mannheim) 
Samples were incubated at 37°C for 10 mins, heat inactivated at 95°C for 2 mins and 
then stored at -20°C until ready to use 
Sequencing reactions 
An Amersham ThermoSequenase Kit (US 78500) was used for sequencing. 
1 
	
	4p1 of each termination mix (ddATP, ddCTP, ddGTP, ddGTP) was added to a 
strip of 0.2 p1 PCR tubes 
2 	The reaction mix was made by adding the following to 12.5 p1 of beads: 
2 p1 ThermoSequenase reaction buffer 
1 p1 [32P] - end labelled primer (0.5 pmole) 
2 .t1 ThermoSequenase 
3 	4 p1 of reaction mix was added to each tube containing the termination mix and 
reactions were overlaid with 20 i1 of mineral oil 
40 cycles of sequencing were performed using the following conditions 
95°C 30 sec 
60°C 30 sec 
72°C 1 mm 
4 p.1 of stop solution was added when cycling was complete and the samples were 
heated to 80°C for 3 minutes and load on sequencing gel 
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6.2.10 Polymerase chain reaction (PCR) 
Screening by colony PCR 
Bacterial colonies were screened for the presence of inserts by colony PCR. PCR 
primers which flanked the insertion site in pBluescript were used for amplification 
(normally T3 and 17). If possible one of these primers was replaced with an insert 
specific primer. A toothpick was used to transfer a small amount of each bacterial 
colony onto a fresh gridded bacterial plate and into a tube containing the following 
PCR reaction: 
2jt1 PCR Buffer (I OX) 
2p1 MgCl2 (25mM) 
0.4.il dNTPs (10mM) 
ipi Primer 1 (lOOng) 
1 jil Primer 2 (1 OOng) 
0.2jil Taq polymerase 
13.4 p1 water 
The following cycles were performed: 
1 cycle 	94°C 	5mm 
25 cycles 	94°C 	30sec 
55°C 	30sec 
72°C 	45sec 
PCR reactions were separated on an agarose gel and positive colonies were picked 
from the gridded master plate and grown for plasmid preparation. 
Ligation Mediated PCR 
The following protocol is based on a method of (Garrity and Wold, 1992). Solutions 
were made on ice. 
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5 X 1st strand buffer 
	
1st strand synthesis mix 
200 mM NaC1 
	
6 p.1 5 X 1st strand buffer 
50 mM Tris-HC1 (pH 8.9) 
	
0.3 p1 primer 1 (0.3 pmol) [-40 primer] 
25 MM MgSO4 
	
0.25 p.1 25mM dNTPs 
0.05 % gelatin 
	
18.2 91 H20 
(store -20oC) 
	
0.25 p1 Vent DNA polymerase (0.5 u) 
Vent dilution solution 
	
Ligation solution 
2.2 p.! Tris-HC1 (pH 7.5) 
	
0.25 p1 1M MgCl2 
0.35 p.1 1M MgC12 
	
0.5i.tl lMDrr 
1 p1 1MDTT 
	
0.75 p1 rATP 
0.25 p.110 mg/ml DNase-free BSA 
	
0.13 p.1 DNase-free BSA 
16.2 p1 H20 
	
17.37 p1 H20 (chill, then add) 
5 p1  (100 pmol) unidirectional linker 
1 p1 (3u) T4 DNA ligase 
Precipitation solution 
	
5 X Amplification Buffer 
8.4 p.1 3M Na Acetate (pH 7) 
	
200 mM NaCl 
1 p.110 mg/mi yeast tRNA 
	
100 mM Tris-HC1 (pH 8.9) 
25 MM MgSO4 
0.05 % gelatin 
0.05 % Triton-X100 
Amplification Mix 	 Diluted Vent Polymerase 
20 p1 5 X amplification buffer 	0.6 p1 5 X amplification buffer 
1 p.1(10 pmol) Linker Primer 	 1.9 p.1 H20 
1 p.1(10 pmol) CD4 Primer * 	 0.5 p.1 (I u) Vent DNA polymerase 
0.8 p.1 25 mM dNTPs 
7.2 p.1 H20 
* 1st round PCR use CD4 Primer 1, 2nd round PCR use CD4 Primer 5 
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Preparation of unidirectional linker. 
Linker oligonucleotides were denatured for 5 min at 95°C. (20mM of each 
oligo in 250mM Tris pH7.7). 
After transfer to a 70°C heat block they were gradually cooled to room 
temperature over a 1 hour period to allow annealing and then left for a further 
hour. To complete the annealing the oligonucleotides were left overnight at 
4°C. 
Aliquots of linker were stored at -20°C. In future operations linker was always 
thawed and handled on ice to prevent denaturation. 
Synthesis of first strand and ligation of unidirectional linker. 
20 jig of genomic DNA was digested overnight with an appropriate enzyme in 
a volume of 60 j.tl. The reaction was phenol/chloroform extracted and 
precipitated by adding 6 p1 of 3M sodium acetate and 120 p1 ethanol and 
incubated at -20°C for 30 minutes. The precipitated DNA was pelleted, 
washed in 70 % ethanol and resuspended in 8 p1 of TE. The concentration of 
DNA was estimated by taking a OD26Onm reading. The DNA was diluted to 
0.4 p.g/j.tl. 
5 p1 of cleaved genomic DNA (2 jig) was chilled on ice in a PCR tube. 25 p1 of 
ice-cold 1st strand synthesis mix was added and the tube was placed into a 
thermocycling block. The mixture was denatured for 5 mins at 95°C, annealed 
for 30 mins at 60°C and finally extended for 10 mins at 76°C. 
The mix was cooled on ice and briefly pulsed in a microfuge before addition of 
20 p1 of ice-cold Vent dilution solution followed by 25 p1 of ice-cold ligation 
solution. The mixture was then incubated at 17 °C for 12-16 hrs. 
9.4 p1  of ice-cold precipitation solution was added to the sample and 220 pA of 
ice-cold 100% ethanol. After mixing by inversion the DNA was precipitated at 
-20°C for at least 2 hours. 
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PCR amplification. 
The precipitated DNA was pelleted by spinning for 15 minutes, washed in 
70 % ethanol, air-dried, resuspended in 70 p.1 of H20 and stored on ice. 
30 p.1 of ice-cold amplification mix and 3 p.1 of diluted Vent polymerase was 
added and the reaction was overlain with 90 p.1 of mineral oil. PCR was 
performed in an Omnigene thermocycler as follows: 
Cycle 1 
Denature 	95°C 	4 mins 
Anneal 	60°C 	 2 mins 
Extend 	76°C 	 3 mins 
Cycles 2-17 
Denature 	95°C 	1 mm 
Anneal 	60°C 	 2 mins 
Extend 	76°C 	 3 mins (+5 secs )* 
Cycle 18 
Denature 	95°C 	1 mm 
Anneal 	60°C 	 2 mins 
Extend 	76°C 	 10 mins 
*increased by 5 second increments at each cycle 
A second round of PCR was performed using a nested vector primer and 
biotinylated adapter primer. To 5 p.! of 1st round products, 65 p.l of water, 30 
p.l of amplification mix and 3 p.1 of diluted Vent polymerase was added. The 
reaction was overlain with 90 p.1 of mineral oil and PCR was performed using 
the same conditions as above. 
Second round products were purified using a prep-a-gene kit (BioRad) 
according to the manufacturers instructions and sequenced directly. 
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Cloning of products 
Second round products were cloned for line ET105, as a probe was required to 
identify a genotyping RFLP. Products were digested with XbaI, which cuts in the 
unidirectional adapter, and cloned into pBluescript digested with XbaI and EcoRV (the 
latter enzyme generates a blunt ended fragment which is compatible with the blunt end 
of the PCR products). 
(c) Reverse Transcriptase PCR 
1-3pg of RNA was transcribed in the same buffer used to amplify cDNAs. 
Reverse transcription reaction 
The following components were mixed in a 1 .5ml eppendorf tube: 
lOp1 RNA 
3p1 	PCR buffer (lOX) 
2.5jil 10mM dNTPs 
6pJ 25mM M902 
1il 	random primers (1.8mg/ml) 
0. 5pJ MMLV reverse transcriptase (200u/jil) 
l6pJ H20 
Samples were left at 250C for 10 minutes, followed by 1 hour at 42 0C. 
cDNAs were denatured at 950C and placed on ice. 
PCR 
The following components were mixed in a 0.5m1 PCR tube: 
6p1 	cDNA 
1.5pJ PCR buffer (lOX) 
0.2j.il Taq polymerase 
1p1 	primer 1 (20pM) 
ipi 	primer 1 (20pM) 
10.3p1 H20 
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Products were amplified for 30 cycles using the following conditions: 
	
95 0C. 	30 sec 
600C. 	45 sec 
720C. 	60sec 
6.2.11 Rapid amplification of cDNA ends (5'RACE) 
The gene disrupted in JST 197 was identified by Anne Camus, a visiting scientist to the 
laboratory from the Pasteur Institute, Paris. 
The following protocol has been streamlined and contains a number of modifications 
to the original method described by (Frohman et al., 1988). The most important of 
these are 1) alkaline hydrolysis of the RNA (required for efficient T-tailing with 
terminal deoxytransferase), 2) synthesis of second strand cDNA with Kienow instead 
of Taq polymerase and 3) the use of microdialysis filters, which serves a dual role to 
remove primers/buffers between steps and to size-select informative cDNA fragments 
above 300 bp in length. Primer numbers refer to those on the RACE schematic in 
Figure 2.6. 
1st strand eDNA Synthesis 
The following were mixed on ice: 
1 il lOng /pJ primer 1 
1 g RNA (5-10ig) 
Sterile distilled H20 to 11 91 
After heating to 70°C for 5 mins samples were chilled on ice and collected at the 
bottom of the sample tube by a brief pulse in a microcentrifuge. 
The following were added on ice: 
4j.0 5x 1st strand buffer (supplied with Superscript) 
2j.iJ 0.1M DTT 
lpJ 10mM dNTP 
After 2 minutes at 37°C ipi of Superscript II was added and the samples incubated at 
37°C for 1 hr. 
2.2j.tl of 1M NaOH was added to each sample followed by incubation at 65°C for 20 
minutes. Samples were neutralised by adding 2.2pJ of 1M HCI. 
Microdialysis 
The 1st strand reaction was loaded onto a 0.025pm microdialysis filter (Millipore) 
floating in a petri dish (-50m1) of T. E. and left for 4hrs to dialyse. Samples were 
then removed in a volume of 20p1 H20. 
Poly A addition 
To 20p1 of 1st strand reaction, 6pJ 5X TdT buffer (supplied with TdT) and 2p1 of 
2mM dATP were added and samples left at 37°C for 2 minutes. 2pJ of TdT 
(500u/33.7ml) were added and reactions incubated for Smins at 37°C followed by 
2mins at 70°C. Samples were spun briefly in microfuge. 
2nd Strand Synthesis 
To 15t1 of tailed cDNA the following were added: 
2pJ lOx restriction buffer M (Boehringer) 
1 111  10mM dNTPs 
1tl primer 2 (lOng/ml) 
ijil Kienow (2U/ml) 
A 30 minute incubation at room temperature was followed by 30 mins at 37°C and 5 
mins at 70°C. 
Microdialysis 
cDNAs were microdialysed on 0.1 pm microdialysis filters as above and samples were 
collected in 37pi of H 20. 
1st Round PCR amplification 
37pi cDNA 
5tl 	1OxPCR buffer (500mM KCl/lOOmM Tris, pH8.3) 
4tl 25mM M902 
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ipi 	10 m dNTPs 
ipi 	Primer 3 (bOng) 
1j.tl 	Primer 4 (bOng) 
ipi 	Amplitaq (Perkin Elmer) 
Samples were overlaid with 50p1 of mineral oil and amplified using the following 
conditions, 
30 cycles of: 94°C I min 30sec 
60°C Imin 30sec 
72°C 3mm 
Size selection of 1st Round PCR products 
PCR products were dialysed on 0.1 gm filters as above and collected in 40 jil H20. 
2nd Round PCR amplification 
The following reactions were set up. If 2nd round products were to be sequenced 
directly then biotinylated primer 6 was used, if samples were to be cloned then primer 
4 was used. 
5pi 	dialysed 1St round products 
5jil 	lOx PCR buffer (500mM KC1/lOOmM Tris (pH8.3) 
4jiI 25mM M902 
ipi 	10m1V1 dNTP's 
ijil 	Primer 5 (bOng) 
lpJ 	Primer 6 (b Ong) or Primer 4 (b Ong) 
ipi 	Taq polymerase 
32j.fl dH2O 
Samples were amplified using the same conditions as in the first round of PCR. 
Size Selection 2nd round PCR Products 
Selection was performed as for 1st round products. 
Products were either cloned (see below) or directly sequenced (see Section 6.2.9b). 
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Cloning of Amplified cDNA 
cDNAs amplified from JST lines were digested with XbaI and Asp718 and 
phenol/chloroform extracted. Samples were precipitated with ammonium acetate 
(0.2M final concentration) and 2.5 volumes of ethanol. cDNA fragments were cloned 
into KpnI/XbaI digested Bluescript II SK+ 
6.2.12 X Zap II eDNA Library Screening 
Bacterial strains 
The various E. coli strains used for plating phage cDNA libraries and conditions for 
their propagation are summarised in the table below. 
Bacterial strains 	Agar plate for bacterial streak 	Medium for plating cultures 
XL1 Blue F' 	LBteta 	 LB + 0.2% maltose + 10mM 
MgSO4 
XL1 Blue MRF' LBteta 	 as above 
SOLR 	 LBkanb 	 no 
XL1 Blue F' (supE44 hsdR17 recAl endAl gyrA46 thi relAl lac [F' proAB laclq Z 
M15 TnlO (Tetr)]  was used as a host strain for plating the D3 ES cell cDNA library. 
Plating cultures were always started from a fresh LB plate (supplemented with the 
appropriate antibiotic) of cells using a single colony and grown overnight with 
vigorous shaking in 50 ml LB (with or without supplements as appropriate). The next 
morning, the cells were spun at 3560 rpm for 15 minutes in a Beckman-GPR benchtop 
centrifuge and gently resuspended in -20 ml 10 mM MgSO4. For in vivo excision of 
insert-containing Bluescript plasmid from ?ZAP II, the strains XL1 Blue MRF' and 
SOLR were used. 
Titration of lambda phage 
Titers of phage libraries and clones were determined by serial dilution as follows: 
1. 	Make appropriate dilution series in SM. 
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Add 100 pi of the diluted phage to 100 pl plating culture (section 4.3. 1) and 
allow the phage to adsorb for 20 minutes at 37 0C. 
Add 3 ml molten (45 0 C) LB top agarose, invert 1-2 times to mix and 
immediately pour onto pre-warmed (to 42 0C) LB plates. 
Allow top agarose to set and incubate inverted at 37 0C overnight. 
Count the number of plaques and calculate the titre taking into account the 
dilution factor. For example, if there are 20 plaques on a plate made from a 
1/10,000 dilution, that means there are 20 x 10,000 x 10 = 2 x 10 6 plaque 
forming units (pfu) per ml of the original phage stock. (The last 10 of the 
calculation converts the 100 jil of the diluted phage which was plated to a per 
ml basis.) 
Plating and transferring phage libraries 
Bacteriophage cDNA libraries were plated at high density onto agar plates and then 
transferred to nylon filters according to the following protocol: 
Pour LB plates several days in advance and allow them to dry at room 
temperature prior to plating. 
Melt top agarose, allow to cool to 45 0C and supplement with maltose to 0.2% 
andMgSO4 to 10 niM. 
Mix phage with plating cultures according to Table 2. 
TABLE 2- Proportion of phage to plating cells and volume of 
top agarose required for different plate sizes 
Plate size 
10 cm 15 cm 24.5 x 24.5 cm 
bacteria/ml 	 0.2 0.5 2 
phage/pfu 5,000 20,000- 150,000 
30,000 
top agarose/ml 	 3 7 30 
Incubate at 370C for 20 minutes. 
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5. 	Add top agarose, invert to mix and quickly pour onto plate. Disperse bacteria 
and agarose by tilting plates back and forth. 
Incubate plates at 37 0C until plaques cover the plate but not confluent (6 - 12 
hours). 
Leave plates at 4 0C for 1 hour at least to allow agarose to harden before 
performing plaque lifts. 
Leave nylon filters (Hybond N from Amersham) on plates for 3 - 5 minutes to 
allow phage particles to transfer. Make orientation marks by stabbing a 23-G 
needle through the filter into the agar at several asymmetric points. For 
second, duplicate filter (replica filter), allow 5 - 7 minutes for transfer. 
Dry filters on the benchtop for at least 10 minutes. The drying process binds 
the plaques to the filter. 
Place filters on a sheet of Whatman 3 MM paper in a tray saturated with 0.2M 
NaOH, 1.5M NaCl. The 3MM paper should be wet enough to allow 
immediate saturation of filters but not so wet that the solution pools on the 
surface. Leave for 5 minutes. 
Transfer filters to 3MM paper saturated with 0.4M Tris pH7.6, 2X SSC for 5 
minutes and then to 3MM paper saturated with 2X SSC for 2 minutes. 
Allow filters to dry briefly on bench and then UV irradiate (one auto cross link 
cycle in a Stratalinker). Prehybridize immediately or, if storing filters, dry at 
Screening of ES cell eDNA libraries 
A random-primed D3 ES cell cDNA library was cloned in the vector XZAP II (Hitoshi 
Niwa, unpublished). Approximately 1 x 106  recombinants of the library were 
screened by plating 2 x 0 plaques per 245 x 245 mm plate (Nunc) as described 
above. 
113 
The filters (no more than four 245 x 245 mm filters per stack) were transferred to 
hybridisation bottles (Hybaid) and prehybridised for at least 2-4 hours at 650C in 25m1 
of pre-hybridisation buffer (see below). Hybridisation was performed overnight at 
650C with not more than 2 x 106  cpm per ml of hybridisation buffer (see below) of a 
probe labelled to a specific activity in excess of 1 x 10 9 dpni1pg. On the following 
day, filters were washed to a final stringency of 2X SSC, 0.1% SDS at 650C. 
Exposure at 800C  in the presence of two intensifying screens was usually for 5 days. 
Positive plaques (those demonstrating radioactivity on replica filters) were each cored 
with the wide bore end of a glass pasteur pipette and transferred to 0.5 ml SM 
overnight at 4°C. A secondary screen was then performed on 2 or 3 plates (<100 
plaques/plate) of each primary plaque. A single, well isolated hybridising plaque for 
each clone was picked and the process repeated until pure clones were obtained. 
For lOOmIs of pre-hybridisation buffer 	For lOOmls of hybridisation buffer 
0.5 ml 	100X Denhardts 	 0.5 ml 	100X Denhardts 
30 ml 	20XSSC 	 30 ml 	20XSSC 
5 ml 	10% Sarkosyl 	 5 ml 	10% Sarkosyl 
64.5 ml 	water 	 64.5 ml 	water 
1 ml 	herring sperm (10mg/mi) 	lOg 	Dextran Sulphate 
I ml 	herring sperm 
In vivo excision of Bluescript plasmid from XZAPII clones 
The Bluescript SK- plasmid portion carrying the cloned insert of AZAPII clones was 
excised using the Ex Assist helper phage (Stratagene). The helper phage gene II 
protein recognises two signals in the XZAPII vector arms, initiator (I) and terminator 
(T), where fl(+)- strand DNA synthesis will initiate and terminate, respectively. The 
newly synthesised DNA strand is circularised and can be recovered by infecting an F' 
strain and growing in the presence of Ampicillin. In addition, the helper phage carries 
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an amber mutation that prevents its replication in a non suppressing E.coli strain such 
as SOLR. This allows only the excised plasmid (actually phagemid) to replicate in the 
host. The ExAssist helper phage was used for in vivo excision as follows: 
Prepare plating cultures of XL-1 Blue MRF and SOLR as described in Table 1. 
Dilute cells to an 0D600 of 1.0 in 10mM MgSO4. 
In a 50 ml conical tube combine the following: 
200p1 of XL1 Blue MRF 
250pJ of XZAPII phage supernatent (from cored plaque of interest) 
ipi of ExAssist helper phage (_1010  pfu/ml) 
Incubate at 37°C for 15 minutes 
Add 3 ml LB and incubate at 37°C for 2-2.5 hours with shaking 
Heat at 70°C for 15 mins and pellet cells by centrifugation at 4000xg for 15 
mins. Save supematent (may be stored at 4°C for up to 2 months). 
To recover the excised phagemids, add 2000 of a plating culture of SOLR cells 
to 1111,  10 and 100 of the supernatent in separate tubes. 
Incubate at 37°C for 15 minutes then plate 2001.11 from each tube on LB/Amp 
plates. Incubate plates at 37°C overnight. 
The excised plasmid possesses a pBR322 ori and is thus maintained at a low copy 
number per cell. A starter culture was prepared by inoculating a single bacterial colony 
into 10 ml LB/Amp and shaken vigorously at 37 0C. At the end of the day, 2.5 ml of 
this culture was inoculated into 250 ml LB/Amp and, following vigorous shaking 
overnight at 370C, 200 ml was used for plasmid preparation (see chapter 2). Under 
these conditions, the yield of plasmid DNA was 50 - 100 .tg. 
6.3 ES Cell Culture 
ES cells were maintained at 7.5 % CO2, at 37 °C in a humidified incubator (Heraeus). 
Methods for routine culture of CGR-8 ES cells are based on those described in (Smith, 
1991). All ES cell manipulations were carried out in a laminar flow sterile hood (ICN, 
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flow). All solutions were warmed in a 37°C water bath prior to use. Tissue culture 
grade flasks and dishes (Corning) were gelatin coated (0.1 % in PBS, Sigma) for at 
least 15 minutes and aspirated before use. 
6.3.1 	Passage and expansion of ES Cells 
Careful maintenance of ES cells was crucial for successful germline transmission of 
gene trap cell lines. Medium was changed every day and cells were not allowed to 
grow past confluence (approximately 107  cells per 25cm 2 tissue culture flask). 
ES cells were passaged once they had nearly reached confluence. Medium was 
aspirated off and cells were rinsed twice with 5 to 10 ml of PBS. 
Enough trypsin solution was added to cover over the cells (1 ml / 25 cm 2) and 
the flask was incubated at 37 0C for 1 to 2 minutes until a uniform suspension 
was formed. Flasks were tapped to ensure complete dislodging of cells from the 
surface. 
9 ml of ES cell medium was added to stop trypsinization. 
Cells were counted and 106  (approximately 1/10 of a nearly confluent 25 cm 2 
flask) were seeded in a freshly gelatinised flask containing 10 ml of medium 
supplemented with 100 Units/ml of DIA/LIF (see section 6.1.4). 
6.3.3 	Freezing ES Cells 
Cells were harvested as in steps 1-3 above. After transfer to a 20 ml Universal 
tube they were pelleted by centrifugation (Denley BS400 Benchtop, 1200 rpm, 5 
minutes, RT). 
5 % of DMSO (Analar, BDH) was added to the cell suspension and the cells 
again pelleted by centrifugation. 
The cell pellet was resuspended in 0.5 ml of freezing medium (culture medium + 
10 % DMSO) per 5 X 106  cells, quickly aliquotted into cryotubes (Nunc) and 
placed in a -80 °C freezer for 24 hours before being transferred to a liquid 
nitrogen cell bank for long term storage. 
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The cryoprotector dimethyl sulfoxide (DMSO) is toxic to cells and also an 
inducer of ES cell differentiation so exposure time was minimised before 
freezing. 
6.3.4 	Thawing ES Cells 
Frozen vials were retrieved from storage and quickly thawed in a 370C  water 
bath. The contents were transferred into a 20 ml centrifuge tube containing 
10 ml of pre-warmed medium. 
Cells were pelleted at 1200 rpm for 5 minutes; the supernatant aspirated and the 
cells were gently resuspended in 10 ml of pre-warmed DIAJLIF conditioned 
medium. 
Medium was changed after about 8 hrs growth to remove dead cells and any 
residual DMSO (an inducer of ES cell differentiation). 
6.3.5 	Electroporation 
Gene trap vectors were introduced into ES cells by electroporation. The procedure 
involves exposure of a suspension of ES cells and vector DNA to a high voltage 
electric discharge. This leads to the formation of membrane pores that are large 
enough to allow macromolecules such as DNA to enter. 
(a) Vector preparation 
150 .tg of vector DNA was linearised with the appropriate restriction enzyme in 
a volume of 0.3 ml. (Plasmid DNA for electroporation was prepared by alkaline 
hydrolysis and banded on a caesium chloride gradient as described in 6.2.2b). 
Digested DNA was precipitated in 2 volumes of absolute ethanol on ice for 5 
minutes. After spinning in the microfuge the pellet was washed several times 
with 70% ethanol and as much of the ethanol as possible was drained off. 
The remaining ethanol was allowed to evaporate in the hood by keeping the lid 
of the tube open (for approximately 1 hour). The DNA pellet was resuspended 
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in lOOj.tl of sterile PBS and vortexed occasionally over a period of 4 hours to 
ensure that the DNA was completely dissolved. 
(b) Electroporation 
A total of 108  cells were required for each electroporation. 3 x 106  cells were 
seeded in a 80 cm2 flask containing 30 ml of medium. Once the cells reached 
confluence two 175 cm2 flasks were seeded with 5 x 106 cells each containing 
50 ml of medium. The next day the flasks were topped up with 40 ml of fresh 
media. The morning of the electroporation the media was replaced with 50 ml of 
fresh media. Each confluent flask should yield about 8 x 10 7 cells. 
Each 175 cm2 flask was trypsinised using 5 ml trypsin as described above. 
Once the cells were sufficiently disaggregated and freed from the flask the 
trypsin was inactivated with 15 ml media. Cells were pelleted at 1200 rpm for 3 
minutes and resuspended in 10 ml of cool PBS which had been taken from the 
fridge 15 minutes prior to use. 
The pooled cells were counted and after re-pelleting were resuspended at a 
concentration of 108  cells in 0.7 ml of cool PBS. 
The cells were added to the eppendorf tube containing the 0.1 ml (150pg) of 
linearised vector and then immediately transferred to a 0.4 cm electroporation 
cuvette. The cuvette was pulsed in a Bio-Rad Gene Pulsar unit set at 3j.tF, 
0.8kV which gave a time constant of 0.1 msec. 
Twenty 8.5 cm2 plates were gelatin coated whilst the cells were left to recover in 
the cuvette for 20 mm. 
Cells were diluted in 200 ml of medium (without selection) and 10 ml (5 x 106 
cells) of the cell suspension was plated onto each 8.5 cm2 plate and incubated 
over-night. 
On the following day the media was replaced with medium containing 200 jig/ml 
G418. For the first five days the medium was changed daily until most of the 
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cells had died and G418-resistant colonies had started to appear. Then the 
medium was changed every other day. 
(c) Picking G418 resistant colonies 
After about 10-12 days colonies were about 1 mm in diameter and ready to be 
picked. Colonies were circled with a marker pen on the bottom of the dish. 
Enough 24-well plates for the number of colonies to be picked were gelatin 
coated (one colony per well). 
Each 8.5 cm2 plate was rinsed with PBS and then 10 ml of PBS was added. 
Colonies were picked under a dissecting microscope on the bench using flame 
pulled glass pipettes which had been snapped to produce a tapered end of 
approximately 1-2 mm in diameter. Each colony was removed from the dish by 
gentle scraping and suction by mouth and transfer to a 24-well dish in a volume 
of about 100 1.11. Once 24 colonies had been picked, the plate was transferred to 
the laminar flow hood and 100 il of trypsin was added to each well and 
incubated at 37 0C for 10 minutes. The dish was tapped several times to disperse 
the cells and then 2 ml of medium was added to each well. 
To identify Bgal-positive colonies, 4/5 of a nearly confluent well were split into a 
new 24-well plate (Experimental) for staining with X-gal and the remaining 115 
split into a second 24-well plate (Master) for maintenance and subsequent 
expansion of selected cell lines. Since the colonies grow at different rates, the 
cells are split in batches over a period of several days. Cells in the Experimental 
plates are stained with X-gal the following day (see below) and Bgal activity is 
scored after an overnight incubation. By this time the cells on the Master plate 
should be ready to expand for further analysis. (see Section 6.6.1 for X-gal 
protocol) 
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6.4 Blastocyst injections 
Most of the injections of JST lines were performed by W.C. Skarnes. 
The procedure used for blastocyst injection was essentially the same as that outlined in 
(Robertson, 1987). Most of the blastocysts used for the production of chimaeras were 
flushed from mice of the C57BL/6 inbred strain on the fourth day of pregnancy using 
PB1 medium supplemented with 10% FCS (see below). Occasionally, mice of the 
MF1 Swiss albino outbred strain were used. Unexpanded embryos were transferred 
to ES cell medium and placed in a humidified incubator at 37°C with 6% CO2, to allow 
expansion to occur. When required for injection, blastocysts were transferred to small 
hanging drops of PB 1 medium with FCS on a siliconised (Repelcote; BDH) coverslip 
suspended over a manipulation chamber (Custom-made by G. Robertson) flooded 
with liquid paraffin (Boots). Trypsinised cells, generally single cells or pairs, were 
placed in the same hanging drop, and the chamber refrigerated for at least 10 minutes. 
Injections were performed by means of a rounded holding pipette of internal diameter 
20jJm, and a heat-polished, flat-ended injection pipette of internal diameter 15jim, both 
constructed from glass capillary tubing (0.1mm I. D.; Drummond). For these, 
suitable needles were pulled using an electrode puller (Camden Instruments), and cut 
to size and heat-polished by means of a microforge (DeFonbrune). 
Holding and injection pipettes were each attached to instrument holders (Leitz) 
and operated by Leitz manipulators. The suction of the holding and injection pipettes 
were controlled by specialised injectors (Narashige for the holding pipette, 
DeFonbrune for the injection pipette). An IMT2 image-corrected microscope 
(Olympus) was integrated into the micro manipulation assembly. Between 10 and 20 
cells were injected into each blastocyst. Operated embryos were then allowed to 
recover for a few hours in ES cell medium in the incubator before being transferred to 
pseudopregnant recipients. The recipient mothers selected were of an Fl stock from 
matings between C57BL/6 and CBA strains. Fl females had been mated with 
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vasectomised DBA males 2.5 days previously. Unilateral transfers to the uterus were 
performed; each inoculum contained 6 to 12 embryos. 
Contribution of ES cells to resulting pups was estimated by coat colour. When 
blastocysts from C57131/6 mice were used the appearance of sandy coloured, agouti or 
white hairs amongst the host black hairs indicated successful incorporation of the ES 
cells into the resulting individual. Germline transmission was ascertained by test 
breeding. Generation of agouti offspring indicated successful transmission through 
the germline of the ES cells, whereas black offspring were indicative of transmission 
from the host blastocyst. 
PB1 solution (pH7.0-7.2): 	822 mg NaCl 
21 mg 	KC1 
300 mg Na2HPO4 
20 mg KH2PO4 
104 mg Glucose 
4.5 mg Sodium pyruvate 
6.2 mg 	Penicillin 
1.4 mg CaCl2 
1 mg 	MgCl2 
1 ml 	phenol red (1%) 
Made up to 100 ml with UHP H20 
6.5 Sample collection 
6.5.1 	Embryo collection (8.5dpc-10.5dpc) 
Females were mated overnight. Stages of embryos are represented as number of days 
post coitum (dpc), assuming fertilisation to have occurred in the middle of the dark 
period preceding the discovery of the vaginal copulation plug. In PB 1 supplemented 
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with 10% FCS, the embryos were dissected free from the decidual tissue and 
Reichert's membrane was removed. 
	
6.5.2 	Caesarean sections (18.5dpc) 
Caesarean sections were performed on I 8.5dpc pregnant females essentially according 
to the method in (Nagy and Rossant, 1993). Following dissection of neonates from 
the uterus and removal of foetal membranes the umbilicus was cut. The neonates were 
then placed under a heat lamp on a damp tissue. They were prodded gently at intervals 
until they began to breath normally. 
6.5.3 	Lung inflation 
Protocol provided by Gillian Morrison. 
A lethal injection of Euthatol (0. lml) was administered to an adult mouse. The chest 
cavity was opened and the heart removed to expose the lungs. A stretch of ligature 
was wrapped around the trachea and tied in a loose knot. A small incision was made 
in the trachea and a 21gauge needle attached to a syringe was inserted. The ligature 
was secured around the needle to keep it in place and lml of Bouin's fixative was 
injected into the lungs. The needle was quickly removed and the ligature was 
tightened around the trachea so the lungs remained inflated with fixative. The lungs 
were completely dissected from the chest cavity and fixed in Bouin's overnight. 
6.6 Histology 
6.6.1 	Staining cells and embryos for 3gal activity 
Based on the protocol in Beddington et al, 1989 
Solutions for X-gal staining: 
X-gal (5-Bromo-4-chloro-3-indolyl-3-D-ga1actopyranoside) 
Stock solution, 50 mg/mI, dissolved in dimethylformamide (Sigma). Store in the 
dark at -200C 
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Phosphate Buffer (0. 1M) 
Made by adding 21 parts of 0.1M Na2HPO4 (Sigma) to 4 parts 0.1M NaH2PO4 
(Sigma) to give a final pH 7.5. 
Phosphate buffer stock (5X) store at room temp, do not autoclave 
298.1 g Disodium hydrogen phosphate anhydrous 
55.2 g Sodium dihydrogen phsphate.1H20 
10.2 g Magnesium chloride.6H20 
Bring to 5 litres in dH20 
Fix store at 40C for up to 1 month 
Dilute stock 1 to 5 (200m1 5X stock to 1 litre final) 
Add to 1 litre, 8 ml 25% gluteraldehyde 
20 ml 0.25M EGTA 
Wash store at 40C 
Minus detergent: 	Dilute stock 1 to 5 (200m1 5X stock to 1 litre final) 
Plus detergent: 	Dilute stock 1 to 5 (200m1 5X stock to 1 litre final) 
10 ml 	10 % deoxycholate stock solution 
2m1 	10%NP40 
0.5 ml 	0.05 % BSA 
X-gal staining solution store in the dark at 4 0C. Filter before use to remove 
crystals. To 50 ml of X-gal wash buffer add: 
Potassium ferrocyanide (Sigma) 	 0.106g 
Potassium ferricyanide (Sigma) 	 0.082g 
X-gal (50 mg/mI in Dimethyl formamide) 	1 ml 
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I . 	Cells and embryos were washed in PBS and fixed for 5 minutes (cells), 15 
minutes (8.5dpc embryos) or 30 minutes (9.5dpc embryos) at room temperature. 
Cells were washed 3 times for 5 minutes (wash buffer - detergent), embryos 
were washed 3 times 20 minutes (wash buffer + detergent) 
Cells and embryos were left to stain in X-gal solution overnight in a humidified 
chamber at 37 0C. 
After staining, cells and embryos were rinsed in wash solution and stored in 4% 
paraformaldehyde as this treatment was found to intensify the stain. 
6.6.2 	Cryostat sections 
(a) Treatment of slides 
Glass slides (Chance Popper) were treated with 2% TESPA (3-
aminopropyltritheoxysilane; Sigma, A3648) in acetone for 2 minutes. 
The slides were then rinsed twice in acetone for 2 minutes and stored desiccated 
at 40C for up to one month. 
(b) Treatment of tissue 
Freshly dissected embryos were embedded in OCT compound and frozen at 
-20C overnight. 
The next day samples were transferred to -70 0C. 
Before sectioning, the frozen embryos were transferred to the cryostat and 
allowed to equilibrate to the cutting temperature for about 1 hour. 
Embryos were sectioned at -14°C and sections were immediately transferred to 
TESPA coated slides. 
Sections were then stained for flgal activity using the same conditions as for cells 
in Section 6.6.1. 
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6. 	After overnight staining sections were either counter stained with neural red (see 
below) or post-fixed for 1 hour and mounted under coverslips using Moviol 
(Hoechst). 
(c) Neutral red counter staining 
Neutral red was used to stain the nuclei of X-gal stained sections 
After overnight staining in X-gal solution (Section 6.6. 1) sections were washed 
three times in X-gal wash buffer and then stained for 30 minutes in Neutral red 
(1%, pH3.3). 
Sections were dehydrated as follows: 
3x 5 minutes 30% Ethanol 
2x 5 minutes 70% Ethanol 
5 minutes 	95% Ethanol 
5 minutes 	100% Ethanol 
5 minutes 	propanol 
3 	After 5 minutes in histoclear sections were mounted under coverslips using DPX 
mountant (BDH, 36125) 
6.6.3 	Wax sections 
(a) Fixing, dehydrating and embedding 
Bouin's reagent (BDH) was used to fix samples which were going on to be analysed 
for histology and for elastin staining. Buffered formalin was used to fix samples 
which were going on to be analysed by immunohistochemistry. Freshly dissected 
tissues were fixed overnight and then processed for paraffin wax embedding in an 
automatic tissue processor (Shandon, Citadel 2000). 
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Tissues were placed through the following solutions as described below: 
70% ethanol 1 hour 
80% ethanol 1 hour 
90% ethanol 1 hour 
100% ethanol 1 hour 
100% ethanol 2 hours 
100% ethanol 2 hours 
histoclear 1 hour 
histoclear 1 hour 
histoclear 1 hour 
wax 3 hours 
wax 4 hours 
Sections were embedded in wax using an embedder (Blockmaster III, Raymond 
Lamb). 7-1Opm wax sections were deposited on polylysine coated microscope slides 
(BDH). 
(b) Haematoxylin and Eosin staining 
Haematoxylin (1:3 in water) was used to stain nuclei and eosin (made in 70% EtOH) 
to stain cytoplasm. Harris haematoxylin solution (Sigma) was diluted 1:3 in water. 
Eosin was made by mixing 3 parts 1% eosin to 1 part 1% ethanol and adding acetic 
acid to give 0.05% final concentration. Sections were treated in histoclear for 5 
minutes, rehydrated through an ethanol series of 100%, 96%, 90% and 70% for 5 
minutes each and then stained in haematoxylin for 30 seconds. Sections were rinsed 
briefly in tap water and stained in eosin for 90 seconds. After another brief wash in 
water, sections were dehydrated through the same ethanol series as before, but in the 
reverse order. Finally, sections were treated in histoclear for 5 minutes before 
mounting in DPX. 
126 
Elastin and Van Geison stain 
Miller's elastin and Van Geison's stain were from Raymond A. Lamb. The protocol 
was provided by Pauline Lamb. Sections were de-waxed in xylene for 5 minutes and 
then placed in 100% ethanol for 5 minutes prior to staining in Miller's elastin for 2 
hours. After a 100% ethanol and a water rinse, sections were stained in Van Geison's 
for 5 minutes. Sections were dehydrated through an ethanol series (see above), 
cleared in xylene for 5 minutes and mounted under coverslips using DPX mountant. 
The sections stain elastin a blue/black colour, muscle is yellow and collagen red. 
Antibody staining 
Immunohistochemistry was performed using the Vector Elite ABC system (Vector 
Labs). The protocol used was adapted from the manufacturers recommendations by 
Euan Slorach. 
Formalin fixed sections were de-waxed in Xylene and rehydrated through an 
ethanol series of 100%, 90%, 70%, 50% and 30% for 5 minutes each. After 5 
minutes in water, the endogenous peroxidase activity was blocked by treating 
with hydrogen peroxide (3% in methanol) for 10 mins. 
Sections were rinsed gently with TBS (Iris  Buffered saline, 0.05M Tris HC1 
(pH 7.6), 0.15M NaCI), using a wide bore plastic pastette and washed for 5 
minutes in TBS. 
TBS was removed and blocking serum was added to sections for 20 minutes. 
Serum was removed and, without rinsing, the primary mouse antibody in 
blocking serum solution was added to sections and left for 30 minutes at room 
temperature. (Monoclonal anti-a-smooth muscle actin, Sigma A-2547 was used 
at 1:400 dilution). 
Antibody was removed and sections rinsed with TBS, followed by a 5 minute 
wash in TBS. 
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Biotinylated antibody (made up in TBS with blocking serum) was added for 30 
minutes. During this incubation step the ABC solution was mixed and left to 
stand for 30 minutes. 
Biotinylated antibody was removed and sections rinsed with TBS, followed by a 
5 minute wash in TBS. 
TBS was removed and the ABC solution was added to sections for 30 minutes 
Sections were rinsed in TBS and then washed for 5 minutes in TBS 
TBS was removed and peroxidase activity was visulaised using a DAB substrate 
kit (Vector labs). 
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27/59 (46%) restricted expression at 9.5dpc. 
In the 2 cases analysed expression of endogenous genes 
was more widespread than reporter activity. 
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splice acceptor (ie compared to pGT4.5) 
In 8.5dpc embryos 13% of lines show restricted patterns, 
32% widespread expression and 55% show no expression 
Between 8.5-12.5dpc 28 % of embryos show restricted 
expression patterns 
In an induction screen 0.6% lines respond to retinoic acid 
treatment in vitro, of these 95% show restricted expression 
in embryos between 8.5-11 .5dpc 
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(Skarnes eta!, 1995 
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unpublished results) 




N.D. 	Between 8.5-12.5dpc 77 % of embryos show restricted 
expression patterns 
27% 	Broad range of 3gal staining intensities and lower number of 
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71% of lines show similar reporter expression in heart 
[49/64] 	[6/15] and liver. Postulated preferred integration site. 3/3 
integrations map to same region of same chromosome. 
30% 	N.D. 
75% 	N.D. 	Three fold more G418 colonies are obtained when 
an IRES is added to pSA3geo. No embryo 
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Polv A traD vectors 
Ui 	
I gIoSA 	IactInI:: 	I 	 16.1 % 	N.D. (Niwa eta!, 1993) 	 [11/68] ATG 
U2 	 i gio SA' 	 act inl , ., 	I 	 7.7% 	N.D. 
(Niwaetal, 1993) 	 [9/1171 pA ATG 
pPAT 	 _____________________________ 
(Yoshida et al, 1995) 	I fvn SA IPGK V 	I fyn SD I 	8% 	0/1 
pA 	 [4/49] 
4/4 insertions into promoter regions 
2/2 insertions asociated with >10kb genomic deletion 
2-20 bp of vector (inc SA) deleted before insertion 
3' RACE succesful in 25 % of 0418 lines 
4/6 lines analysed represent proper gene trap events 
which pick-up a pA signal 
1' promoter 
J3geo (fusion between lacZ and 
neomycin phosphotransferase) 
TM 
 transmembrane domain 
from CD4 
u:u:u histididinol dehydrogenase 
nuclear transport signal 
phleomycin 
hsp68 mouse heat shock protein 68 
ATG initiation methionine 
tk thymidine kinase 
En-2 SA engrailed-2 splice acceptor E 	Gre recombinase  
fos SA c-fos gene splice acceptor 
glo SA rabbit f3-globin splice acceptor 
fyn SA fyn splice acceptor 
fyn SD fyn splice donor 
pgk phosphoglycerate kinase-] 
3X SA splice acceptor of MoMuLV env gene 
allowing splicing products in all three reading frames 
hBA human /3-actin 
LTR long terminal repeat 
vir SA adenovirus major late transcript splice acceptor 
* point mutation known to reduce neomycin 
activity (Skarnes eta!, 1995) 
zpfSA zinc finger protein 40 
IRES internal ribosomal entry site from encephalomyocarditis virus 
Ed ______ Lac Z 
neomycin 
Appendix II 
5'RACE sequence for JST lines 
JST51 (LDL receptor) 
1 ccgtgtcagccgatgcattcctgactcctggagatgtgatgganaggtagactgtgaaaa 60 
R VS R CI PD SW R CD G ? V DC EN 
SA 
.1 
61 tgactcagacgaanaaggctgtcgtcccagg 91 
D SD E ? G C 	PR 
JST62 (novel, myeloblast CDNA) 
1 accattctccagcagctggattcccaggcctgcacctcagaaaaccagaagtctgaggag 60 
TI L Q Q 	D S 	ACT S E N Q K SEE 
'I, 
61 aatgaacagacagaggaggggaagccaagcgccattgaaggtcccaggtccc 112 
N E 	TEE G K PS Al E G PR S 
JST71 (hsp 86) 
1 gaagaagctttcagagctgttgcggtactacacatctgcttctggggacgagatggtttc 60 
E E A FR A V A V L H IC F W G RD G F 
61 tctgaaggactactgtaccagaatgaaggaaaannagaacnnatctattttatcacaggt 120 
SE G L L Y Q NE G K? E ? I Y FIT G 
121 cccaggtcc 129 
PR S 
JST85 (novel, myeloid cDNA, no open reading frame) 
1 aatggtagtgtctagaaagggtatgtcccttcaagagagaggtgccaatgtccaaccggc 60 
N G S V * KG Y V P SR ER C Q C PT G 
W * CL ER V C P F K REV PM S 	R P 
61 ctaataacaatccaggggggtcactgcgacgttcacagaggaacactgccggggcccaac 120 
LIT I Q G G H C D V HR G T L PG P N 
N N N PG G S L R R S 	RN TAG A Q P 
'I, 
121 cacaagacgactcaataggaggaaggtcccaggtcc 156 
H K T T Q * E E G P R S 	—ga1ORF 
Q D D S I G G R S Q V - myeloid cDNAORF 
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JST136 (p23, 5'UTR) 
1 
1 agncccncccacccgtttgtctgnccctctgccccgttcaccatgtcccaggtccc 56 
? pp T R L S ? P L PR S PC PR S 
JST185 (novel) 
1 tttctgggggctttgggaatattcagtctcagataccctggtgactcctcaaagactgtc 60 
FL GAL G IFS L R Y PG D S S K TV 
61 ctaatggcgctttgtttaatggcgttaccatttatttccgcatcaaacctgttctttcct 120 
L MA L CL MA L P F I S A S 	L F F P 
121 gttggatttgtggttgctgagcgagtactatatgttcctagcatggggttctgtatttta 180 
V G F V VA ER V L Y V P S M G F C IL 
181 gtagcccatggatggcaaaagatttcaaacaaaagtgtgctgaaaaagctctcgtgggtt 240 
V A HG W Q K IS N KS V L K K L SW V 
241 tgtctgtccatggtgatactaacccatgccttgaaaacacttcatagaaattgggactgg 300 
C L S M V I L T H A L K T L H R N W D W 
301 gagtcagnatatacattgtttatgtcagccctaaaggtgaataaaaacaatgccaaatta 360 
ES? Y T L F MS AL K V N K N N A K L 
361 tggaataatgtgggtcatgctctggagaatgagaagaactttgagaaagctttgaaatac 420 
W N N V G H A LEN E K N FE K AL KY 
421 ttcttgcaggctacccatgttcagccaggtcccaggtccc 460 
FL Q AT H V Q PG PR S 
JST191 (novel) 
1 gcgggagccaccgtaccgccgccgcctcccgggtgggcgcccttctccttggacgccggc 60 
A GA TV PP P P PG WA P F S L D AG 
61 gacccaggacgaggtcccaggtccc 85 
D PG R G PR S 
JST197 (non-muscle myosin, 5UTR) 
1 cccgagcgctcgagaaagtccactcggaagaaccagcgcctggttccccgggcagaccca 60 
1 
61 ggttcaggtcccaggtccc 79 
JST203 (3 1-4, galactosyltransferase) 
1 aactgtcttcgttgccagtgcccaccaccactggactgttgtcgctgccagcttgccctg 60 
L SS L P V PT T T G L L S L PA C P E 
61 aggagtccccgctgctcggtcccaggtccc 90 
E S P L L G P R S 
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JST213 (murine DNAJ-2) 
1 tatgatcagncagctggcnccaggaatggtgcagcagatgcagtccgtgtgctccgactg 60 
MI? Q LAP GM V Q Q M Q S V CS DC 
61 taatggagaaggtcccaggtccc 83 
N GE G PR S 
J5T219 (murine fat) 
1 ggccgttgacgcgaatgagaacctacacactccggtgttctccagctttnaagagaaggg 60 
A V DANE N L H T P V F S SF? E KG 
61 tatagtgaaagaagacgtccctactggctcatcagtcatgaccgtgtcagctcacgacga 120 
IV K ED VP T G SS V MT VS A H D E 
121 agacacaggcagagacngagagatccggtattccattagagatggctctggaattggtgt 180 
D T G RD ? El R Y SIR D G S GIG V 
181 cttcaggatagatgaagaaacaggtgtnatagagacttcagaccgactggatagagagtc 240 
F RIDE E T G VIE T SD R L DR ES 
241 gacttcccactactggctcacggtctatgccacagatcagggcgtggtgcctctgtcgtc 300 
T SHY W L TV Y AT D Q G V VP L SS 
301 cttnatagaggtctacatagaggtggagggtgtcaatgacaacgcgccacagacatcaga 360 
? 1EV Y 1EV E G V N DNA P Q T SE 
361 acccgtgtactatccagaaatcatggaaaactcacccaaggatgtatctgtggtccagat 420 
P V Y Y P El MEN S P K DV S V V Q I 
421 tgaggcttttgacccggattctagctccaatgacaaactgacatacagaattacaagcgg 480 
E A F D PD S S S ND K L T Y 	ITS G 
'I, 
481 gaaccctcaaggattcttctcaatacatcctaagacaggtcccaggtccc 
NP Q G F F S I HP K T G PR S 
J5T232 (RBP-JK pseudogene) 
1 
1 ccctgactctaggcgtctgcttaacccggcttctcaaatgttggnctataggtcccaggt 60 
L T L G V CL T R L L K C W ? I G PR S 
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Appendix III 
LM-PCR and 5'RACE sequence for ET lines 
I2. (5'ETS) LM-PCR sequence 
1 tagtctagaggccagatctgaattccggtttgtcctccgcgagctctccgccgccgccgc 60 
Fusion to vector 
CD4 
61 ctcctcctcctctctcgcgctctcngtcccgcctggtcctgtcccacccnacgggtgctt 
ET50 (novel) LM-PCR sequence 
1 ctagatctgattcgcccagcgccgcctccgcccgcccgcccgagcaaagtttgatgcgaa 60 
61 cacggcgtgctctaagagctgggtaaactttaggtgcacgaggggcacttaaaaaaaaag 120 
ET80 (novel) 5 RACE sequence 
1 ccgnacagacaaagggacagngagacagacagacagagtcagagagacagagaggtcaat 60 
P ? R Q RD ? E T DR Q S 	RD REV N 
.1 
61 aagacctgtgag 
K T CE 
ET94 (28S rRNA) LM-PCR sequence 
1 gcggagtaactatgactctcttaaggtagccaaatgcctcgtcatctaattagtgacgcg 60 
1 
61 catgaatggatgaacgagattcccacctggctgtcgtgctg 
ET105 (novel) LM-PCR (identical to 5RACE sequence but longer) 
1 ggagttcaagagttgtagaggacagagcatttcagtagattcacaagcagtgatacagaa 60 




ET124 (28S rRNA) 5RACE sequence 
1 cgctgtccttccctattaacactaaggacactagaagagaccctttcgatttaaggctgt 60 
61 tttgcttgtccagcctattctttgtgtcaggtgccgg 
ET138 (novel) LM-PCR (identical to 5 RACE sequence but longer) 
1 aagacaccgtgctcgcgagacttgctgttttccccaattattcttatnttagttgagttt 60 
61 ttatttttagtttctttttaggtttttagagaagggtttctctaagctcactctgtagag 120 
121 caggcaggcctcggactcagagatccacctgacttgatctctggagggtaggtagggatt 180 
181 agaggcctggtggctttgggacagactccaagatccaggttttatccaaa 
ET143 (novel) 5 RACE sequence 
1 atgatggctgattcccagttgactgatgtcaagtcggcttcccagtgcttatattataga 60 
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